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Abstract	
Neural	 crest	 cells	 are	 a	 transient	 cell	 population,	 which	 migrates	 through	 the	
vertebrate	embryonic	body,	and	eventually	gives	rise	to	a	many	different	cell	types	
in	the	adult.	Contact	inhibition	of	locomotion	(CIL)	is	a	fundamental	property	of	the	
collective	 migrating	 neural	 crest	 cells.	 CIL	 describes	 a	 process	 by	 which	 colliding	
cells	change	their	direction	upon	collision	and	move	away	from	each	other,	which	
has	 been	 linked	 to	 cell	 dispersion,	 boundary	 formation	 and	 metastasis.	 CIL	 is	
acquired	in	neural	crest	cells	during	Epithelial-to-Mesenchymal-Transition	(EMT),	by	
a	 switch	 in	 the	 expression	 of	 cadherins,	 from	 E	 to	 N-cadherin.	 To	 examine	what	
governs	 this	 change	 I	 study	 PDGF	 signalling	 during	 Xenopus	 laevis	 cranial	 neural	
crest	migration.	Here	 I	 show	 that	PDGFRα	and	 its	 ligand	PDGF-A	are	expressed	 in	
pre-migratory	and	migrating	cranial	neural	crest	cells.	Inhibition	of	PDGF-A/PDGFRα	
impairs	neural	crest	migration	in	vivo	and	cell	dispersion	in	vitro.	I	find	that	PDGFRα	
inhibition	 leads	 to	 a	 decrease	 of	N-cadherin	 levels	 in	 neural	 crest	 cells.	 Further,	 I	
demonstrate	 that	 PDGFRα	 signalling	 controls	 N-cadherin	 dependent	 CIL.	 This	
cellular	response	is	controlled	by	the	PI3K/AKT	signalling	pathway	as	a	downstream	
effector	of	the	PDGFRα	cellular	response	in	cranial	neural	crest	cells.	This	data	lead	
me	to	propose	a	novel	mechanism	by	which	PDGF	signalling	as	a	tissue-autonomous	
regulator	of	EMT	is	regulating	N-cadherin	dependent	CIL	during	cranial	neural	crest	
cell	migration	in	Xenopus	laevis.	
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1.1 The	Neural	Crest	
The	neural	crest	 is	a	 transient,	migratory	cell	population	unique	to	 the	vertebrate	
embryo.	Also	referred	to	as	the	fourth	germ	layer,	the	neural	crest	 is	a	vertebrate	
synapomorphy	that	divides	vertebrates	from	other	metazoans	(Gans	and	Northcutt,	
1983).	Swiss	embryologist	Wilhelm	His	(1986)	was	the	first	to	described	the	neural	
crest	 in	 the	 chick	 embryo	 calling	 it	 the	 “the	 intermediate	 cord”	 (German:	
Zwischenstrang).	He	was	referring	to	a	thin	band	of	cells	at	the	interface	between	
the	 neural	 epithelium	 and	 surface	 ectoderm.	 After	 induction	 neural	 crest	 cells	
delaminate	from	the	neural	tube	and	undergo	an	extensive	migration	through	the	
embryonic	 body.	At	 their	 target	 destination	 they	differentiate	 and	 give	 rise	 to	 an	
array	of	different	cell	types,	including	cartilage	and	bone	of	craniofacial	structures,	
neurons	and	glia	of	the	peripheral	nervous	system,	pigment	cells,	cardiac	structures	
and	endocrine	cells	 (Figure	1-1;	 reviewed	 in	Theveneau	and	Mayor,	2012).	Due	to	
this	wide-ranging	set	of	derivatives,	 their	stem	cell	properties,	and	their	extensive	
migratory	capabilities	scientists	have	used	neural	crest	cells	extensively	as	a	model	
system	(Theveneau	and	Mayor,	2012).	
The	neural	crest	 is	 comprised	of	 several	populations	 that	are	determined	by	 their	
rostral-caudal	location	and	thus	their	migratory	path	along	the	embryonic	body.	The	
different	neural	 crest	 cell	 populations	 are	 termed:	 cranial,	 vagal	 and	 trunk	neural	
crest	 cells.	The	subpopulation	of	 cranial	neural	 crest	 cells	migrates	along	a	dorso-
lateral	route	through	the	pharyngeal	arches	and	gives	rise	to	craniofacial	structures	
as	cartilage,	bone,	cranial	neurons	and	glia,	and	connective	tissue.	The	vagal	neural	
crest	cells	specified	at	the	caudal	hindbrain	level,	form	part	of	the	enteric	nervous	
system	and	contribute	to	the	heart.	The	trunk	neural	crest	cells	give	rise	to	sensory	
and	sympathetic	ganglia	and	cells	of	the	adrenal	medulla	among	other	derivatives	
(reviewed	 in	 Barembaum	 and	 Bronner-fraser,	 2005).	 Due	 to	 this	 wide	 variety	 of	
neural	crest	cell	contributions	throughout	the	embryonic	body,	disruption	of	neural	
crest	 cell	 development	 can	 lead	 to	 congenital	 defects	 termed	 neurocristopathies,	
which	 include	 craniofacial	 abnormalities,	 hearing	 loss,	 heart	 malformations	 and	
missing	 enteric	 ganglia	 (Mayor,	 Roberto;	 Theveneau,	 2013).	 Furthermore,	
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similarities	between	neural	crest	cell	development	and	cancer	metastasis,	as	well	as	
wound	healing,	have	proven	 it	 to	be	 interesting	model	 that	may	contribute	 to	an	
understanding	 of	 these	 pathological	 conditions	 and	 future	 therapeutic	 strategies	
(Mayor,	Roberto;	Theveneau,	2013;	Theveneau	and	Mayor,	2012).		
This	 thesis	 focuses	 on	 cranial	 neural	 crest	 cell	 migration	 in	 Xenopus	 laevis.	
Therefore	this	part	of	the	introduction	will	concentrate	on	cranial	neural	crest	cell	
delamination,	epithelial	to	mesenchymal	transition	and	migration.	
	
Figure	1-1	Adult	neural	crest	cell	derivatives	
The	neural	crest	becomes	specified	between	the	surface	ectoderm	and	the	neural	
tube.	Neural	crest	migrate	away	from	the	neuroepithelium	and	give	rise	to	different	
cell	 types	as	depicted	 in	 the	 image	 (neural	 crest	 cell	derivatives	 in	pink).	Adapted	
from	Kaltschmidt	et	al.,	2012.	
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1.1.1 Neural	crest	cell	induction	
The	neural	crest	is	induced	in	a	two-step	process,	which	includes	an	initial	induction	
step	 followed	 by	 a	 so-called	maintenance	 step.	 Induction	 of	 the	 neural	 crest	 is	 a	
complex	 process	 and	 beyond	 the	 focus	 of	 the	 research	 described	 in	 the	 thesis,	
therefore	I	will	only	give	a	brief	 introduction;	for	more	detailed	description	please	
refer	to	the	following	reviews	(Bronner	and	LeDouarin,	2012;	Duband	et	al.,	2015;	
Milet	and	Monsoro-Burq,	2012;	Sauka-Spengler	and	Bronner-Fraser,	2008)).	In	brief,	
neural	 crest	 cell	 induction	 is	 initiated	 in	 the	 ectoderm	 by	 a	 combination	 of	
instructive	 signals	 between	 the	 presumptive	 neural	 plate	 and	 epidermis	 during	
gastrulation.	 These	 involve	 intermediate	 levels	 of	 BMP4	 and	 BMP7	 signalling	 and	
high	levels	of	WNT6/8	or	10a,	FGF3	and	FGF8	and	RA	signalling.	This	induction	step	
leads	 to	 the	 co-expression	 of	 a	 set	 of	 transcription	 factors	 called	 “neural	 plate	
border	specifiers”	 including	Msx,	Pax3/7	and	Zic1,	whose	co-expression	define	the	
neural	 plate	 border	 territory.	 Once	 the	 neural	 crest	 cells	 are	 induced	 they	 are	
maintained	 by	 signals	 from	 the	 intermediate	 mesoderm	 and	 adjacent	 ectoderm,	
which	together	with	the	first	set	of	transcription	factors	activates	the	“neural	crest	
specifiers”.	This	set	of	transcription	factors	includes	Snail/Slug,	FoxD3,	Id,	cMyc	and	
Sox9/10	which	maintain	and	 further	direct	neural	 crest	 cell	development	 towards	
delamination,	 EMT	 and	 migration	 (Bronner	 and	 LeDouarin,	 2012;	 Duband	 et	 al.,	
2015;	Milet	and	Monsoro-Burq,	2012;	Sauka-Spengler	and	Bronner-Fraser,	2008).		
1.1.2 Delamination	and	Epithelial-to-mesenchymal	transition	
Delamination	
Delamination	 is	 the	process	 of	 physical	 segregation	of	 the	neural	 crest	 cells	 from	
the	 neural	 tube.	 It	 is	 also	 been	 referred	 to	 as	 emigration,	 individualization	 or	
segregation	 and	 is	 seen	 as	 the	 final	 step	 of	 specification	 and	 transition	 into	
migration	 (Duband	 et	 al.,	 2015).	 It	 should	 be	 noted	 that	 delamination	 cannot	 be	
interchanged	 with	 Epithelial-to-mesenchymal	 transition	 (EMT),	 a	 process	 of	
molecular	changes	orchestrating	the	transition	from	epithelial	to	mesenchymal	cell	
state	(Thiery	et	al.,	2009;	discussed	in	detail	at	the	end	of	this	section).	Neural	crest	
undergo	 EMT	 in	 order	 to	 acquire	 their	 mesenchymal	 migratory	 properties,	 but	
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delamination,	the	segregation	from	the	neural	tube,	does	not	match	the	timing	of	
EMT	completion	(Theveneau	and	Mayor,	2012).	That	both	are	distinctive	processes	
is	 for	 example	 shown	 in	 trunk	 neural	 crest	 cells,	 where	 entering	 into	 S-phase	 is	
required	 for	 delamination.	However	 inhibition	of	G1/S-phase	 transition	by	noggin	
overexpression	 impairs	delamination	but	does	not	disrupt	EMT	 (Burstyn-Cohen	et	
al.,	2004).	Though,	both	processes	cannot	be	seen	independently	of	each	other,	as	
for	example	Sox9,	which	alone	controls	neural	crest	cell	specification	but	no	EMT.	
However	 Sox9	 together	 with	 Snail2	 can	 start	 EMT	 process	 (Cheung	 and	 Briscoe,	
2003;	Cheung	et	al.,	2005).	
Cranial	neural	crest	cells	delaminate	all	at	once	(Theveneau	and	Mayor,	2012),	and	
in	chick	embryos	onset	of	delamination	overlaps	with	the	closure	of	the	neural	tube	
(Duband	and	Thiery,	1982;	Le	Douarin	and	Kalcheim,	1999;	Théveneau	et	al.,	2007).	
In	 Xenopus	 and	 mouse	 cranial	 neural	 crest	 cell	 delamination	 happens	 while	 the	
neural	 tube	 is	 still	 open	 (Nichols,	 1981;	 Nichols,	 1987;	 Sadaghiani	 and	 Thibaud,	
1987).	 In	contrast,	 trunk	neural	 crest	 cell	delamination	starts	 in	all	animal	models	
after	neural	tube	closure	and	the	cells	leave	the	neural	tube	over	time	as	single	cells	
in	rostral-caudal	wave	(Ahlstrom	and	Erickson,	2009;	Berndt	et	al.,	2008;	Clay	and	
Halloran,	2010;	Duband,	2010).	 It	should	be	noted	that	closure	of	the	neural	 tube	
and	start	of	neural	crest	cell	delamination	are	not	functionally	coupled	(Copp	et	al.,	
2003).		
On	 the	 molecular	 level	 delamination	 is	 orchestrated	 by	 “neural	 crest	 specifier”	
transcription	 factors,	 including	 Snail2,	 Sox9	 and	 FoxD3	 (Sauka-Spengler	 and	
Bronner-Fraser,	 2008).	 When	 overexpressed,	 these	 factors	 are	 able	 to	 induce	
ectopic	neural	crest	cells	(Cheung	et	al.,	2005).	Additionally,	a	recent	report	shows	
that	 temporary	 and	 reversible	 Wnt	 inhibition	 is	 required	 for	 delamination	 in	
Xenopus	and	chick	embryos	(Rabadán	et	al.,	2016).		
Epithelial-to-	mesenchymal	transition		
In	the	neuroepithelial	sheet	the	neural	crest	displays	epithelial	characteristics	with	
apical	basal	polarity	and	strong	intracellular	adhesion	supported	by	a	basal	lamina.	
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In	order	to	start	 their	migration	neural	crest	cells	need	to	undergo	a	change	from	
this	 steady	 epithelial	 to	 a	 migratory	 mesenchymal	 state.	 To	 achieve	 this,	 neural	
crest	cells	undertake	a	molecular	process	termed	EMT.	This	program	includes	a	loss	
of	 apical-basal	 polarity,	 reduction	 of	 intercellular	 adhesion	 and	 acquisition	 of	
migratory	 and	 invasive	 properties	 (Theveneau	 and	 Mayor,	 2012;	 Thiery	 and	
Sleeman,	2006).	 To	 start	 their	migration	neural	 crest	 cells	undergo	a	 complete	or	
partial	EMT	allowing	them	to	emerge	from	the	neural	tube	and	ectoderm.	Complete	
EMT,	 is	 a	 type	 of	 EMT	where	 all	 cells	 of	 an	 epithelium	 undergo	 a	 full	 transition,	
which	 is	 mainly	 observed	 in	 cell	 culture.	 In	 contrast,	 partial,	 progressive	 EMT,	 is	
most	 common	 during	 developmental	 processes,	 as	 trunk	 neural	 crest	 cell	
delamination	(Duband,	2010).	It	is	not	quite	clear	whether	cranial	neural	crest	cells	
undergo	a	complete,	or	a	partial	EMT.	Partial	EMT	occurs	when	one	or	more	of	the	
key	features	of	complete-EMT	are	not	shown,	such	as	 loss	of	cell-cell	contact.	The	
collective	 mode	 of	 cranial	 neural	 crest	 cell	 migration	 suggests	 a	 mixed	 trait	 of	
epithelial	 and	mesenchymal	 character,	 also	 called	 hybrid	 state.	 Hereby	 cells	 only	
undergo	 a	 partial	 transition	 into	 the	 mesenchymal	 fate,	 instead	 of	 completing	
mesenchymal	cell	fate	transition.	(Friedl	and	Gilmour,	2009).	Not	only	the	mode	of	
EMT	in	neural	crest	cells	may	differ	between	subpopulations	and	species,	but	also	
the	onset	of	 the	process	varies.	 In	Xenopus	 laevis	 EMT	occurs	after	delamination,	
permitting	migration	as	a	group	(Theveneau	and	Mayor,	2012).		
A	hallmark	of	EMT	is	the	diminution	of	epithelial	cell-cell	 junction	proteins,	 like	E-
cadherin,	 gap	 and	 tight	 junction	 molecules	 (Thiery	 et	 al.,	 2009).	 E-cadherin	 is	 a	
central	 component	 of	 cell-cell	 adhesions	 and	 is	 prerequisite	 for	 the	 formation	 of	
epithelia.	In	neural	crest	cells	a	change	from	the	strong	adhesion	type	I	cadherin,	E-
cadherin	 to	 weaker	 adhesion	 type	 II	 N-cadherin	 occurs	 at	 the	 end	 of	 neural	
induction	(Dady	et	al.,	2012;	Nandadasa	et	al.,	2009;	Theveneau	and	Mayor,	2012).	
On	 a	 molecular	 level	 transcription	 factors	 of	 the	 “neural	 crest	 specifier”	 set,	
including	Slug/Snail	and	Twist,	repress	expression	of	E-cadherin	and	other	junction	
components	 (Carl	 et	 al.,	 1999;	 Kang	 and	 Massagué,	 2004;	 Nieto	 et	 al.,	 1994;	
Taneyhill	et	al.,	2007).	Therefore,	neural	crest	cells	that	start	migrating	express	N-
cadherin	(Bronner-Fraser	et	al.,	1992;	Theveneau	et	al.,	2010;	Xu	et	al.,	2001)	and	
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low	 levels	of	E-cadherin	 (Barriga	et	al.,	2013).	However	this	change	 is	 followed	by	
another	switch,	from	high	to	low	N-cadherin	expression	and	overlaps	with	the	onset	
of	expression	of	weaker	type	II	cadherins	(6/7/11)	(Chalpe	et	al.,	2010;	Cheung	and	
Briscoe,	 2003;	 Cheung	 et	 al.,	 2005;	 Dottori	 et	 al.,	 2001;	 Kashef	 et	 al.,	 2009;	
Nakagawa	 and	 Takeichi,	 1995;	 Nakagawa	 and	 Takeichi,	 1998).	 This	 change	 is	
controlled	by	an	additional	 set	of	 transcription	 factors	 in	 cranial	neural	 crest	 cells	
including	Snail/Slug,	Foxd3,	Sox9/10,	Ets1,	and	p53	(Cheung	et	al.,	2005;	McKeown	
et	al.,	 2013;	Perez-Alcala	et	al.,	 2004;	Rinon	et	al.,	 2011;	Théveneau	et	al.,	 2007).	
The	timed	expression	of	cadherins	does	not	only	decrease	cell	adhesion	but	is	also	
required	 for	 change	 in	 cell	 polarization.	 For	 example,	 Cadherin6B	 expression	 is	
needed	to	polarize	Rho	GTPases	and	actomyosin	in	zebrafish	trunk	neural	crest	cells	
(Clay	and	Halloran,	2014).	 Likewise,	N-cadherin	has	been	 reported	 to	polarize	 the	
small	GTPase	Rac1	at	the	leading	edge	in	emigrating	neural	crest	cells	(Theveneau	
et	al.,	2010).	Not	only	does	the	expression	of	cadherin	during	neural	crest	cells	EMT	
change,	 neural	 crest	 cells	 also	 express	 metalloproteases,	 such	 as	 ADAM	 10	 and	
ADAM13,	capable	of	cleaving	cadherins.	This	further	reduces	the	cell-cell	adhesion	
properties	 of	 delaminating	neural	 crest	 cells	 and	 increases	 their	 invasiveness	 into	
surrounding	 tissue	 (Neuner	 et	 al.,	 2009;	 Shoval	 et	 al.,	 2007).	 Furthermore	 the	
cytoplasmic	 fragment	 of	 the	metalloproteases	 cleaved	N-cadherin	 translocates	 to	
the	nucleus	and	supports	survival	and	delamination	(Shoval	et	al.,	2007).	In	addition	
to	the	metalloproteases,	a	endogenous	inhibitor	of	matrix	metalloproteases	TIMP2	
is	 also	 required	 for	 neural	 crest	 cell	migration	 in	 chick	 embryos	 (Cantemir	 et	 al.,	
2004)	
Besides	 the	 regulation	 of	 cell-cell	 adhesion,	 the	 transcription	 factor	 set	 also	
promotes	the	acquisition	of	migratory	capabilities	 in	neural	crest	cells	by	 inducing	
expression	of	β1-Integrin	and	the	small	GTPase	RhoB	(Cheung	et	al.,	2005;	McKeown	
et	al.,	2013).	Exogenous	upregulation	of	β1-Integrin	may	lead	to	emigration	through	
integrin-to-cadherin	negative	crosstalk.	In	addition	inhibition	of	integrin	function	in	
chick	neural	crest	cells,	with	RGD	fibronectin-derived	peptides	or	antibodies	against	
β1-Integrin	 and	 β3-Integrin,	 increases	 N-cadherin	 levels	 at	 the	 cell	 junction	 and	
induces	cell	clustering	(Monier-Gavelle	and	Duband,	1997).		
	 22	
Moreover,	 the	 acquisition	 of	 a	migratory	 phenotype	 involves	 the	 cytoskeletal	 re-
organisation,	including	expression	of	intermediate	filament	proteins,	the	change	to	
a	 flatter	 rear-front	 polarity	 and	 the	 ability	 to	 generate	 lamellipodia	 and	 filopodia	
(Theveneau	 and	Mayor,	 2012).	 For	 example,	 in	 zebrafish	 trunk	 neural	 crest	 cells	
onset	 of	 migration	 is	 characterized	 by	 myosin	 II	 and	 Rho-kinase	 (ROCK)	 activity	
blebbing.	Once	migrating,	neural	crest	cells	start	to	produce	robust	lamellipodia	and	
filopodia	that	create	the	traction	required	for	migration	(Berndt	et	al.,	2008)	
Overall	the	EMT	process	is	a	complex	event	that	requires	cell	changes	driven	by	cell	
junction	 alterations,	 cytoskeletal	 re-organisation,	 remodelling	 of	 the	 extracellular	
matrix	and	cellular	polarity	(Thiery	et	al.,	2009).	Interestingly	EMT	is	also	a	hallmark	
in	 cancer	 which	 shows	 similarities	 to	 the	 process	 acquired	 in	 neural	 crest	 cells	
(Theveneau	and	Mayor,	2012).	
1.1.3 Neural	crest	migration	
After	delamination	and	EMT,	neural	crest	cells	start	their	dorso-ventral	migration	to	
reach	 their	 target	 location.	 In	 this	 section	 I	will	 specifically	discuss	mechanisms	of	
collective	 cranial	 neural	 crest	 cell	 migration.	 These	 include	 restriction	 of	 the	
migrating	 neural	 crest	 cells	 into	 discrete	 streams,	 cell-substrate	 interactions,	
chemotaxis,	co-	attraction	and	contact	inhibition	of	locomotion	(Figure	1-2).	
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Figure	1-2	Neural	crest	cell	migration	
Collaborative	 actions	 of	 physical	 restraints,	 contact	 inhibition	 of	 locomotion	 (CIL),	
co-attraction,	 cell-cell	 interactions,	 cell-substrate	 interactions	 and	 chemotaxis	
control	 cranial	 neural	 crest	 cell	 migration	 in	 Xenopus	 laevis.	 Physical	 restraints	
inhibitory	 signals	 guide	 neural	 crest	 cell	 into	 streams.	 CIL	 orientates	 protrusions	
towards	the	neural	crest	cell	 free	space	and	promotes	directionality.	Co-attraction	
prevents	 dispersion	 and	 promotes	 clustering	 of	 the	 stream,	 thus	 developing	
collectivity.	Chemotactic	signals	directs	migration	of	the	stream	towards	the	target	
regions	(figure	adapted	from	Theveneau	and	Mayor,	2012).	
	
	
Physical	restraint	of	the	neural	crest	cell	streams		
Cranial	neural	crest	cells	in	Xenopus	embryos	migrate	away	from	the	neural	tube	in	
three	 defined	 streams,	 mandibular,	 brachial	 and	 hyoid,	 towards	 the	 pharyngeal	
arches	 (Sadaghiani	 and	 Thibaud,	 1987;	 Theveneau	 and	Mayor,	 2012).	 Permissive	
spaces	 in	 the	 pharyngeal	 arches	 might	 support	 splitting	 of	 the	 neural	 crest	 cell	
populations	 (Theveneau	 and	 Mayor,	 2012).	 For	 example	 the	 extracellular	 matrix	
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with	proteins	like	fibronectin	and	laminin	has	been	suggested	to	have	a	permissive	
role	(Perris	and	Perissinotto,	2000;	see	also	section	1.1.3	Cell	substrate	interaction).	
An	 additional	mechanism,	 defined	 as	 “chase	 and	 run”,	 has	 been	 suggested	 to	 be	
involved	in	the	coordination	of	neural	crest	cell	 into	streams.	The	“chase	and	run”	
mechanism	 requires	 chemotaxis	 of	 the	 neural	 crest	 towards	 the	 placodes	 and	
contact	 inhibition	 of	 locomotion	 of	 the	 placodes	 after	 neural	 crest	 cell	 contact	
(Theveneau	et	al.,	2013).	For	a	thorough	discussion	of	the	chase	and	run	mechanism	
see	next	sections	of	this	chapter.		
Nevertheless,	 the	 exact	 subdivision	 of	 the	 streams	 seems	 to	 be	 more	 due	 to	
negative	 and	positive	external	 regulators.	 The	 tissue	 surrounding	 the	neural	 crest	
expresses	non-permissive	ligands,	which	restrict	ectopic	neural	crest	cell	migration.	
This	 exchange	 is	 mediated	 by	 a	 set	 of	 reciprocally	 expressed	 receptor-ligand	
systems,	 whereby	 the	 receptors	 are	 expressed	 in	 the	 neural	 crest	 cells	 and	
corresponding	 ligands	 in	the	surrounding	tissue.	So	far	three	main	receptor-ligand	
groups	mediating	the	restrictive	signal	have	been	described,	namely-	Eph	receptors	
and	ephrin,	Neuropilin	receptors	and	Semaphorin,	Robo	receptors	and	Slit.	These	all	
work	 via	 induction	 of	 cell	 protrusion	 collapse	 to	 ensure	 stream	 formation	
(Theveneau	and	Mayor,	2012).	
Ephs	are	 tyrosine	kinase	 receptors,	which	bind	 to	 their	 corresponding	cell-surface	
associated	 ephrin	 ligands,	 on	 neighbouring	 cells,	 thus	 triggering	 bidirectional	
signalling	(Lisabeth	et	al.,	2013).	The	Ephs	and	ephrins	expressed	by	cranial	neural	
crest	 cell	 and	 surrounding	 tissues,	 vary	 across	 different	 animal	models	 (Adams	et	
al.,	2001;	Davy	et	al.,	2004;	Mellott	and	Burke,	2008a;	Smith	et	al.,	1997).	However	
they	 function,	 as	 restrictive	 signal,	 mediating	 neural	 crest	 cell	 stream	 formation,	
seems	to	be	conserved.	 Indeed,	 the	Eph/ephrin	bidirectional	 signalling	 is	 required	
for	 proper	 formation	 of	 neural	 crest	 cell	 streams	 in	 mouse,	 chick	 and	 Xenopus	
embryos	 (Theveneau	and	Mayor,	2012).	For	example	 in	Xenopus	embryos	ephrin-
B2	is	expressed	in	the	second	branchial	arch	and	acts	as	a	negative	cue	for	neural	
crest	 cells	 that	 are	 set	 to	migrate	 into	 the	 third	 and	 fourth	brachial	 arch,	 as	 they	
express	 the	 corresponding	 receptor	 EphrinA4	 and	 EphrinB1	 (Smith	 et	 al.,	 1997).	
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Indeed,	 in	 Xenopus	 embryos	 where	 this	 Eph/Ephrin	 signalling	 is	 inhibited	 neural	
crest	 cells	 show	 ectopic	 migration	 outside	 their	 normal	 routes	 and	 a	 mixing	 of	
neural	 crest	 cell	 from	different	 streams	occurs	 (Smith	 et	 al.,	 1997).	 This	 indicates	
that	Eph/Ephrins	not	only	have	a	non-permissive	role,	but	also	a	sorting	function	of	
neural	 crest	 cell	 into	 their	 separate	 streams	 depending	 on	 their	 rostro-caudal	
location.	Inhibition	of	Ephrins,	specifically	of	EphrinB1	leads	to	ectopic	neural	crest	
cell	migration	in	normally	non-permissive	areas	in	mouse	and	chick	embryos	(Davy	
et	 al.,	 2004;	Mellott	 and	 Burke,	 2008b).	 Additionally,	 to	 their	 role	 cranial	 neural	
crest	cell	migration,	Eph/Ephrins	are	also	essential	to	limit	migration	of	trunk	neural	
crest	 cells	 to	 the	 anterior	 part	 of	 the	 somites	 (Krull	 et	 al.,	 1997;	 Santiago	 and	
Erickson,	2002).		
Similar	 to	 the	 Eph/Ephrins	 are	 the	 neuropilin/plexin	 receptors	 and	 their	 ligands	
semaphorins	expressed	in	a	reciprocal	way	in	the	neural	crest	cells	and	surrounding	
tissue	 and	 exert	 restrictive	 signals	 to	 the	 neural	 crest	 cell.	 Neuropilins	 have	 to	
associate	with	members	of	the	plexinA	family	to	convey	the	intracellular	signalling	
after	 binding	 of	 the	 semaphorin	 ligand	 (Jackson	 and	 Eickholt,	 2009).	 Also	
neuropilins	and	semaphorins	are	expressed	in	a	reciprocal	way.	Class	3-semaphorin	
family	members	 (3A,	 3F	 and	 3G),	 are	 expressed	 in	 tissues	 adjacent	 to	 the	 cranial	
neural	crest	cell	streams.	Their	correlated	neuropilin	receptors	(Npn1	and	Npn2)	are	
expressed	 by	 the	 cranial	 neural	 crest	 cells	 (Eickholt	 et	 al.,	 1999;	 Gammill	 et	 al.,	
2007;	 Koestner	 et	 al.,	 2008;	 Osborne	 et	 al.,	 2005;	 Yu	 and	Moens,	 2005).	 Indeed,	
mutation	of	Npn2	or	Sem3F	in	mouse	embryos	causes	ectopic	migration	of	cranial	
neural	 crest	 cells	 into	 normally	 non-permissive	 areas	 (Gammill	 et	 al.,	 2007).	
Interestingly,	in	Xenopus	embryos	Neuropilins	and	Semaphorins	are	both	expressed	
in	the	cranial	neural	crest	cells	and	surrounding	tissue	(Koestner	et	al.,	2008).	So	far,	
no	functional	studies	of	semaphorin-neuropilin	interactions	in	Xenopus	laevis	have	
been	 done	 so	 far.	 However,	 the	 complementary	 expression	 patterns	 of	 both	
Sema3A/Nrp1	 and	 Sema3F/Nrp2	 are	 preserved	 in	 vertebrates	 across	 hundreds	 of	
millions	 of	 years,	 possibly	 showing	 a	 conserved	 role	 in	 the	 guidance	 of	migrating	
neural	crest	cells	(Koestner	et	al.,	2008).	
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The	 third	 receptor-ligand	 system	 that	 restricts	 the	 neural	 crest	 cell	 migration	 to	
their	 streams	 is	 the	Robo/Slit	 system.	Hitherto	 a	 role	 for	Robo/Slit	 has	been	only	
investigated	 in	 trunk	neural	 crest	 cells.	Here,	Slit/Robo	signalling	was	 found	 to	be	
necessary	 to	 confine	 neural	 crest	 cells	 to	 the	 ventral-medial	 migratory	 pathway,	
thus	preventing	premature	dorso-lateral	migration	(Giovannone	et	al.,	2012;	Jia	et	
al.,	2005).		
Polarization	of	migrating	cells:	Rho	GTPases	
In	 general	 collective	 cell	 migration	 is	 driven	 by	 lamellipodia	 and	 filopodia	 in	 the	
leading	front	and	suppression	of	these	protrusions	in	the	follower	cells.	To	establish	
this	cellular	polarity	a	central	role	has	been	attributed	to	members	of	Rho	GTPases	
family,	 specifically	 -RhoA,	 Rac	 1	 and	 Cdc42.	 Small	 GTPases	 of	 the	 Rho	 family	 are	
main	 regulators	 of	 the	 actin	 and	 microtubule	 cytoskeletal	 dynamics	 and	 their	
activity	 needs	 to	 be	 tightly	 regulated	 to	 coordinate	 the	 complex	 cytoskeletal	
machinery	 that	 is	 required	 for	 efficient	 cell	 migration	 (Mayor	 and	 Etienne-
Manneville,	 2016;	 Ridley,	 2015).	 Small	 GTPases	 of	 the	 Rho	 family	 are	 molecular	
switches,	which	change	from	an	active	GTP-bound	and	to	an	inactive	GDP-unbound	
state.	 The	 GDP/GTP	 exchange	 is	 mediated	 by	 Guanine	 Exchange	 Factors	 (GEFs),	
such	 as	 SCRIB,	 TIAM1	 or	 PAR3,	 which	 mediate	 small	 GTPase	 activation.	 GTPase	
Activating	 Proteins	 (GAPs)	 on	 the	 other	 side	 can	 mediate	 inactivation	 of	 the	
GTPases	(Bos	et	al.,	2007;	Ridley,	2015).		
In	 general,	 Rho	GTPases,	 Rac	 and	 Cdc42	 induce	 cytoskeletal	 rearrangements	 that	
polarize	a	single	migrating	cell.	Rac	and	Cdc42	induce	membrane	protrusions	at	the	
front,	 by	 inducing	 actin	 polymerization	 and	 promotion	 of	 protrusion	 engagement	
with	 integrins	and	the	ECM	(Ridley,	2015;	Ridley	et	al.,	1992).	 In	order	to	regulate	
cytoskeletal	rearrangement	Rac1	controls	protein	complexes	such	as	the	Scar/Wave	
complex,	which	 induces	 actin	 polymerization	 via	N-WASP-Arp2/3	 actin	 nucleation	
complex	 (Ridley,	 2015).	 Cdc42,	 however	 is	 controlling	 actin	 polymerization	 at	 the	
very	front	of	the	cell	during	filopodium	formation	(Itoh	et	al.,	2002).	At	the	rear	Rho	
induces	 stress-fibre	 formation	 and	 activates	 the	 Rho-associated	 kinase	 (ROCK),	
which	promotes	acto-myosin	contraction	and	protrusion	collapse,	via	triggering	of	
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phosphoinositides	 phosphatase	 (PTEN)	 activation	 (Chrzanowska-Wodnicka	 and	
Burridge,	1996;	Ridley,	2015;	Ridley	and	Hall,	1992;	Ridley	et	al.,	1992).	 In	general	
this	mutual	exclusive	activity	establishes	a	 front	 to	rear	polarity	and	consequently	
allows	 directional	migration	 (Mayor	 and	 Etienne-Manneville,	 2016;	 Ridley,	 2015).	
Mutual	exclusion	of	Rac1	and	RhoA	is	a	complex	process	but	in	a	simplified	model,	
Rac1	 inhibits	 RhoA	 at	 the	 front,	 by	 triggering	 p190RhoGAP	 activity	 (Bustos	 et	 al.,	
2008).	 At	 the	 rear	 of	 the	 cell	 RhoA	 inhibition	 of	 Rac1	 is	 mediated	 via	 ROCK	
phosphorylation	 of	 FilGAP,	 which	 inactivates	 Rac1	 (for	 overview	 see	 Figure	 1-3;	
Ohta	et	al.,	2006).	Although,	a	transient	activity	of	RhoA,	associated	with	cycles	of	
protrusion	collapses	has	also	been	observed	at	the	cell	front	(Machacek	et	al.,	2009;	
Pertz	et	al.,	2006).	
A	 similar	 mechanism	 as	 for	 single	 cell	 migration	 is	 used	 for	 collective	 migration,	
however	 cellular	 contacts	 change	 the	 classical	 Rho	 GTPase	 distribution.	 The	
contacts	involve	the	leader	cells	at	front	of	the	cluster	and	follower	cells	at	back	and	
middle.	 Follower	 cells	 are	 exposed	 to	 different	 cues	 as	 leader	 cells,	 for	 example	
chemoattractants	and	ECM	of	surrounding	cells	(Krause	and	Gautreau,	2014;	Mayor	
and	Etienne-Manneville,	2016).	Depletion	of	small	Rho	GTPases	in	neural	crest	cells	
in	 various	 animal	 models	 lead	 to	 inhibition	 of	 migration,	 indicating	 their	
requirement	 (Berndt	et	al.,	2008;	Clay	and	Halloran,	2013;	Groysman	et	al.,	2008;	
Liu	and	Jessell,	1998;	Matthews	et	al.,	2008;	Phillips	et	al.,	2012;	Rupp	and	Kulesa,	
2007;	 Shoval	 and	 Kalcheim,	 2012;	 Stewart	 et	 al.,	 2007;	 Thomas	 et	 al.,	 2010).	
Analysis	 of	 their	 activity	 distribution	 in	 Xenopus	 and	 Zebrafish	 neural	 crest	 cells	
showed	the	mutual	exclusive	behaviour	of	both,	increased	Rac1	activity	at	the	front	
and	 increased	RhoA	activity	 at	 the	back	 (Carmona-Fontaine	et	 al.,	 2011;	Clay	 and	
Halloran,	 2013;	 Matthews	 et	 al.,	 2008;	 Theveneau	 et	 al.,	 2010).	 In	 Xenopus	
collective	neural	crest	cell	migration,	Rac1	activity	is	polarized	to	the	leading	edge,	
where	 it	 has	 been	 shown	 to	 promote	 lamellipodia	 formation	 (Matthews	 et	 al.,	
2008;	Scarpa	et	al.,	2013;	Theveneau	et	al.,	2010).	Indeed,	the	localized	activation	of	
Rac1	in	a	neural	crest	cell-cell	duplets	at	the	free	edge	leads	to	protrusion	formation	
and	 increased	 separation.	 Whereas	 the	 activation	 of	 a	 dominant	 negative	 form	
inhibits	protrusion	formation	and	impairs	separation	(Scarpa	et	al.,	2015).	As	RhoA	
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and	Rac1	mutually	inhibit	each	other,	RhoA	is	active	at	the	cell-cell	contact	in	neural	
crest	cells	(Mayor	and	Etienne-Manneville,	2016).	This	inhibition	is	dependent	upon	
the	activation	of	 the	non-canonical	Wnt-planar	 cell	polarity	 (PCP)	pathway	by	 the	
cell-cell	 contact	 via	 the	 process	 called	 contact	 inhibition	 of	 locomotion	 (CIL)	
(Carmona-Fontaine	 et	 al.,	 2008b;	 Matthews	 et	 al.,	 2008;	 Mayor	 and	 Theveneau,	
2014).	Notably,	 the	cell–cell	 contact	during	CIL	of	neural	 crest	cells	 leads	 to	RhoA	
stimulation	 and	 Rac	 inhibition	 at	 the	 site	 of	 cell	 contact	 (Matthews	 et	 al.,	 2008;	
Teddy	 and	 Kulesa,	 2004;	 Theveneau	 et	 al.,	 2010).	 The	 connection	 and	 regulation	
between	 Wnt-PCP	 and	 CIL	 will	 be	 discussed	 in	 detail	 later	 in	 this	 chapter	 (see	
Contact	inhibition	of	locomotion).		
	
Figure	1-3	Cell	polarity	and	Cytoskeletal	organization	in	migratory	cell.	
A	migratory	cell	has	polarised	distribution	of	small	GTPases	Cdc42,	Rac1,	and	RhoA.	
At	 the	 protrusion	 front,	 Rac1	 activity	 regulates	 lamellipodium	 formation	 by	
promoting	actin	assembly	(yellow	lines).	Cdc42-GTP	controls	actin	polymerisation	in	
the	 filopodium.	 Rac1	 and	 Cdc42	 at	 the	 front	 regulate	 the	 formation	 of	 cell–
substrate	adhesions	(red	dots).	At	the	back	of	the	cell,	RhoA	activity	promotes	actin-cells perform u-turns, rather than repolarize, in order to migrate toward the
attractant (Xu et al., 2003; Zigmond, Levitsky, & Kreel, 1981). These obser-
vations suggest that, in these cells, planar polarity is established intrinsically—
the chemotactic signal merely provides guidance.
During collective migration cells also migrate by following external cues,
however, cells within the group are actively communicating and coordinat-
ing their migration. These communications are described as an emergent
feature of cadherin-based cell contact and confer polarity and directionality
to the migratory group (Friedl, Hegerfeldt, & Tusch, 2004; Rørth, 2012;
Winklbauer, Selchow, Nagel, & Angres, 1992).
Figure 3 Small GTPases controlling cell polarity and cytoskeletal reorganization.
A migratory cell shows polarized activities of Cdc42, Rac1, and RhoA small GTPases.
At the rear of the polarized cell, RhoA activity (pail purple (light gray in the print version)
in the gradient) promotes contractile activity by influencing the for ation of stress
fibers (yellow (white in the print version) stripes) and mature cell–substrate adhesions
(red (dark gray in the print version) ellipses). Toward the front of the cell Rac1 activity
controls lamellipodium formation by promoting actin assembly (yellow (white in the
print version) lines) and the formation of nascent cell–substrate adhesion (red (dark gray
in the print version) dots). At the very front of the polarized cell, Cdc42 is thought to
control filopodium and nascent adhesion formation.
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myosin	 contractility	 via	 the	 formation	 of	 stress	 fibres	 and	 mature	 cell–substrate	
adhesions.	Adapted	from	Barriga	and	Mayor,	2015.		
 
Cell	substrate	interaction	
During	migration,	interaction	with	the	underlying	ECM	is	crucial	to	allow	traction.	At	
the	 leading	 edge	 lamellipodia	 are	 associated	 with	 the	 ECM,	 which	 leads	 to	 the	
stabilization	 of	 actin	 flow	 and	 eventually	 cell	 protrusion	 formation.	 At	 the	 rear,	
anchoring	 cell–ECM	 contacts,	 allow	 actin-myosin	 mediated	 cell-retraction.	 These	
cell-substrate	 contacts	 are	 mediated	 via	 specific	 protein	 complexes	 named	 focal	
contacts	(Abercrombie	and	Dunn,	1975;	Izzard	and	Lochner,	1976;	Mui	et	al.,	2016).	
At	the	cell	front,	focal	contacts	stabilize	the	protrusions,	whereby	Rac1	is	required	
for	 the	 assembly	of	 the	 focal	 complex.	 Focal	 contact	points	with	 the	ECM	have	a	
high	turnover	during	migration.	However,	in	the	back	of	the	cell	focal	contact	points	
can	 develop	 into	 larger	 structures,	 named	 focal	 adhesions,	 connected	 to	 RhoA	
stimulated	 stress-fibers.	 Focal	 adhesions	 are	 complex	 cell-substrate	 protein	
complexes	 including	 extra	 cellular-adhesion	 molecules,	 like	 integrins	 and	
intracellular	adaptor	proteins	 that	 connect	 the	cytoskeleton	 to	 the	 focal	adhesion	
(Ridley,	2015).		
Thus,	in	order	to	allow	migration,	ECM	components	need	to	support	cell-substrate	
interactions.	 Indeed	 it	 has	 been	 shown	 that	 neural	 crest	 cells	 move	 along	
permissive	 ECM	 routes	mainly	 supported	 by	 integrin	 interaction	 (Theveneau	 and	
Mayor,	 2012).	 In	 avian	 trunk	 neural	 crest	 cells	 ECM	 components	 involved	 in	
migration	include	fibronectin,	collagen,	laminin	and	integrins	(Delannet	et	al.,	1994;	
Dufour	et	al.,	1988;	Newgreen,	1982;	Perris	and	Perissinotto,	2000;	Rovasio	et	al.,	
1983;	 Testaz	 and	 Duband,	 2001).	 Especially	 fibronectin	 has	 been	 shown	 to	 be	
expressed	in	neural	crest	cell	migratory	pathways	(Newgreen	and	Thiery,	1980).	In	
Xenopus	 cranial	 neural	 crest	 cells	 fibronectin	 is	 required	 for	migration,	 at	 least	 in	
vitro	 (Alfandari	 et	 al.,	 2003;	 Epperlein	 et	 al.,	 1988).	 Fibronectin	 contains	multiple	
binding	sites	that	that	can	interact	with	integrin	receptors.	The	integrins,	expressed	
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by	cranial	neural	crest	cells,	include	the	β1-	and	α5-integrin	subunits	(McKeown	et	
al.,	2013)	and	integrin	α5β1	is	required	for	avian	and	amphibian	cranial	neural	crest	
cell	migration	on	fibronectin	in	culture	(Alfandari	et	al.,	2003;	Kil	et	al.,	1998;	Lallier	
et	 al.,	 1993).	 Indeed,	 using	 a	 function	 blocking	 antibody	 against	 α5β1-integrin	 on	
Xenopus	cranial	neural	crest	cells	 inhibits	migration	 in	vivo	(Alfandari	et	al.,	2003).	
Additional	 depletion	 of	 β1-integrin	 subunit	 in	 chick	 has	 been	 shown	 to	 lead	 to	
inhibition	 of	 cranial	 neural	 crest	 cell	 migration	 (Boucaut	 et	 al.,	 1984;	 Bronner-
Fraser,	1986).	Conversely,	β1-integrin	subunit	conditional	depletion	in	mouse	using	
Wnt1-cre	driver	did	not	show	any	impairment	of	cranial	neural	crest	cell	migration	
(Turlo	 et	 al.,	 2012).	 However	 recent	 research	 also	 showed	 that	 conditional	
knockdown	of	fibronectin	and	integrin	α5	 in	mouse	cranial	neural	crest	cells	 leads	
to	 a	 decreased	 number	 of	 cells	 due	 to	 increased	 apoptosis	 and	 decreased	
proliferation	(Mittal	et	al.,	2010).	This	suggests	that	fibronectin	and	integrin	α5	are	
critical	for	the	survival	of	mouse	cranial	neural	crest	cells.		
Next	to	integrin,	cranial	neural	crest	cells	express	also	the	proteoglycan	syndecan-4	
which	binds	to	fibronectin	(Matthews	et	al.,	2008).	Syndecan-4	has	been	proposed	
as	 a	 key	 regulator	 of	 RhoA	 and	 Rac	 activities	 and	 focal	 adhesion	 formation	
(Alexopoulou	 et	 al.,	 2007).	 Indeed,	 Syndecan-4	 is	 expressed	 in	 Xenopus	 cranial	
neural	crest	cells	and	has	been	shown	to	regulate	the	migration	through	 localized	
inhibition	of	Rac1	at	the	cell	contact	(Matthews	et	al.,	2008).	
Chemotaxis	and	co-attraction		
The	front–rear	polarization	of	cells	or	clusters	can	be	stimulated	by	chemical	signals	
gradient	 such	 as	 chemokines	 (Mayor	 and	 Etienne-Manneville,	 2016).	 Thus	
directional	migration	 towards	a	gradient	 is	 called	chemotaxis.	 In	detail,	 the	 target	
tissue	 needs	 to	 express	 and	 secrete	 the	 chemotaxing	 signal	 or	 ligand	 and	 the	
responding	 cell	 has	 to	 express	 an	 appropriate	 receptor	 to	 allow	 chemotaxis.	
Consequently,	depletion	of	both,	chemoattraction	signal	or	receptor,	should	impair	
directional	 migration	 towards	 its	 target	 region.	 Further,	 ectopic	 chemoattractant	
should	lead	to	diversion	of	normal	migration	in	vivo	and	loss	of	the	chemoattractant	
should	be	able	to	be	rescue	by	localized	exogenous	ligand	(Cai	and	Montell,	2012;	
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Shellard	and	Mayor,	2016).	The	validation	of	these	criteria	is	fundamental	to	prove	
that	 a	 given	 signal	 is	 exerting	 chemotaxing	 behaviour.	 If	 no	 in	 vivo	 chemotaxis	
driven	directional	migration	can	be	proven,	changed	migration	could	be	also	be	due	
to	chemokinesis,	a	process	which	only	supports	and	maintains	migration	but	gives	
no	directional	information	(Kay	et	al.,	2008;	Shellard	and	Mayor,	2016).	So	far,	none	
of	the	published	chemotaxing	signals	have	been	shown	to	fulfil	all	above-mentioned	
criteria.	Nevertheless	there	is	amounting	evidence	that	vascular	endothelial	growth	
factors	 (VEGFs)	 (McLennan	 et	 al.,	 2010),	 platelet-derived	 growth	 factors	 (PDGFs)	
(Eberhart	et	al.,	2008;	He	and	Soriano,	2013),	and	stromal	cell-derived	factor	1	(SDF-
1)	(Kasemeier-Kulesa	et	al.,	2010;	Saito	et	al.,	2012;	Theveneau	et	al.,	2010)	could	
function	as	neural	crest	cell	chemoattractant.	
VEGF	 signalling	 has	 been	 implicated	 to	 work	 as	 a	 chemoattractant	 during	 chick	
cranial	neural	crest	cell	migration	 into	the	second	branchial	arch	(ba2)	 (McLennan	
et	 al.,	 2010).	 Indeed,	 VEGF	 is	 expressed	 in	 the	 ectodermal	 lining	 of	 ba2	 and	 its	
corresponding	 receptor	VEGFR2	and	 co-receptor	 neuropilin1	 in	 avian	neural	 crest	
cells	 (McLennan	 and	Kulesa,	 2007;	McLennan	 and	Kulesa,	 2010;	McLennan	 et	 al.,	
2010).	Inhibition	the	of	receptor	leads	to	impairment	in	migration	and	ectopic	VEGF	
source	is	able	to	divert	neural	crest	cells	from	there	normal	path	(McLennan	et	al.,	
2010).	 Further,	 some	 experimental	 data	 is	 implicating	 VEGF	 as	 an	 intracellular	
polarization	 cue.	Whereby	VEGF	expression	and	behaviour	of	neural	 crest	 cells	 at	
the	 leading	 edge,	 is	 thought	 to	 drive	 directional	 migration	 by	 a	 self-generated	
gradient	 regulated	 by	 the	 endocytosis	 of	 the	 ligand	 (McLennan	 et	 al.,	 2012;	
McLennan	et	al.,	2015).		
The	PDGF	receptor	a	(PDGFRα)	is	expressed	in	migrating	neural	crest	cells	(Eberhart	
et	al.,	2008;	Ho	et	al.,	1994;	Orrurtreger	and	Lonai,	1992;	Schatteman	et	al.,	1992;	
Takakura	 et	 al.,	 1997)	 and	 its	 corresponding	 ligands	 PDGF-A	 and	 PDGF-C	 in	 the	
surrounding	 tissue	 (Ding	et	al.,	2000;	Eberhart	et	al.,	2008;	He	and	Soriano,	2013;	
Ho	et	 al.,	 1994;	 Tallquist	 et	 al.,	 2000).	Depletion	of	PDGF	 signalling	 in	mouse	and	
zebrafish	 leads	 to	 impairment	 in	 neural	 crest	 cell	 migration	 in	 vivo	 (for	 more	
detailed	 discussion	 see	 section	 1.2.3	 PDGF	 signalling	 during	 neural	 crest	 cell	
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migration).	 Further	 neural	 crest	 cell	 derivatives	 can	 undergo	 chemotaxis	 towards	
PDGF-A	in	vitro	(He	and	Soriano,	2013)	and	a	exogenous	PDGF-A	source	was	shown	
to	attract	mouse	cranial	neural	crest	cells	in	vivo	(Kawakami	et	al.,	2011).	Although,	
it	has	not	yet	been	fully	established	 if	PDGFRα	signalling	can	act	as	a	chemotactic	
signal	during	neural	crest	cell	migration.	
Another	potential	chemo-attractive	cue	for	cranial	neural	crest	cells	is	SDF-1.	While	
the	 ligand	 SDF1	 is	 expressed	 in	 the	 pharyngeal	 arch	 and	 ectoderm,	 the	
corresponding	receptor	Cxcr4	 is	expressed	 in	cranial	neural	crest	cells	 in	zebrafish	
and	 Xenopus	 embryos	 (Olesnicky	 Killian	 et	 al.,	 2009;	 Theveneau	 et	 al.,	 2010).	
Moreover,	SDF-1-Cxcr4	signalling	 is	required	for	the	migration	of	neural	crest	cells	
around	the	optic	stalk	and	 into	the	branchial	arches	(Olesnicky	Killian	et	al.,	2009;	
Theveneau	 et	 al.,	 2010).	 SDF-1	 has	 been	 proposed	 to	 work	 via	 increasing	 Rac1	
activity	towards	the	chemoattractant	and	thus	stabilizing	the	protrusion	at	the	free	
edge	 (Theveneau	 et	 al.,	 2010).	 Additionally,	 the	 hypoxia	 inducible	 factor	 1	 (Hif-1)	
and	 its	 ability	 to	 promote	 Cxcr4	 expression	 have	 been	 shown	 to	 be	 essential	 for	
chemotaxis	towards	SDF-1	(Barriga	et	al.,	2013).	During	pre-migratory	stages	SDF-1	
is	expressed	 in	the	epibranchial	placodes	 in	Xenopus,	a	tissue	that	 lies	adjacent	to	
the	neural	crest	cells	(Theveneau	et	al.,	2013).	Cranial	neural	crest	cell	explants	are	
attracted	to	placode	explants	 in	vitro	and	it	is	assumed	that	SDF-1	could	provide	a	
short	range	attractive	signal	stimulating	the	directional	migration	of	the	neural	crest	
in	vivo	(Theveneau	et	al.,	2013).	
Next	 to	 long-range	 chemotaxis	 neural	 crest	 cells	 maintain	 a	 collective	 during	
migration	 via	 short-range	 chemotaxis	 process,	 also	 called	 co-attraction.	 Co-
attraction	 promotes	 mutual	 attraction	 between	 neural	 crest	 cells	 (Carmona-
Fontaine	et	al.,	2011;	Theveneau	et	al.,	2010).	This	process	of	co-attraction	is	seen	
when	 two	Xenopus	neural	 crest	 cell	 explants	 in	 close	 vicinity,	 attract	 each	 other.	
Complement	 factors	of	 the	 innate	 immune	response,	 the	 ligand	C3a	and	 receptor	
C3aR,	 have	 been	 shown	 to	 be	 required	 for	 co-attraction	 in	 Xenopus	 neural	 crest	
cells.	Both	ligand	and	receptor	are	expressed	in	neural	crest	cells	and	C3a	secretion	
by	the	neural	crest	cells	leads	to	a	short-range	gradient	towards	higher	cell	density.	
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Thus	if	a	cell	detaches	from	a	cluster,	it	consistently	move	back	towards	the	higher	
C3a	 concentration,	 to	 re-join	 the	 group.	 Indeed,	 inhibition	 of	 C3a/C3aR	 signalling	
leads	to	neural	crest	cell	dispersion	in	vitro	and	inhibition	of	migration	in	vivo,	as	the	
neural	 crest	 cells	 can	 no	 longer	migrate	 as	 a	 collective	 (Carmona-Fontaine	 et	 al.,	
2011;	Woods	et	al.,	2014).	The	C3a/C3R	signalling	response	has	been	found	to	be	
mediated	via	Rac1	activation	by	the	C3a/C3aR	signalling	and	repolarization	towards	
the	C3a	source	(Carmona-Fontaine	et	al.,	2011).		
Contact	inhibition	of	locomotion	and	collective	migration	
Constraint	 into	 streams,	 cell	 substrate	 adhesion,	 chemotaxis	 and	 co-attraction	
provide	means	that	support	migration	of	cranial	neural	crest	cells	(see	Figure	1-4).	
A).	Nevertheless,	they	are	not	sufficient	to	drive	directional	collective	migration.	An	
additional	 process,	 termed	 contact	 inhibition	 of	 locomotion	 (CIL),	 is	 needed	 to	
convene	 appropriate	 polarity	 to	 the	migrating	 neural	 crest	 cells.	 Here,	 I	 will	 only	
discuss	CIL	of	cranial	neural	crest	cells,	please	refer	to	section	1.3	Contact	Inhibition	
of	locomotion	for	a	broader	description	of	the	CIL.	CIL	is	the	process	by	which	cells	
in	contact	break	down	their	protrusions	towards	each	other	and	polarise	away	from	
the	 contact	 (Mayor	 and	 Carmona-fontaine,	 2010;	 Roycroft	 and	 Mayor,	 2015;	
Theveneau	et	al.,	2010).	That	the	CIL	process	between	neural	crest	cells	is	required	
for	them	to	exert	their	directional	migration	has	been	shown	in	in	vitro,	in	vivo	and	
in	 silico	 (Carmona-Fontaine	 et	 al.,	 2008b;	 Scarpa	 et	 al.,	 2015;	 Theveneau	 et	 al.,	
2010;	 Theveneau	 et	 al.,	 2013;	 Woods	 et	 al.,	 2014).	 In	 vitro	 CIL	 has	 been	 first	
characterized	 using	 an	 explant	 invasion	 assay	 by	 Abercrombie	 (1954).	 Here	 two	
chick	heart	fibroblast	cultures	were	plated	 in	close	proximity	and	outgrowing	cells	
were	 undergoing	 contact	 inhibition.	 Thus	 the	 two	 cultures	 were	 inhibited	 to	
invading	 each	 other	 (Abercrombie	 and	 Heaysman,	 1954).	 Indeed,	 direct	
confrontation	 of	 two	 neural	 crest	 cell	 cluster	 using	 an	 explant	 invasion	 assay	 did	
show	CIL	behaviour	 in	Xenopus	cranial	neural	crest	cells	 (Carmona-Fontaine	et	al.,	
2008b;	Moore	et	al.,	2013;	Scarpa	et	al.,	2015;	Theveneau	et	al.,	2010).	Additionally,	
CIL	of	Xenopus	neural	crest	cells	in	vitro	was	also	shown	by	random	migration	in	2D	
culture	of	dissociated	neural	crest	cells	and	analysis	of	the	angle	of	migration	before	
and	after	collision.	This	randomized	collision	analysis	showed	that	neural	crest	cells	
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change	 their	 direction	 of	 migration	 after	 contact	 with	 another	 neural	 crest	 cell	
(Carmona-Fontaine	et	al.,	2008b;	Moore	et	al.,	2013;	Scarpa	et	al.,	2015;	Theveneau	
et	 al.,	 2013).	 Moreover,	 neural	 crest	 cell	 CIL	 behaviour	 has	 been	 demonstrated	
using	 micro-pattern	 lanes,	 which	 restrict	 the	 collision	 angle	 to	 a	 head	 to	 head	
collision	(angle	of	180	degrees).	Using	this	confinement	assay	colliding	neural	crest	
cells	 undergo	 CIL	 and	 completely	 repolarize	 away	 from	 each	 other	 (Scarpa	 et	 al.,	
2013).	 In	 vivo,	neural	 crest	 cell	 CIL	was	 shown	 in	 Zebrafish	were	 cells	 undergoing	
collisions	were	shown	to	have	comparable	trajectories,	than	those	of	CIL	events	 in	
vitro	 (Carmona-Fontaine	 et	 al.,	 2008b).	 Furthermore,	 a	 computational	 model	 of	
neural	crest	cell	migration	found	that	CIL	is	required	for	collective	neural	crest	cell	
migration	 (Woods	 et	 al.,	 2014).	 In	 the	 neural	 crest	 collective	 CIL	 is	 thought	 to	
promote	 migration	 by	 preventing	 formation	 of	 protrusions	 toward	 the	 cell-cell	
contact	in	the	cluster	and	promotion	of	protrusions	at	the	leading	edge	(Carmona-
Fontaine	et	al.,	2008b;	Stramer	and	Mayor,	2016).	Consequently	CIL	in	a	cluster	of	
neural	 crest	 cells	 has	 also	 been	 described	 as	 “contact	 dependent	 polarity”	
(Theveneau	et	al.,	2010).	Inhibition	of	protrusive	activity	at	the	cell-cell	contact	has	
been	shown	 to	be	dependent	on	 the	non-canonical	Wnt-planar	cell	polarity	 (PCP)	
pathway	 and	 RhoA	 activation	 (Carmona-Fontaine	 et	 al.,	 2008b;	 De	 Calisto	 et	 al.,	
2005;	Matthews	et	al.,	2008;	Theveneau	et	al.,	2013).	This	 interaction	 leads	 to	an	
asymmetric	distribution	of	RhoA	at	the	cell-cell	contact	and	Rac1	at	the	free	edge	of	
the	cluster.	This	promotes	a	change	in	polarity	towards	the	direction	of	neural	crest	
cell	migration	(see	Polarization	of	migrating	cells:	Rho	GTPases).	 Indeed,	 inhibition	
of	the	Wnt-PCP	pathway	in	Xenopus	leads	to	an	inhibition	of	cranial	neural	crest	cell	
migration	 in	 vivo	 and	 a	 loss	 of	 CIL	 behaviour	 in	 vitro	 (Carmona-Fontaine	 et	 al.,	
2008b;	De	Calisto	et	al.,	2005).	However,	the	PCP	signalling	pathway	is	not	the	only	
controller	of	CIL	in	cranial	neural	crest	cells;	Syndecan-4,	Par3	and	N-cadherin	have	
also	 been	 implicated	 in	 the	 process	 (Matthews	 et	 al.,	 2008;	Moore	 et	 al.,	 2013;	
Theveneau	 et	 al.,	 2010).	 Syndecan-4,	 as	 the	 Wnt-PCP,	 has	 also	 been	 shown	 to	
control	contact	dependent	protrusion	inhibition	at	the	side	of	cell-cell	contact,	in	a	
RhoA-dependent	manner	 (Matthews	 et	 al.,	 2008).	 Par3,	 a	 tight	 junction	 complex	
protein,	 similarly	plays	 a	 role	 in	CIL	 in	 the	neural	 crest	by	promoting	microtubule	
catastrophe	at	the	site	of	cell-cell	contact	(Moore	et	al.,	2013).	Moreover	the	cell-
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cell	 adhesion	molecule	N-cadherin	 has	 been	 shown	 to	 be	 required	 for	 CIL	 during	
neural	crest	cell	migration.	Although	additional	signalling	pathways/molecules	have	
been	 implicated	 in	 CIL	 (for	 a	 more	 detailed	 overview	 see	 1.3.3	 Molecular	
mechanism	of	contact	 inhibition	of	 locomotion),	all	 converge	on	 the	 regulation	of	
cell	polarity	via	small	GTPases.	
Besides	the	discussed	homotypic	CIL	between	neural	crest	cells,	heterotypic	CIL	has	
been	shown	between	the	neural	crest	and	placodal	cells	 (Theveneau	et	al.,	2010).	
As	 described	 in	 chapter	 1.1.3	Chemotaxis	 and	 co-attraction,	 placodes	 express	 the	
chemokine	 SDF-1	 and	 attract	 neural	 crest	 cells	 with	 it	 (Theveneau	 et	 al.,	 2010).	
However	if	they	collide,	CIL	occurs	and	the	protrusion	of	both	placodal	and	neural	
crest	 cells	 collapse.	 The	 placodes	 then	 repolarizes	 and	 migrate	 away	 from	 the	
contact,	 thus	 creating	 a	 “chase	 and	 run”	mechanism	by	which	 the	neural	 crest	 is	
attracted	towards	the	placode,	but	upon	contact	CIL	occurs	and	the	placode	moves	
away	again	(Theveneau	et	al.,	2010).		
To	ensure	directional	and	collective	neural	crest	cell	migration	the	process	of	CIL	is	
balanced	by	the	process	of	co-attraction	(see	Figure	1-4	A,	B).	Thus,	both,	CIL	and	
Co-attraction,	are	intrinsic	neural	crest	cell	forces	that	are	required	for	neural	crest	
cell	migration.		
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Figure	1-4	Neural	crest	cell	migration	integrates	EMT,	CIL	and	co-attraction	
(A)	 Induced	 neural	 crest	 cells	 undergo	 EMT	 at	 the	 neural	 tube	 and	 acquire	 CIL	
behaviour	 and	 disperse.	 Co-attraction	 maintains	 the	 cohesive	 stream	 and	
chemotactic	cues	(green)	guide	through	the	migration	pathway.	Restrictive	signals	
in	surrounding	tissues	(red	dotted	line)	prevent	divergent	migration.		
(B)	CIL	 is	a	cellular	phenomenon	by	which	cells	upon	contact,	halt	 their	migration	
and	repolarize	in	opposing	directions.	When	two	neural	crest	cells	collide	transient	
N-cadherin-based	 cell–cell	 adhesions	 (green	 lines)	 are	 formed	 and	 produce	 local	
Wnt/PCP	signals	(blue).	Wnt/PCP	activates	RhoA	and	represses	Rac1	at	the	contact.	
(C)	 Co-attraction	 is	 a	 process	 whereby	 neural	 crest	 cells	 mutually	 attract	 one	
another	by	secretion	of	C3a	(light	blue	dots).	CIL	and	co-attraction	counterbalance	
each	other	Adapted	from	(Barriga	and	Mayor,	2015).	
Figure 4 Integration of chemotaxis, contact inhibition of locomotion (CIL), and
coattraction along neural crest cells collective migration. (A) Events occurring within
a stream of migratory neural crest cells. Restrictive signals are shown as parallel dotted
red lines; chemotactic cues (Sdf1) are represented as a green gradient (with high con-
centration of Sdf1 in green). After prospective neural crest cells undergo EMT, cells expe-
rience CIL, repolarize, and disperse. If Sdf1 levels are low neural crest cells disperse and
become polarized single cells. Sdf1 can guide polarized cells and, by coattraction, these
cells come together to form transient cell–cell contacts. Upon contact, cells undergo CIL,
repolarize, and move away from each other again. Repetitive cycle of CIL and
coattraction are proposed tomaintain cellsmigrating in a collective anddirectionalman-
ner. (B) Contact inhibition of locomotion (CIL). CIL is a cellular behavior by which upon
contact, two migratory cells stop their migration and repolarize in opposite directions.
(Continued)
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1.2 PDGF	signalling	
Platelet-derived	 growth	 factor	 (PDGF)	 was	 first	 found	 as	 a	 serum	 component	 to	
stimulate	proliferation	of	vascular	smooth	muscle	cells	 (Ross	et	al.,	1974).	By	now	
the	repertoire	of	known	PDGF	signalling	cellular	mechanisms	has	been	expanded	as	
diverse	 as	 proliferation,	 survival,	 cell	 migration,	 EMT,	 ECM	 production,	 and	
differentiation.	During	vertebrate	development,	PDGF	signalling	has	been	shown	to	
play	a	 role	 in	neural/oligodendrocyte,	vascular	and	hematopoietic,	organogenesis,	
somitogenesis,	 skeletogenesis	 and	 neural	 crest	 cell	 development	 (Smith	 and	
Tallquist,	2010).	 In	the	following	section	I	will	discuss	the	PDGF	signalling	pathway	
and	 its	 components,	 its	 role	 in	 cell	 migration	 and	 its	 role	 neural	 crest	 cell	
development	and	migration.	
1.2.1 PDGF	and	PI3K	signalling	pathway	
Studies	 in	 different	model	mechanisms	 of	 PDGF-	 and	 PDGFR-related	 forms	 imply	
that	 some	 developmental	 roles	 are	 conserved	 (Hoch	 and	 Soriano,	 2003).	 For	
example	 PDGFs	 role	 in	 neural	 development	 is	 conserved	 from	 Drosophila	 to	
Humans	(Duchek	et	al.,	2001;	 Jeibmann	et	al.,	2015;	Learte	et	al.,	2008;	Lui	et	al.,	
2014;	Mellström	 et	 al.,	 1983;	 Richardson	 et	 al.,	 1988),	 similarly	 its	 role	 in	 neural	
crest	 cell	 development	 has	 been	 shown	 to	 be	 conserved	 between	 vertebrates	
(Cebra-Thomas	et	al.,	2013;	Eberhart	et	al.,	2008;	Ho	et	al.,	1994;	Klinghoffer	et	al.,	
2001;	Morrison-Graham	et	al.,	1992).	Additionally	PDGFs	are	related	to	VEGF,	with	
the	PDGFs	being	most	 likely	evolved	 through	divergent	evolution	 from	a	common	
PDGF/VEGF	 ancestor	 present	 in	 C.	 elegans	 and	 Drosophila,	 by	 gene	 duplication	
(Andrae	et	al.,	2008b;	Grassot	et	al.,	2006;	Holmes	and	Zachary,	2005).		
So	 far	 four	 different	 PDGF	 ligand	 variants	 have	 been	 described,	 PDGF-A,	 PDGF-B,	
PDGF-C	and	PDGF-D.	In	general,	PDGFs	build	homodimeric	ligands	via	two	cysteine	
bridges,	although	one	heterodimer	PDGF-AB	has	been	described	in	vitro	(see	Figure	
1-5;	Demoulin	and	Essaghir,	2014;	Heldin,	2004).	The	PDGF-AA	ligand	exists	in	two,	
a	 “short”	 and	 “long”	 from,	 produced	by	 alternative	 splicing.	 In	 the	 long	 from	 the	
ligand	retains	a	C-terminal	basic	retention	motif,	which	binds	to	extracellular	matrix	
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components,	a	positively	charged	motive	which	is	missing	in	the	short	isoform.	This	
motif	 does	 not	 restrain	 binding	 to	 the	 receptor	 but	 confines	 diffusion	 (Demoulin	
and	Essaghir,	2014).	The	consequence	of	this	retention	motif	was	highlighted	during	
Xenopus	 laevis	 gastrulation.	 Here,	 the	 spreading	 and	 intercalation	 of	 mesoderm	
requires	 long-range	 signal	 from	 the	 short	 splicing	 isoform	of	 PDGF-A,	 but	not	 the	
long	matrix-binding	isoform	(Damm	and	Winklbauer,	2011).	The	long	form	has	been	
found	 to	 bind	 directly	 to	 fibronectin	 and	 require	 heparin	 sulphate	 proteoglycans	
(HSPGs)	for	this	interaction	(Smith	et	al.,	2009).	However	a	physiological	role	for	the	
long	form	has	so	far	not	been	reported.	The	PDGF-BB	ligand	similarly	to	the	PDGF-
AA	 ligand	 can	 have	 a	 C-terminal	 retention	 motif.	 However,	 in	 contrast	 to	 the	 A	
from,	 PDGF-BB	 gets	 translated	 with	 the	 retention	 motif	 and	 intracellular	 or	
extracellular	 proteases	 can	 convert	 it	 to	 a	 short,	 soluble	 from	 (Demoulin	 and	
Essaghir,	2014).	Studies	 in	mice	with	a	deletion	mutation	in	the	retention	motif	of	
PDGF-B	 have	 shown	 its	 requirement	 for	 proper	 recruitment	 and	 organization	 of	
pericyte	migration	towards	microvessels	(Lindblom	et	al.,	2003).	More	recently	the	
PDGF-C	and	PDGF	-D	ligands	were	described	in	mouse	and	human	(Bergsten	et	al.,	
2001;	Lee	et	al.,	2016;	Li	et	al.,	2000).	In	contras	to	both	other	PDGF	ligands,	PDGF-C	
and	PDGF-D,	are	secreted	in	an	inactive	form	and	are	only	activated	by	proteolytic	
removal	 of	 the	 extracellular	 matrix	 binding	 CUB	 (complement	 subcomponent	
C1r/C1s,	Uegf,	Bmp1)	domain	(Demoulin	and	Essaghir,	2014).	The	protease	plasmin	
is	 able	 to	 activate	 both	 PDGF-C	 and	 –D	 (Bergsten	 et	 al.,	 2001;	 Li	 et	 al.,	 2000),	
whereas	 the	 serine	 protease,	 tissue	 plasminogen	 activator	 (tPA)	 is	 exclusively	
activating	PDGF-CC	(Fredriksson	et	al.,	2004).		
All	PDGFs	exercise	their	biological	tasks	through	the	activation	of	dimeric	receptors	
made	 up	 of	 two,	 structurally	 alike	 protein-tyrosine	 kinase	 receptor	 subunits,	
PDGFRα	and/or	PDGFRβ.	Whilst	PDGFRαα	can	be	activated	by	PDGF-AA,	-AB,	-BB,	or	
-CC,	the	PDGFRββ	form	is	only	activated	by	PDGF-BB	or	-DD.	The	heterodimeric	αβ	
receptor	has	been	reported	to	bind	and	be	activated	by	PDGF-	AB,	-BB	and	possibly	
-CC	and	–DD	(Figure	1-5;	Demoulin	and	Essaghir,	2014).	Additionally	to	PDGF	ligand	
binding,	 it	 has	 been	 reported	 that	 the	 PDGFR	 signalling	 can	 be	 triggered	 in	 an	
indirect	 way,	 via	 several	 G	 protein-coupled	 receptors,	 for	 example	 angiotensin	 II	
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(Demoulin	 and	 Essaghir,	 2014;	 Heeneman	 et	 al.,	 2000).	 Furthermore	 it	 has	 been	
shown	that	 ligand	VEGF-A	can	bind	 to	PDGF	receptors,	agonize	PDGF	binding	and	
activate	 mesenchymal	 cell	 migration	 (Ball	 et	 al.,	 2007;	 Pennock	 and	 Kazlauskas,	
2012).	To	activate	the	conventional	signalling	pathway	dimeric	PDGFs	bind	to	two	
receptor	 molecules.	 The	 receptor	 is	 build	 up	 of	 an	 extracellular	 ligand	 binding	
domain,	consisting	of	five	 immunoglobulin-like	motifs	and	an	 intracellular	tyrosine	
kinase	domain.	 If	 there	 is	 no	 signalling	 activation	 through	 a	 ligand,	 the	 activation	
loop	conformation	does	not	allow	substrate	access	to	the	catalytic	pocket	and	thus	
no	 signalling	 activation	 happens.	 In	 the	 presence	 of	 the	 ligand,	 receptor	
dimerization	and	conformational	changes	 trigger	auto-phosphorylation	of	 tyrosine	
residues.	 These	 auto-phosphorylation	 sites	 work	 as	 docking	 sites	 for	 signalling	
proteins	 containing	 Src	 homology	 2	 (SH2)	 domains,	 leading	 to	 a	 relocalization	 of	
signalling	molecules	from	the	cytosol	to	the	plasma	membrane.	These	proteins	are	
themselves	 phosphorylated	 on	 tyrosine	 residues,	 generating	 further	 docking	 sites	
or	 inducing	 conformational	 changes	 that	 transform	 their	 activity	 (Demoulin	 and	
Essaghir,	 2014;	 Ostman	 and	 Heldin,	 2007).	 The	 activated	 PDGFR	 can	 bind	 SH2	
domain	containing	molecules	at	to	specific	phosphorylation	residues,	 including	Src	
tyrosine	 kinases,	 phosphatidylinositol	 kinase	 (PI3K),	 the	 Grb2/Sos1	 complex	 that	
activates	 MAP	 kinase	 (MAPK)	 pathway,	 phospholipase	 C	 γ	 (PLCγ),	 GTPase‐
activating	 protein	 for	 Ras	 (RasGAP),	 the	 tyrosine	 phosphatase	 SHP-2,	 and	 STAT	
family	 transcription	 factors	 (see	 Figure	 1-6).	 Next	 to	 those	 direct	 downstream	
activators,	the	receptor	can	bind	some	SH2	domain	containing	adaptor	molecules,	
as	 Nck,	 Shc,	 and	 Crk,	 whose	 function	 it	 is	 to	mediate	 between	 the	 receptor	 and	
further	effector	molecules	(Ostman	and	Heldin,	2007).	Several	signalling	pathways	
have	been	described	downstream	of	PDGFR	signalling,	 including	MAPK,	PI3K,	 JNK,	
PKC	 and	Rac	 related	 pathways	 (Demoulin	 and	 Essaghir,	 2014).	However	 PI3K	 and	
PLC	downstream	of	PDGF	signalling	have	been	mainly	linked	to	PDGF	induced	actin	
reorganization	and	chemotaxis,	while	the	MAPK	and	Src	pathway	have	been	found	
as	major	contributors	to	cell	proliferation	(Ostman	and	Heldin,	2007).	Nevertheless,	
wide-ranging	 cross	 talk	 between	 the	 downstream	 signalling	 pathways	 and	 the	
cellular	effect	of	the	pathway	changes	from	cell	type	to	cell	type.	
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In	the	following	only	the	PI3K	pathway	will	be	discussed	in	detail,	please	refer	to	the	
following	 reviews	 for	 more	 information	 on	 other	 PDGF	 downstream	 signalling	
pathways	 (Demoulin	 and	 Essaghir,	 2014;	 Heldin	 and	 Westermark,	 1999;	 Ostman	
and	Heldin,	2007).		
	
Figure	1-5	PDGF	signalling:	receptor	and	ligands.	
PDGF-A,	 -B,	 -C	 and	 -	 D,	 PDGFs	 are	 secreted	 as	 homodimeric	 or	 heterodimeric	
proteins	(PDGF-AA,	-BB,	-CC,	-DD	and	–AB)	linked	by	two	cysteine	bridges.	PDGF-AA	
(red)	 exits	 in	 two	 splice	 variations	 a	 short	 and	 a	 long	 isoform.	 The	 long	 isoform	
posses	 a	 C-terminal	 basic	 retention	 motif	 (green	 box),	 which	 does	 not	 inhibit	
binding	to	the	receptor,	but	restricts	diffusion.	Also	PDGF-BB	(blue)	has	a	C-terminal	
basic	 retention	 motif	 (green	 box),	 which	 can	 be	 removed	 by	 intracellular	 or	
extracellular	proteases.	PDGF-CC	and	-DD	are	secreted	as	 inactive	precursors,	due	
to	 the	 N-terminal	 CUB	 domain	 (green	 box).	 The	 CUB	 domain	 is	 removed	 by	
proteases	 (plasmin	 or	 tissue	 plasminogen	 activator	 (tPA))	 releasing	 the	 active	
soluble	 ligand.	 The	 two	 RTKs	 PDGFRα	 and/or	 PDGFRβ	 build	 active	 receptor	
complexes	 containing	 two	 receptor	 chains.	 PDGFRα	 is	 activated	 by	 all	 PDGF	
Gene-targeting experiments in mice showed that these
receptors played a key role in embryo development. In parallel,
they were found mutated in different types of relatively rare
tumors and leukemias. During the last decade, clinical trials
indicated that drugs such as imatinib, which blocks the PDGF
receptor kinase activity, can effectively treat human cancers
associated with constitutive PDGF receptor activation, with the
notable exception of brain tumors [7]. Several laboratories are now
trying to decipher the role of PDGF in tumor stroma, angiogenesis,
human fibrotic diseases and stoke, opening new possibilities of
therapeutic interventions [7,8]. Research on PDGF has led to new
paradigms in embryo development [8], in oncology [7], as well as
in signal transduction. The present review will focus on PDGF
receptor signaling networks in normal and cancer cells.
2. Ligands and receptors
PDGFs are encoded by four different genes: PDGF-A, -B, -C and -
D, which are related to VEGF and belong to the ‘‘cystine knots’’
protein superfamily [9]. The PDGF genes likely evolved from VEGF
ancestors present in Caenorhabditis elegans and Drosophila. PDGFs
are secreted as homodimeric proteins linked by two cysteine
bridges. In addition, one heterodimer has been isolated: PDGF-AB
(Fig. 1). PDGF-BB possesses a C-terminal basic retention motif,
which binds to extracellular matrix components. The presence of
this motif does not prevent binding to the receptor but limits
diffusion. It can be removed by intracellular or extracellular
proteases, releasing soluble PDGF-BB. The importance of the
retention motif was highlighted by the study of mice harboring a
mutant PDGF-B gene, in which the retention motif was deleted
[10]. These mice present a phenotype intermediate between wild-
type and PDGF-B knock-out animals. Two forms of PDGF-AA are
produced by a different mechanism: alternative splicing of the
PDGF-A transcript.
PDGF-CC and -DD were characterized more recently [11,12]. By
contrast to the AA and BB ligands, they are secreted as inactive
precursors, due to the presence of a N-terminal CUB domain, which
binds to extracellular matrix. This domain is removed by proteases
releasing the active soluble factor (Fig. 1). More precisely, plasmin
can activate both PDGF-CC and -DD, while tissue plasminogen
activator (tPA) is specific for PDGF-CC [9,13]. PDGF-CC activation
was associated with increased brain barrier permeability and
hemorrhages that follow the administration of tPA as a treatment
of stroke [14].
PDGF is secreted by activated platelets, from which it was
initially purified, and by many other cell types, such as
endothelial, epithelial, glial or inflammatory cells. In most cases,
this cytokine acts on neighboring cells in a paracrine manner.
PDGF receptors are expressed in oligodendrocytes and in cells
derived from mesenchymal stem cells, such as fibroblasts and
vascular smooth muscle cells. The two PDGF receptors, namely
PDGFRa and b, are receptor tyrosine kinases (RTK) belonging to
the so-called type III family, which also includes c-KIT, c-FMS and
FLT3 (the receptors of stem cell factor, CSF1 and FLT3-ligand,
respectively). They are more distantly related to the receptors of
VEGF and fibroblast growth factors (FGF). The active receptor
complex consists of two receptor chains associated with one
dimeric ligand. PDGFRa binds to all PDGF isoforms except PDGF-
DD, while PDGFRb is activated by PDGF-BB and -DD (Fig. 1). A
heterodimeric ab receptor has been reported, and binds to PDGF-
AB, -BB and possibly -CC and -DD.
PDGFR can be activated in an indirect manner via a number of G
protein-coupled receptors. For instance, angiotensin II and
dopamine transactivate PDGFRb and induce its tyrosine phos-
phorylation [15,16]. Factor VIIa complexed with tissue factor also
induces a modest PDGFRb phosphorylation and strongly potenti-
ate chemotaxis induced by low dose PDGF-B [17]. The mechanism
of transactivation remains poorly understood. It does not involve
the release of PDGF ligands, by contrast to the transactivation of
other receptor tyrosine kinases, such as the EGF receptor [18].
Two reports suggest that VEGF-A binds to PDGF receptors. Ball
et al. showed that VEGF-A induces the migration of mesenchymal
cells by signaling through PDGFRa and PDGFRb [19]. The direct
binding of VEGF-A to PDGF receptors was confirmed by Pennock
and Kazlauskas, who observed that VEGF-A is a weak agonist only
at supraphysiological concentrations and a stronger PDGF
antagonist [20].
3. Physiological functions of PDGF
PDGF stimulates cell proliferation and migration in a number of
physiological processes, as detailed in the comprehensive review
of Andrae et al. [8]. Mice deficient in PDGF ligands and receptors
have revealed the critical roles of PDGF in embryo development.
Fig. 1. PDGF receptors and ligands. Green rectangles represent domains that bind to extracellular matrix components. See text for details.
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isoforms	 except	 PDGF-	 DD,	 while	 PDGFRβ	 is	 activated	 by	 PDGF-BB	 and	 -DD.	 A	
heterodimeric	 PDGFR-α/β	 receptor	 has	 been	 reported,	 and	 binds	 to	 PDGF-AB	
(Figure	adapted	from	Demoulin	and	Essaghir,	2014.)	
	
Figure	1-6	PDGF	signalling	pathways.	
Upon	 ligand	 binding	 multiple	 phosphorylation	 sites	 (red	 circles)	 at	 the	 PDGF	
receptor	 convey	 different	 downstream	 signalling	 pathways	 via	 adaptor	 proteins.	
PDGF	 signalling	 downstream	pathways	 include	 the	PI3K,	 RAC-JNK,	 PKC	 and	MAPK	
pathway.	 Domains	 of	 adaptor	 proteins	 depicted	 on	 the	 right	 side;	 SH2	 (Src	
Homology	 2),	 PTB	 (phosphotyrosine-binding),	 PH	 (Pleckstrin	 homology).	 (Figure	
adapted	from	Demoulin	and	Essaghir,	2014).	
	
PI3K	signalling	pathway	
Phosphatidylinositol-3	kinase	(PI3K),	pathway	is	named	after	 its	signalling	effector,	
PI3K	 a	 heterodimeric	 lipid	 kinase	 that	 consists	 of	 a	 regulatory	 and	 a	 catalytic	
subunit.	 P85	 is	 the	 regulatory	 subunit,	 which	 binds,	 upon	 receptor	 activation,	 to	
specific	 phosphorylation	 sites	 at	 the	 receptor	 tyrosine	 kinase	 (RTK).	 Activation	 of	
by the activated PDGF receptor TEL-PDGFRb and SRC over-
expression in these cells even delays leukemia [55]. By contrast,
drugs targeting most SRC family kinases, such s SU6656 and PP2,
decrease fibroblast proliferation induced by PDGF [56]. Similar
results were produced by microinjecting anti-SRC blocking
antibodies or introducing dominant negative SRC constructs
[54]. Again, these effects were not observed in the presence of
SV40 large T or in the absence of p53. Hence, SRC kinases may be
required for PDGF-induced proliferation of normal fibroblasts but
not of transformed cells of mesenchymal or hematopoietic origin.
In vitro, SRC kinases phosphorylate at least one site within
PDGFRb (Tyr934) as well as several cytosolic proteins such as SHC
and CBL (Fig. 3) [56,57]. Using a proteomics approach, many more
potential substrates of SRC downstream PDGF receptors were
identified [58]. SRC can also phosphorylate the tyrosine kinase c-
ABL, whose activity is much increased upon PDGF stimulation [59].
ABL activation depends on the same PDGFRb tyrosine as SRC [60].
In ABL-null murine fibroblasts, PDGF is unable to induce the
reorganization of actin filaments and the entry into the cell cycle is
delayed [59]. The existence of a PDGFR-SRC-ABL kinase cascade
was confirmed by an independent group using domina t negative
constructs and microinjections of blocking antibodies [61].
Phospholipase Cg also contributes to PDGF-induced ABL activation
by hydrolyzing phosphatidylinositol-4,5-bisphosphate, which acts
as an inhibitor of ABL [62]. The small GTPase RAC was identified as
downstream effector of SRC and ABL, consistently with its
regulatory role on the cytoskeleton and the cell cycle [63,64].
The activation of RAC by PDGF is mediated by guanine nucleotide
exchange factors (GEF) such as VAV2 and DOCK180, which are
phosphorylated in a SRC-dependent manner [64,65]. STAT3 may
also be a mediator of SRC and possibly of ABL and RAC downstream
of PDGF receptors (see below for details) [66]. Altogether, SRC, ABL,
RAC and STAT3 were reported to control the up-regulation of MYC
expression by PDGF [56,63,64,66]. Whether these molecules form
a linear pathway or a more complex network remains to be
determined (Fig. 4).
Although FER is activated by PDGF as well, inactivation of FER in
mice does not lead to any defect in PDGF signaling, except for a lack
of cortactin phosphorylation [67]. Nevertheless, FER was shown to
contribute to the transformation of fibroblasts by PDGF via STAT3
activation in a process that may also involve SRC [68]. Interesting-
ly, this effect does not require FER catalytic activity, suggesting an
adaptor role.
Fig. 3. The PDGF receptor signalosome. Signaling by PDGFRb is shown as example. Red dots represent key phosphorylated tyrosine residues. See text for details.
Fig. 4. Potential roles of cytosolic protein tyrosine kinases in PDGF signaling. See
Fig. 3 for domain color legend.
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p85	 leads	 to	 membrane	 localization	 and	 catalytic	 activity	 of	 the	 second	 subunit	
p110.	 P110	 is	 the	 catalytic	 subunit,	 which	 mediates	 the	 phosphorylation	 of	 the	
second	 messenger	 phosphatidylinositol-	 4,5-triphosphate	 (PIP2)	 to	
phosphatidylinositol-	 3,4,5-triphosphate	 (PIP3)	 (Demoulin	 and	 Essaghir,	 2014;	
Vivanco	and	Sawyers,	2002).	Additionally,	PI3K	has	also	been	indicated	to	regulate	
other	 cellular	 targets	 than	 PIP3,	 such	 as	 the	 serum	 and	 glucocorticoid-inducible	
kinase	 (SGK)	 (Park	 et	 al.,	 1999),	 the	 small	 GTP-binding	 proteins	 RAC1	 and	 CDC42	
(Jiang	et	 al.,	 2000;	 Liliental	 et	 al.,	 2000;	Welch	et	 al.,	 1998),	 and	protein	 kinase	C	
(PKC)	 (Fan	 et	 al.,	 2009).	 The	 PIP3	 lipid	 second	 messenger	 triggers	 a	 cascade	 of	
effector	 kinases,	 beginning	 with	 the	 activation	 and	 translocalisation	 of	 3-
phosphoinositide-dependent	protein	kinase-1	 (PDK1),	which	binds	 to	PIP3	with	 its	
pleckstrin	 homology	 (ph)	 domain.	 Membrane	 bound	 PDK1	 activates	 further	
downstream	kinases	by	phosphorylation	of	AKT/PKB,	the	p70	S6	kinase	and	atypical	
protein	kinase	C	isoforms	(see	Figure	1-7;	Hanada	et	al.,	2004;	Heldin	et	al.,	1998).	
All	 these	 kinases	 have	 been	 linked	 to	 PDGF	 signalling	 (Heldin	 et	 al.,	 1998).	
Additionally	there	are	several	PIP3	phosphatases	known	which	negatively	regulate	
PI3K	signalling,	 the	best	studied	 is	PTEN	(Demoulin	and	Essaghir,	2014;	Hanada	et	
al.,	 2004).	 Interestingly,	 AKT	might	 be	 the	 only	 vital	 effector	 of	 PIP3	 signalling.	 A	
study	in	Drosophila	found	that	of	Pten	could	be	rescue-able	by	a	PH-domain	mutant	
of	AKT	that	cannot	bind	PIP3	(Stocker	et	al.,	2002).		
In	 general,	AKT	has	different	downstream	effectors	 it	 can	activate.	AKT	 can	block	
cell	death	by	 inhibition	of	pro-apoptotic	BAD	and	Forkhead	or	NF-κβ	transcription	
factors	(Brunet	et	al.,	1999;	Datta	et	al.,	1997;	Peso	et	al.,	1997;	Romashkova	and	
Makarov,	1999).	Moreover,	AKT	can	also	stimulate	the	cell	cycle	by	phosphorylation	
of	MDM2	and	subsequent	inhibition	of	pro-apoptotic	p53	(Mayo	and	Donner,	2001;	
Zhou	et	al.,	2001)	and	has	been	shown	to	regulate	glucose	metabolism	(Cho	et	al.,	
2001).		
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Figure	1-7	PI3K	signalling	
Schematic	 representation	 of	 PI3K	 signalling	 pathway.	 Upon	 ligand	 binding	 the	
receptor	dimer	autophosphorylates	 specific	 tyrosine	 residues	 (see	Figure	1-7).	 IRS	
(Insulin	receptor	substrate)	adaptor	protein	facilitates	activation	and	translocation	
of	PI3K,	comprising	a	regulator	(p85)	and	catalytic	subunit	(p110).	Translocated	PI3K	
mediates	 phosphorylation	 of	 PIP2	 to	 PIP3.	 The	 PIP3	 lipid	 second	 messenger	
activates	 and	 translocalisation	 PDK1/2,	 which	 further	 activates	 AKT/PKB	 by	
phosphorylation.	 Activates	 AKT/PKB	 can	 trigger	 different	 downstream	 signalling	
effectors	 and	 cellular	 events.	 PI3K	 has	 also	 been	 indicated	 to	 regulate	 (SGK)	 the	
small	GTP-binding	proteins	RAC1	and	CDC42	and	PKC.	 (Adapted	from	Vivanco	and	
Sawyers,	2002)	
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targeted for mutation in human cancer74. A truncated
p65 PI3K subunit — isolated originally from a human
tumour cell line — causes constitutive activation of
PI3K and cell transformation75. Some primary human
colon and ovarian cancers have mutations in p85α,
which produce deletions in the inter-SH2 region and
lead to PI3K activation74. These structural alterations
presumably release the p85–p110 complex from negative
regulation, bypassing the normal role of RTK signalling
in PI3K activation. Activating mutations in the RTKs
themselves provide additional — although less direct —
evidence for the importance of the PI3K–AKT pathway
in human cancer.For example, a truncated variant of the
epidermal-growth-factor receptor (EGFR) that lacks the
extracellular domain (EGFR viii) potently activates the
PI3K–AKT pathway,but not the RAS–MAPK pathway76.
In addition, downstream effectors of the pathway, such
as RSK (S6 kinase), are amplified at the genomic level in
breast and ovarian cancer, often in conjunction with the
neighbouring gene ERBB2 (REFS 77–79).
As alluded to earlier, the most compelling evidence
for the PI3K–AKT pathway being involved in human
cancer comes from studies of the PTEN tumour-sup-
pressor gene. Comprehensive surveys of several human
cancers for PTEN gene deletion or mutations indicate
that PTEN loss occurs in a wide spectrum of human
cancers80 (TABLE 1). As loss of PTEN function can also
occur through transcriptional silencing or protein insta-
bility81,82, it is likely that the frequency of PTEN abnor-
malities in human cancer will rise as additional surveys
are conducted using immunohistochemical analysis.
Finally, there might be previously unsuspected con-
nections between known oncogenes and the
PI3K–AKT pathway. For example, TCL1 can bind
AKT an  promote its constitutive dimerization, phos-
phorylation and nuclear translocation30,83. The func-
tional importance of the AKT pathway in TCL1
leukaemogenesis remains to be defined, but this obser-
vation indicates that the PI3K–AKT pathway might
become activated in human tumours by a diverse array
of mechanisms. Estimating the true frequency of
PI3K–AKT-pathway abnormalities in human cancer
will be challenging, particularly in the absence of a full
understanding of all the factors that affect pathway
activation. Nevertheless, this task is important because
the potential application of anticancer drugs that are
targeted against the pathway is nearly upon us (see
below). One approach might be to measure the activa-
tion state of the pathway in large surveys of human tis-
sue using phosphospecific antibodies to key pathway
components (such as PIP3, AKT, mTOR or RSK), then
to determine the molecular basis for that activation
later. This approach might also help to develop clinical
assays to diagnose PI3K–AKT-pathway activation so
that appropriate patients can be selected in clinical 
trials of drugs that are designed to target this pathway.
Gain-of-function mouse models
Finding DNA-based alterations in components of the
PI3K–AKT pathway in human tumours provides
compelling evidence that this pathway has a causal
A full account of the AKT-independent effects of
PI3K and their functional significance in cancer will
require extensive investigation using genetic models. A
recent study in Drosophila, by Stocker and colleagues,
reports that the phenotype of Pten loss in flies (lethal-
ity) is rescued by a PH-domai  mutant of Akt that
lacks the ability to bind PIP3 (REF. 69;see also BOX 2). This
result indicates that Akt might be the only important
effector of PIP3. It remains to be seen if the same is true
in mammals.
PI3K/AKT deregulation in cancer
As the list of proteins that are involved in the PI3K–AKT
pathway grows, the number of these genes that are
reported to have structural alterations at the DNA level
in human tumours continues to increase (TABLE 1). The
gene that encodes the p110 catalytic subunit of PI3K is
amplified in some cases of ovarian cancer, and amplifica-
tion ofAKT2can occur in breast, ovarian and pancreatic
cancers70–73. In both cases, the overexpression of a struc-
turally normal protein is presumed to contribute to
transformation, analogous to the amplification of the
non-mutant ERBB2 (also known as HER2/neu) RTK in
breast cancer.The regulatory p85 subunit of PI3K is also
Figure 4 | PI3K signalling: the big picture. Activation of class IA phosphatidylinositol 3-kinases
(PI3Ks) occurs through stimulation of receptor tyrosine kinases (RTKs) and the concomitant
assembly of receptor–PI3K complexes. These complexes localize at the membrane where the
p110 subunit of PI3K catalyses the conversion of PtdIns(4,5)P2 (PIP2) to PtdIns(3,4,5)P3 (PIP3).
PIP3 serves as a second messenger that helps to activate AKT. Through phosphorylation,
activated AKT mediates the activation and inhibition of several targets, resulting in cellular growth,
survival and proliferation through various mechanisms. Additionally, PI3K has been sh wn to
regulate the activity of other cellular targets, such as the serum and glucocorticoid-inducible
kinase (SGK), the small GTP-binding proteins RAC1 and CDC42, and protein kinase C (PKC), in
an AKT-independent manner through poorly characterized mechanisms. The activity of these
targets leads to survival, cytoskeletal rearrangement and transformation. GSK3β, glycogen
synthase kinase-3β; NF-κB, nuclear factor of κB; PDK1/2, 3-phosphoinositide-dependent
protein kinase 1/2.
P P P p85
p110
SGK RAC1/CDC42 PKC
PDK1 PDK2
AKT
PH
PTEN
IRS P
P P
P
P
P P P P P P
PIP3
MDM2 mTOR GSK3β NF-κB FKHR BAD
p53
Survival Transformation
Cytoskeletal rearrangement
Transformation
Cell-cycle arrest
Apoptosis
DNA repair
Growth
Translation
Cell cycle
Glucose metabolism
Apoptosis
RTK
	 44	
1.2.2 PDGF	signalling	in	migrating	cells	
In	 this	 section	 I	will	 discuss	 PDGF	 signalling	 in	migrating	 cells	 in	 vitro	and	 in	 vivo,	
with	a	particular	focus	on	the	effector	PI3K/AKT.	PDGF	signalling	and	its	specific	role	
in	 neural	 crest	 cell	 development	 and	migration	will	 be	 discussed	 in	 the	 following	
section	(see	section	1.2.3	PDGF	signalling	and	neural	crest	cells).	
PDGF	signalling	and	cell	migration	in	vitro	
The	PDGFRα	and	PDGFRβ	signalling	roles	have	been	extensively	studied	 in	 in	vitro	
and	 have	 been	 associated	 with	 regulation	 of	 proliferation,	 cell	 migration	 and	
chemotaxis	 in	 response	 to	PDGF	 ligands	 (Demoulin	and	Essaghir,	2014).	Especially	
PI3K	 downstream	 signalling	 has	 been	 implicated	 in	 this	 process.	 (Bazenet	 and	
Kazlauskas,	 1994;	 Brachmann	 et	 al.,	 2005;	 Joly	 et	 al.,	 1994;	 Kundra	 et	 al.,	 1994;	
Valius	 and	 Kazlauskas,	 1993).	 Indeed,	 in	 vitro	 studies	 using	 pharmacological	
inhibitors,	PDGFR-PI3K	binding	site	mutants	or	mouse	fibroblasts	from	PI3K	subunit	
knock-downs	 have	 shown	 that	 PI3K	 dependent	 downstream	 signalling	 is	 required	
for	PDGF	mediated	cell	ruffling	and	chemotaxis	(Brachmann	et	al.,	2005;	Kundra	et	
al.,	1994;	Severinsson	et	al.,	1990;	Wennstrom	et	al.,	1994;	Wennström	et	al.,	1994)	
	As	 discussed	 in	 chapter	 1.1.2	 Polarization	 of	 migrating	 cells:	 Rho	 GTPases	
polarization	of	migrating	cells	 is	mediated	by	small	GTPases.	 In	cell	 culture	assays	
PDGFs	have	been	shown	to	strongly	activate	the	small	GTPase	Rac1	which	leads	to	
reorganization	and	protrusion	formation	in	the	leading	edge	(Nimnual	et	al.,	2003;	
Pertz	et	al.,	2006;	Ridley	and	Hall,	1992;	Sander	et	al.,	1999).	Furthermore,	mutual	
inhibition	between	Rac1	and	RhoA	has	been	suggested	as	a	prominent	role	during	
migration	in	the	leading	edge	of	a	PDGF-AA	treated	cells	(Pertz	et	al.,	2006).	Indeed,	
inhibition	 of	 RhoA	 activity	 has	 been	 especially	 observed	 in	 randomly	 migrating	
fibroblast	cells.	These	cells	have	a	small	stripe	of	RhoA	activity	in	the	leading	edge,	
which	has	been	associated	with	peripheral	ruffles	and	pinocytic	vesicles	production.	
However,	 if	 fibroblasts	are	 treated	with	PDGF-AA	 the	RhoA	activity	vanishes	 from	
the	leading	edge	potentially	by	inhibition	via	Rac1	(Pertz	et	al.,	2006).	Interestingly,	
the	Rac1	activity	is	though	to	be	regulated	by	downstream	PI3K	signalling.	PI3K	and	
as	a	consequence	PIP3	get	concentrated	at	the	leading	edge	and	recruit	Rac	GEFs,	
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as	Tiam1	and	Dock4,	to	the	plasma	membrane	to	trigger	Rac	(Buchanan	et	al.,	2000;	
Goicoechea	 et	 al.,	 2014;	 Han	 et	 al.,	 1998;	 Kawada	 et	 al.,	 2009).	 Although	 AKT,	
another	 PI3K	 downstream	 effector,	 has	 been	 implicated	 in	 cell	 polarity	
establishment	 via	 small	 GTPases	 (Xue	 and	 Hemmings,	 2013).	 Dominant	 negative	
mutation	 of	 AKT	 was	 able	 to	 decrease	 PDGF-Rac1	 mediated	 cell	 migration	 in	
fibroblasts	(Higuchi	et	al.,	2001).	Interestingly	polarizing	PI3K/Rac1	activity	has	been	
shown	 to	 be	 inhibited	 by	 N-cadherin	 junctions	 in	 cell	 clusters	 (Charrasse	 et	 al.,	
2002;	Dupin	et	al.,	2009;	Haÿ	et	al.,	2009;	Theveneau	et	al.,	2010).	A	recent	study	
found	 that	N-cadherin	 in	 cell-cell	 adhesions	of	 cell	 doublets	plated	on	 fibronectin	
micropatternstripes,	 promotes	 the	 activation	 of	 PDGF	 dependent	 PI3K	 and	 Rac	
localization	at	the	free	edge.	This	is	thought	to	work	via	inhibition	of	integrin	at	the	
cell-cell	 contact	 by	 N-cadherin	 bound	 p120,	 while	 integrin-PI3K-Rac	 activation	 is	
supported	at	the	free	edge	(Ouyang	et	al.,	2013).	Moreover	direct	 integrin-PDGFR	
interaction	 has	 been	 shown	 to	 influence	 receptor	 activation	 and	 downstream	
signalling.	 Thus	 adhesion	 to	 fibronectin	 via	 integrin	 have	 been	 shown	 to	 strongly	
potentiate	PDGF-induced	PDGFR	signalling	(Amano	et	al.,	2008;	Borges	et	al.,	2000;	
Minami	et	 al.,	 2007;	 Schneller	 et	 al.,	 1997;	Woodard	et	 al.,	 1998;	 Zemskov	et	 al.,	
2009).	 A	 recent	 publication	 in	 mesenchymal	 stem	 cells	 found	 that	 PDGFRβ	
mediated	PI3K/AKT	activation	as	well	as	actin	assembly	and	migration	is	controlled	
by	 fibronectin	 and	 integrin	 α5β1	 interactions	 (Veevers-Lowe	 et	 al.,	 2011).	 They	
found	 that	 adhesion	 to	 ECM,	 specifically	 fibronectin,	 induces	 PDGFRα	 and	PDGFβ	
phosphorylation	 in	 a	 α5β1-integrin	 dependent	 manner.	 And	 this	 leads	 to	
downstream	 activation	 of	 PI3K/AKT	 signalling	 pathway	 and	 actin	 assembly	 and	
finally	 migration.	 Thus,	 they	 conclude	 that	 the	 synergistic	 interactions	 between	
integrin	and	PDGFR	are	fundamental	for	cell	migration	(Veevers-Lowe	et	al.,	2011).	
Moreover	 a	 recent	 study	 showed	 that	 uniform	 PDGF	 can	 induce	 rapid,	 uni-
directional,	 and	 persistent	 migration	 in	 fibroblasts,	 if	 the	 cells	 are	 polarized	 by	
adhesion	on	a	fibronectin	line.	This	unidirectional	migration	was	not	observed	if	the	
PDGF	 ligand	 was	 not	 applied	 or	 the	 cells	 were	 plated	 on	 uniform	 fibronectin	
substrate	(Martin	et	al.,	2014).	This	suggests	that	cells	can	independently	integrate	
chemical	 (PDGF)	 and	 physical	 cues	 (fibronectin	 line)	 and	 indicates	 that	 PDGF-
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induced,	 directional	 fibroblast	 migration	 might	 not	 be	 essentially	 required	 as	 a	
chemotactic	cue,	rather	more	as	a	chemokinetic	factor.	
PDGF	signalling	in	vivo	
PDGF	 signalling	 has	 been	 implicated	 in	 plethora	 of	 developmental	 processes	 and	
wound	healing,	 tissue	homeostasis	and	cancer	metastasis	 in	 the	adult.	Here	 I	will	
focus	on	 its	developmental	 role.	Please	 refer	 to	 the	 following	 reviews	on	 roles	of	
PDGF	in	the	adult	(Demoulin	and	Essaghir,	2014;	Heldin,	2012;	Ostman	and	Heldin,	
2007).	
As	 described	 in	 the	 section	 before,	 cell	 migration	 is	 a	 highly	 investigated	
consequence	 of	 PDGF	 stimulation	 in	 vitro	 (Andrae	 et	 al.,	 2008a;	 Heldin,	 2012),	
however	the	knowledge	about	PDGF-dependent	cell	migration	 in	vivo	 is	restricted.	
PDGF	 signalling	 in	 developmental	 processes	 have	 been	 strongly	 implicated	 in	 cell	
spreading	of	different	populations,	such	as	oligodendrocyte	or	glia	spreading	in	the	
spinal	cord,	neural	crest	cell	spreading	towards	its	migratory	pathways	and	targets,	
pericyte	 spreading	 along	 newly	 building	 vasculature	 and	 mesoderm	 spreading	
during	gastrulation.		
One	early	role	of	PDGF	signalling	has	been	shown	during	Xenopus	gastrulation.	Here	
PDGF-A	and	PDGFRα	have	been	 implicated	 in	mesoderm	migration	and	spreading	
over	 the	 fibronectin	 covered	 blastocoel	 roof	 in	 a	 PI3K-dependent	 mechanism.	
PDGF-A	is	expressed	by	the	ectodermal	cells	 in	the	blastocoel	roof	and	works	as	a	
gradient	that	drives	mesodermal	cell	movements	along	the	blastocoel	roof	(Ataliotis	
et	al.,	1995;	Nagel	et	al.,	2004;	Symes	and	Mercola,	1996;	Winklbauer	et	al.,	1996).	
Thus	PDGFRα	expressing	mesoderm	cells	migrate	directionally	over	a	matrix	bound	
gradient,	of	the	PDGF-A	long	form,	over	the	blastocoel	roof.	The	PDGF-A	gradient	is	
generated	by	 the	 fibronectin	binding	of	 the	PDGF-A	 long	 isoform	via	 its	 retention	
motif.	 Indeed,	 PDGF-A	 signalling	 gradient	 impairment	 leads	 to	 depletion	 of	
persistent	 migration	 in	 direction	 of	 the	 animal	 pool	 in	 Xenopus	 laevis	 embryos	
(Nagel	 et	 al.,	 2004).	 A	 more	 recent	 publication	 found	 that	 also	 that	 the	 short	
isoform	of	PDGF-A	is	required	during	Xenopus	gastrulation	(Damm	and	Winklbauer,	
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2011).	Here	the	short-form	of	PDGF-A	was	 found	to	be	 important	as	a	 long	range	
guidance	 cue	 for	 protrusion	 orientation	 and	 radial	 intercalation	 of	 the	 deep	
mesoderm	prechordal	cells	(Damm	and	Winklbauer,	2011).	
Additionally	 to	 its	 role	 in	 Xenopus,	 PDGFR	 and	 PI3K	 have	 also	 been	 linked	 to	
collective	mesoderm	migration	in	zebrafish	(Dumortier	et	al.,	2012;	Kai	et	al.,	2008;	
Montero	et	al.,	2003).	This	 role	was	 first	 shown	 in	 leading	cells	during	mesoderm	
migration,	using	a	dominant	negative	 form	of	PI3K	and	showed	 that	 leading	edge	
cells	 need	 a	 PDGF/PI3K	 pathway	 for	 protrusion	 formation	 and	 cell	 polarization	
(Montero	 et	 al.,	 2003).	 However,	 Dumortier	 et	 al.	 (2012)	 showed	 that	 all	 plate	
mesoderm	cells	require	PI3K	signalling	for	proper	protrusion	formation	(Dumortier	
et	 al.,	 2012).	 By	 using	 a	 ph-AKT-mcherry	 biosensor,	 which	 binds	 to	 PIP3	 in	 the	
plasma	membrane,	they	also	found	that	active	PI3K	signalling	 in	mesodermal	cells	
orient	 towards	 the	 anterior,	 that	 means	 towards	 their	 direction	 of	 migration	
(Dumortier	et	al.,	2012;	Montero	et	al.,	2003).	However,	no	effect	on	directionality	
was	 observed	 by	 PDGF	 signalling	 depletion,	 as	 prechordal	 mesoderm	 cells	 still	
migrated	towards	the	animal	pole.	Moreover	no	source	of	PDGF	has	been	described	
in	the	zebrafish	embryo	so	far,	thus	suggesting	the	presence	of	other	process	that	
might	ensure	directionality	(Montero	et	al.,	2003).	 
In	 Drosophila	 PVF1	 and	 PVR,	 the	 PDGF/VEGF	 and	 PDGFR/VEGFR	 homologues,	
respectively,	are	required	for	directional	border	cell	migration	 in	the	egg	chamber	
(Duchek	 et	 al.,	 2001).	 In	 general	 the	 role	 of	 PVR	 signalling	 has	 many	 similar	
characteristics	 to	Xenopus	gastrulation.	 Likewise,	 the	 receptor	 is	 expressed	 in	 the	
migrating	tissue,	 in	this	case	the	border	cells,	and	the	ligand	is	expressed	in	tissue	
over	which	the	cells	migrate,	here	the	egg	chamber.	The	border	cells	migrate	as	a	
collective,	 whereby	 a	 single	 cell	 acts	 as	 the	 leader,	 extending	 a	 long	 protrusion	
towards	the	target	region.	Knockdown	of	either	PVR	or	PVF1,	by	dominant	negative	
form	or	 a	homozygous	mutant,	 respectively,	 leads	 to	 the	 inhibition	of	border	 cell	
migration	(Duchek	et	al.,	2001).	Similarly,	ectopic	expression	of	the	ligand	leads	to	
migration	 of	 boarder	 cells	 to	 their	 endogenous	 path.	 Moreover	 uniform	
overexpression	of	PVF1	impairs	protrusion	formation	and	thus	directional	migration	
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of	border	cells	(McDonald	et	al.,	2006).	Thus	the	directional,	collective	migration	of	
border	 cells	 depend	 on	 the	 PV1	 gradient	 towards	 the	 oocyte	 (Fulga	 and	 Rørth,	
2002),	 similar	 to	 the	 PDGF	 gradient	 in	 the	 blastocoel	 roof	 required	 mesoderm	
migration	 in	 Xenopus	 (Nagel	 et	 al.,	 2004).	 Likewise	 in	 Xenopus,	 disruption	 of	 the	
gradient	 by	 overexpression	 of	 PDGF-A	 in	 the	 whole	 blastocoel	 roof	 leads	 to	
inhibition	 of	mesoderm	migration.	 However,	migration	 of	Drosophila	 border	 cells	
require	EGF	signalling	together	with	PVR	signalling	which	has	so	far	not	been	linked	
to	 Xenopus	 mesoderm	 migration	 (McDonald	 et	 al.,	 2006).	 Only	 Ras	 and	 a	
homologue	 of	 the	 vertebrate	GEF	Dock180,	 seem	 to	 be	 required	 for	 boarder	 cell	
migration	 in	 Drosophila	 (Duchek	 et	 al.,	 2001).	 In	 contrast	 to	 the	 role	 of	 PI3K	
described	 in	 Xenopus	 and	 Zebrafish	 mesoderm	 migration,	 inhibition	 or	 ectopic	
activation	of	the	PI3K	subunit	p110	homologue	does	not	affect	border	cell	migration	
(Duchek	and	Rørth,	2001).	
Thus,	the	ability	to	control	collective	cell	migration	via	PDGF/VEGF	gradients	in	the	
extracellular	space	appears	to	be	a	conserved	mechanism	between	vertebrates	and	
invertebrates	(Andrae	et	al.,	2008a;	Scarpa	and	Mayor,	2016)	
1.2.3 PDGF	signalling	and	neural	crest	cells	
PDGF	 signalling	plays	essential	 roles	during	development	 from	gastrulation	 to	 the	
development	 of	 neural	 crest	 cell,	 gonads,	 lung,	 intestine,	 skin,	 central	 nervous	
system,	 vasculature,	 and	 skeleton	 (Heldin	 and	 Lennartsson,	 2013;	 Hoch	 and	
Soriano,	2003).	This	section	will	mainly	focus	on	PDGF	signalling	in	neural	crest	cell	
development.	
PDGF	signalling	during	neural	crest	cell	migration	
The	 PDGF	 receptor	 α	 (PDGFRα)	 is	 expressed	 in	 migrating	 neural	 crest	 cells	 in,	
mouse,	 zebrafish	and	Xenopus	 (Eberhart	 et	 al.,	 2008;	Ho	et	 al.,	 1994;	Orrurtreger	
and	 Lonai,	 1992;	 Schatteman	 et	 al.,	 1992;	 Takakura	 et	 al.,	 1997)	 and	 its	
corresponding	 ligands	 PDGF-A	 and	 PDGF-C	 in	 the	 surrounding	 tissue	 (Ding	 et	 al.,	
2000;	Eberhart	et	al.,	2008;	He	and	Soriano,	2013;	Ho	et	al.,	1994;	Tallquist	et	al.,	
2000).	 Expression	of	PDGFRβ,	PDGF-B	and	PDGF-D	have	 so	 far	not	been	 reported	
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during	 cranial	neural	 crest	 cell	migration	 in	mouse,	however	PDGF-B	and	PDGFRβ	
have	been	linked	to	vasculagenesis	and	are	expressed	in	endothelial	cells	and	some	
pericytes	 in	 the	mouse	cranium,	 respectively	 (Lindahl	et	al.,	1997;	Soriano,	1994).	
PDGF-B	 expression	 in	 Xenopus	 has	 been	 recently	 shown	 to	 be	 specific	 to	 the	
developing	central	nervous	system,	rather	than	cranial	neural	crest	cells	(Giannetti	
et	 al.,	 2016).	 Although	many	 different	 PDGFR	 and	 PDGF	 ligand	 connections	 have	
been	 shown	 in	 vitro	 (Figure	 1-5),	 so	 far	 in	 vivo	 interaction	 studies	 in	 mouse	
development	 have	 only	 demonstrated	 PDGF-AA	 or	 PDGF-CC	 interaction	 with	
PDGFRα	(Boström	et	al.,	1996;	Ding	et	al.,	2004;	Soriano,	1997),	whereas	PDGF-BB	
exclusively	activates	PDGFRβ	in	vivo	(Levéen	et	al.,	1994;	Soriano,	1994).		
Developmental	 studies	 of	 PDGF	 signalling	 during	 neural	 crest	 cell	migration	 have	
mainly	 been	 done	 in	 mouse	 so	 far.	 In	 general,	 PDGFRα	 signalling	 has	 been	
demonstrated	 to	 be	 essential	 for	 both	 cranial	 and	 cardiac	 neural	 crest	 cell	
development,	while	 a	more	 restricted	 role	 in	 cardiac	NCC	development	 has	 been	
demonstrated	for	PDGFRβ	(Fantauzzo	and	Soriano,	2015).		
The	first	connection	of	a	possible	role	of	PDGFRα	in	neural	crest	cell	development	
was	 drawn	 in	 the	 Patched	 (Ph)	 mouse	 mutant	 (Stephenson	 et	 al.,	 1991).	 A	
spontaneous	mouse	mutant	 that	 was	 studied	 because	 of	 its	 non-pigmented	 hair	
patches	 in	 the	 trunk	 region,	 caused	 by	 a	 large	 deletion	 of	 the	 PDGFRα	 locus	 and	
part	of	the	receptor	cKit	enhancer	(Duttlinger	et	al.,	1995;	Grüneberg	and	Truslove,	
1960;	Stephenson	et	al.,	1991).	Most	of	the	malformations	in	the	Ph	mutants	could	
be	attributed	to	the	PDGFRα	depletion	due	to	the	fact	that	the	only	phenotype	in	a	
cKit	mutant	 is	a	developmental	defect	 in	melanocyte	development	(Geissler	et	al.,	
1981;	Wehrle-Haller,	 2003).	 Apart	 form	 this	 the	 homozygous	 Ph	 allele	 mimicked	
phenotypes	which	where	 generally	 observed	when	 neural	 crest	 cell	 development	
was	disrupted	(Geissler	et	al.,	1981;	Grüneberg	and	Truslove,	1960;	Wehrle-Haller,	
2003),	 including	 severe	 craniofacial	 phenotypes	 as	 complete	 clefting	 of	 the	
frontonasal	process	palate	and	malformation	of	the	heart	septation,	and	heart	valve	
abnormalities	(Grüneberg	and	Truslove,	1960;	Robbins	et	al.,	1999;	Schatteman	et	
al.,	1992).	The	first	set	of	phenotypes	can	be	attributed	to	defects	in	cranial	neural	
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crest	 cell	 development	 and	 the	 heart	 abnormalities	 to	 cardiac	 neural	 crest	 cell	
development.	 Notably,	 the	 craniofacial	 malformations	 could	 be	 traced	 back	 to	
different	arch	 regions.	However	neural	derivatives	 from	the	 same	arch	developed	
normally,	suggesting	that	PDGFR	mutation	might	only	affect	a	subset	of	neural	crest	
cell	 population	 (Morrison-Graham	 et	 al.,	 1992).	 Defects	 of	 the	 Ph	 mutant	 were	
phenocopied	 in	 mice	 having	 a	 targeted	 homozygous	 mutation	 in	 the	 PDGFRα	
including	clefting	of	the	frontonasal	process	palate,	subepidermal	blebbing,	vascular	
abnormalities,	 cardiac	defects,	 abnormalities	 in	neural	 tube	development,	defects	
in	 somite	 pattering,	 and	 skeletal	 defects	 (Soriano,	 1997).	 Interestingly,	 those	
defects	could	be	copied	in	targeted	disruption	of	PDGF	ligands	A	and	C	(Ding	et	al.,	
2004).	 This	 highlights	 the	 functional	 requirement	 of	 PDGF-A	 and	 PDGF-C	 for	
PDGFRα	 signalling	 during	 neural	 crest	 cell	 development.	 Though	 PDGF-B	 is	
proficient	of	binding	to	PDGFRα,	functional	studies	have	not	shown	any	part	for	this	
interaction	so	far.		
Chimeric	analysis	of	PDGFRα	signalling,	with	PDGFRα	deleted	embryonic	stem	cells	
showed	a	high	exclusion	of	depleted	cells	from	neural	crest	cell	derived	tissue.	This	
suggests	that	the	defects	in	the	PDGFRα	null	mutants	are	cell-autonomous	and	can	
be	accounted	to	neural	crest	cell	developmental	disruptions	(Tallquist	et	al.,	2003).	
Interestingly,	 the	 conditional	 knock	 down	 of	 PDGFRα	 in	 neural	 crest	 cell	 tissue,	
using	Wnt1-Cre	driver	line,	showed	only	a	subset	of	the	phenotypes	observed	in	the	
mutant	embryo,	 including	 facial	 clefting,	haemorrhaging	 in	 the	midline,	defects	 in	
the	heart	outflow	tract	and	thymus	malformations	(Tallquist	et	al.,	2003).	The	fact	
that	 only	 a	 subset	 of	 phenotypes	 was	 observed	might	 be	 due	 to	 the	 use	 of	 the	
Wnt1-Cre	 line	 which	 has	 been	 recently	 found	 to	 have	 ectopic	 activation	 of	Wnt	
signalling	(Lewis	et	al.,	2013).	Further	the	Wnt1	driver	might	not	be	perfect	choice	
for	a	conditional	knock	down	of	PDGFRα,	as	the	expression	of	Wnt1	is	not	limited	to	
the	neural	crest	territories	 in	the	embryo	and	the	onset	of	expression	might	be	to	
late	 to	 affect	 early	 neural	 crest	 cell	 developmental	 defects	 (Barriga	 et	 al.,	 2015;	
McMahon	et	al.,	1992).	Nonetheless,	analysis	of	the	cellular	mechanism	involved	in	
the	facial	clefting	phenotypes	in	Pdgfrαfl/fl;	Wnt1-Cre	embryos	showed	that	PDGFRα	
signalling	 is	 required	 for	 migration	 of	 neural	 crest	 cells	 towards	 medial	 lateral	
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prominence	and	later	for	the	proliferation	of	the	neural	crest	cell	derivative	mouse	
embryonic	 palatal	mesenchymal	 cells	 (MEPMs)	 (He	 and	 Soriano,	 2013).	 Indeed,	 it	
has	been	shown	that	ex	vivo	culturing	of	PDGFRα	depleted	neural	crest	cell	explants	
showed	a	decreased	emigration	from	explant	cultures.	Further	analysis	of	PDGFRα	
signalling	in	MEPMs	found	that	the	PI3K/Akt	and	Rac1	to	pathway	are	required	for	
MEPM	proliferation	(He	and	Soriano,	2013).	However,	it	has	not	been	established	if	
PI3K/AKT	 or	 the	 small	 GTPase	 Rac1	 are	 also	 required	 for	 neural	 crest	 cell	
development	and	migration.	
The	PDGFRβ	is	expressed	in	mouse	embryonic	mesenchyme	during	neural	crest	cell	
induction	 and	 early	 migration	 stages	 (E	 8.5),	 however	 the	 expression	 is	 more	
restricted	towards	the	heart,	somite	and	limb	buds	at	later	stages	(Soriano,	1994).	
Targeted	 disruption	 of	 PDGFRβ	 leads	 to	 vascular	 and	 kidney	 defects	 in	 mouse	
embryos	 (Soriano,	 1994).	 The	mouse	 double	 knockdown	 of	 PDGFRα	 and	 PDGFRβ	
exhibit	 defects	 linked	with	 cardiac	 neural	 crest	 cell	 development	 (Richarte	 et	 al.,	
2007;	Van	Den	Akker	et	al.,	2008).	 Interestingly,	 the	conditional	knockdown	using	
the	 Wnt1-Cre	 driver	 of	 both,	 PDGFRα	 and	 PDGFRβ,	 leads	 to	 a	 more	 severe	
phenotype	 in	 cardiac	 neural	 crest	 cell	 derived	 tissues	 than	 each	 depletion	 alone	
(Richarte	 et	 al.,	 2007).	 This	 suggests	 that	 both	 receptors	 are	 needed	 for	 cardiac	
neural	 crest	 cell	 development.	 In	 general,	 the	 difference	 in	 neural	 crest	 cell	
phenotypes	between	PDGFRα	and	PDGFRβ	depleted	mouse	embryos	seems	to	be	
predominantly	 caused	by	differences	 in	 their	 spatiotemporal	expression.	To	 study	
the	 different	 signalling	 capacities	 of	 the	 two	 receptors	 Klinghoffer	 et	 al.	 (2001)	
developed	 two	 complementary	 lines	 of	 knock-in	 mice	 in	 which	 the	 intracellular	
signalling	 domains	 of	 one	 PDGFR	was	 exchanged	 by	 those	 of	 the	 other	 and	 vice	
versa	(Klinghoffer	et	al.,	2001).	Analysis	of	embryos	from	these	two	lines	showed	a	
considerable	 rescue,	while	 the	PDGFRβ	 receptor	with	 a	PDGFRα	 cytosolic	 domain	
resulted	in	vascular	malformations	(Klinghoffer	et	al.,	2001).	Thus	showing	a	strong	
similarity	in	signalling	capabilities	between	the	two	receptor	functions.		
In	zebrafish,	PDGFRα	and	PDGFRβ	are	both	expressed	in	migrating	neural	crest	cells	
and	pharmacological	inhibition	using	a	PDGFR	inhibitor	showed	inhibition	of	neural	
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crest	 cell	 migration	 (McCarthy	 et	 al.,	 2016).	 Interestingly,	 PDGFRα	 depletion	 in	
zebrafish	using	a	mutant	 leads	to	craniofacial	abnormalities	as	observed	 in	mouse	
(Eberhart	 et	 al.,	 2008).	 Eberhard	 et	 al.	 (2008)	 suggested	 a	 mechanism	 by	 which	
cranial	 neural	 crest	 cell	 migration	 is	 dependent	 on	 PDGFRα	 level	 attenuation	 of	
microRNA	140	 (Mirn140).	 Indeed,	 if	Mirn140	expression	 is	 inhibited	or	Mirn140	 is	
overexpressed	 cranial	 neural	 crest	 cell	 defects	 including	 facial	 clefting	 were	
reported.	This	suggests	that	this	attenuation	is	needed	for	cranial	neural	crest	cells	
to	migrate	over	PDGF-AA	expressing	cells	and	reach	the	oral	ectoderm	(Eberhart	et	
al.,	2008).		
Additionally	a	 recent	 study	 looked	 into	 the	 requirement	of	PDGFRβ	 in	mouse	and	
zebrafish	 development.	 They	 showed	 that	 the	 β	 receptor	 is	 replaceable	 for	
craniofacial	 development	 in	 zebrafish.	 Although	 the	 double	 knockdown	 of	 both	
receptors,	in	mouse	and	zebrafish,	displayed	a	stronger	defect	in	palatogenesis	than	
the	 PDGFRα	 mutant	 alone	 (McCarthy	 et	 al.,	 2016).	 Analysis	 of	 the	 cellular	
mechanisms	 in	 PDGFRα-PDGFRβ	mutant	 zebrafish	 revealed	 that	 the	phenotype	 is	
due	 to	 loss	 of	 proper	 condensation	 of	 neural	 crest	 cells	 in	 the	maxillary	 domain	
(McCarthy	 et	 al.,	 2016).	 Overall,	 this	 suggests	 that	 PDGFRβ	 has	 a	 minor,	
complementary	role	and	PDGFRα	has	the	major	role	ensuring	proper	cranial	neural	
crest	cell	migration.	
Downstream	effectors	of	PDGF	signalling	in	neural	crest	cell		
Investigation	 of	 downstream	 effectors	 of	 the	 PDGFRα	 receptor,	 using	
phosphorylation	docking	site	point	mutation	for	either	PI3K,	SRC	or	multiple	other	
pathways	 in	mouse	 embryo	 development,	 revealed	 the	 essential	 requirement	 for	
PI3K	 in	 PDGFRα	 signalling	 (Klinghoffer	 et	 al.,	 2002).	 While	 loss	 of	 the	 phospho-
docking	site	for	Src	and	subsequent	downstream	signalling	had	no	obvious	affect	on	
neural	 crest	 cell	 development	 (Klinghoffer	 et	 al.,	 2002).	Homozygous	mutation	 of	
the	 PI3K	 binding	 site	 in	 the	 PDGFRα	 receptor	 leads	 to	 some	 craniofacial	 defects.	
Interestingly,	only	the	homozygous	double	knockdown	of	PI3K	binding	sites	in	both,	
the	 PDGFRα	 and	 PDGFRβ,	 embryos	 mimics	 the	 PDGFRα	 knockout	 phenotype	
(Klinghoffer	et	al.,	2002).	This	suggests	a	role	for	PDGFRα/β	heterodimers	in	mouse	
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neural	 crest	 cell	 development,	while	PI3K	 signalling	 seems	 to	be	 the	downstream	
effector.	 Moreover	 the	 depletion	 of	 the	 regulatory	 subunits	 p85a	 and	 p85b,	 or	
p110a	 catalytic	 subunit	 of	 PI3K	 mimic	 the	 phenotype	 observed	 in	 the	 PDGFRα	
knock-down	(Brachmann	et	al.,	2005).		
In	 vitro	 experiments	 suggested	 that	 PDGFRα/β	 heterodimers	 have	 different	
downstream	 properties	 than	 homodimeric	 receptor	 complexes	 (Fantauzzo	 and	
Soriano,	 2015).	 For	 instance,	 PDGFRα	phosphorylation	on	 tyrosine	 754,	 for	 SHP-2	
binding,	 has	 been	 exclusively	 reported	 for	 heterodimeric	 receptors	 (Rupp	 et	 al.,	
1994).	Moreover,	the	heterodimeric	receptor	has	been	reported	to	have	increased	
mitogenic	properties	compared	to	the	homodimeric	 receptors	 (Rupp	et	al.,	1994).	
However	the	occurrence	of	these	functional	differences	in	heterodimeric	signalling	
and	 their	 potential	 effect	 on	 cellular	mechanisms	 compared	 to	 the	 homodimeric	
receptors	has	yet	to	be	determined.		
More	recently	Fantauzzo	and	Soriano	(2014)	investigated	intracellular	downstream	
effectors	 of	 the	 PDGFRα-PI3K-Akt	 axis	 in	 neural	 crest	 cell	 derived	 palatal	
mesenchyme.	Using	a	phosphoproteomic	mass	spectrometry	approach	they	found	
that	downstream	effector	proteins	are	involved	mainly	in	cell	and	proliferation	and	
this	to	be,	at	least	in	part,	regulated	by	the	p53	transcription	factor	(Fantauzzo	and	
Soriano,	 2014).	 However,	 downstream	 signalling	 in	 earlier	 stages,	 as	 neural	 crest	
cell	migration,	has	not	been	investigated	yet.	
1.3 Contact	Inhibition	of	locomotion	
Abercrombie	 first	 described	 contact	 inhibition	 of	 locomotion	 during	 chick	 heart	
fibroblast	migration	(1958).	And	he	describes	the	process	as		
“…the	phenomenon	of	a	cell	ceasing	to	continue	moving	in	the	same	
direction	after	contact	with	another	cell.”	
	(Abercrombie,	1978).	
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CIL	by	now	has	been	reported	during	cancer	cell	metastasis,	haemocyte	dispersion	
in	 Drosophila	 and	 most	 important	 during	 neural	 crest	 cell	 migration	 in	 Xenopus	
laevis	and	zebrafish.	In	the	following	section	I	will	discuss	general	cellular	molecular	
aspects	of	CIL,	describe	 its	 in	vivo	roles	and	specifically	 its	 role	 in	neural	crest	cell	
migration	and	EMT.	
1.3.1 CIL	in	general	
CIL	is	a	process	by	which	two	colliding	cells	stop	their	movement	and	migrate	away	
in	 a	 different	 direction.	 Simplified	 the	 process	 of	 contact	 inhibition	 can	 be	
subdivided	into	four	distinct	phases	after	collision	(Figure	1-8).		
1.	build	up	of	a	transient	adhesion	between	the	two	colliding	cells		
2.	repolarization	of	the	cell		
3.	formation	of	new	leading	edge		
4.	moving	away	from	the	point	of	cell-cell	contact	
(Reig	et	al.,	2014;	Stramer	and	Mayor,	2016).		
The	process	of	homotypic	CIL,	whereby	two	cells	of	the	same	cell	type	collide,	can	
be	 subdivided	 into	 the	 following	 two	 types	 (see	 also	 Figure	 1-9).	 The	 first	 type	
describes	the	immobility	upon	contact,	followed	by	cellular	retraction	of	the	leading	
edge	 and	movement	 away	 from	 the	 colliding	 cell,	 thus	 an	 active	migration	 away	
(Abercrombie,	 1970;	 Abercrombie,	 1978;	 Stramer	 and	Mayor,	 2016).	 The	 second	
type	describes	the	inability	of	a	cell	to	move	across	another,	which	leads	to	either	
cessation	of	movement	or	random	diversion	of	the	colliding	cell.	Thus,	compared	to	
the	 controlled	 contraction	 and	 repolarization	 of	 type	 I,	 type	 II	 is	 a	more	 inactive	
reaction	 controlled	 by	 the	 forces	 of	 the	 cell-cell	 contact	 (Abercrombie,	 1970;	
Stramer	and	Mayor,	2016;	Veselý	and	Weiss,	1973).	In	comparison	type	I	CIL	is	most	
possibly	controlled	by	specific	molecular	mechanisms,	as	cell-cell	contact	receptors	
and	 downstream	 signals	 which	 lead	 to	 changes	 in	 cell	 polarization	 and	 actin	
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assembly	(Stramer	and	Mayor,	2016).	Nonetheless	it	is	noteworthy	that	the	type	of	
CIL	a	cell	population	undergoes	underlies	variability.	These	variations	depend	on	the	
orientation	 of	 collision,	 if	 the	 cells	 collide	 front-to-front	 or	 front-to-back.	 Further	
also	changes	in	the	signalling	pathways	recognized	may	lead	also	to	a	different	type	
of	CIL	(Abercrombie,	1967;	Abercrombie,	1970;	Abercrombie	and	Dunn,	1975;	Desai	
et	al.,	2013;	Scarpa	et	al.,	2013).	
	
	
Figure	1-8	Four	phases	of	contact	inhibition	of	cell	locomotion	
The	mechanism	of	contact	inhibition	can	be	subdivided	in	three	different	phases.	–	
(1)	Colliding	cells	get	 into	contact.	 (2)	Cell-cell	contact	 inhibits	protrusion.	(3)	Cells	
repolarise	and	from	protrusion	away	from	point	of	contract.	(4)	Cells	detached	from	
another	and	move	away.	Adapted	from	Roycroft	and	Mayor,	2016	
	
180!. Forcing the cells to completely reverse their front–rear
polarity makes it easier to establish the steps required for this
repolarisation and the temporal regulation of these events. In
addition, restricting the cells to 1D lanes makes it easier to
predict when cells are going to interact and allows for easier
analysis [39, 40]. An additional assay has been generated that
restricts cells to 1D migration through the use of
microchannels. In this assay microfluidic chambers constrain
cell migration to 1D channels whilst allowing chemoattractant
gradients to be generated across the chamber [41]. These
chambers have proved useful in understanding how CIL is
affected by chemotactic cues found in vivo [15]. This is of
particular interest as cancer cells are known to migrate
through tracks generated in the extracellular matrix [40] and
respond to chemotactic cues [42, 43].
Contact inhibition of locomotion in vivo
Contact inhibition of locomotion has been identified as the
driving force behind many phenomena in developing
embryos [44]. As with all in vitro assays, there is some
uncertainty as to whether cells’ behaviour in vitro mimics
their behaviour in vivo. This question has begun to be
addressed thanks to the improvement in imaging of CIL in
the developing embryo. Haemocytes undergoing CIL can
be imaged in vivo in the ventral surface of Drosophila [6].
The behaviour observed between these cells is strikingly
similar to what Abercrombie first observed in fibroblasts
in vitro over 50 years earlier [2, 17]. Further evidence that
CIL is similar in vivo has been observed in the zebrafish
cranial neural crest where the trajectories of cells under-
going collisions in vivo are similar to those of cells in vitro
[5]. These observations confirm that the in vitro assays are
mimicking what is happening in vivo and are therefore
useful in elucidating the molecular mechanisms driving
CIL. The development and improvement of new live
imaging techniques have helped elucidate some of the
mechanisms driving CIL. In the haemocytes of Drosophila
CIL occurs between individual cells and is required to
drive the uniform dispersion of the haemocytes throughout
the drosophila embryo [17]. Interestingly CIL drives a
completely distinct process within the neural crest, where it
is vital for their directional collective migration [5, 10, 30,
45]. It has been proposed that CIL contribute to collective
migration of the neural crest by inhibiting protrusions
Fig. 1 The multiply stages of contact inhibition of locomotion. a
Free migrating cells show polarised migration: Rac1 activity in the
leading edge stimulates protrusion formation. Microtubules stabilise
the directional migration of these cells. In addition, focal adhesions
generation traction forces enabling the cells to migrate along a
substrate. b Initially a contact is formed between the cells: the
lamellae of the colliding cells overlap and cell–cell adhesions form
between the two cells. The cytoskeletons of the colliding cells
become coupled. c Protrusive activity is inhibited at the site of
contact: Rac1 activity is lost at the contact site and RhoA become
active at the point. This causes the protrusions to collapse and
prevents new protrusions from forming at the contact site. d The cells
repolarise and new protrusions form away from the contact: Rac1
becomes active in the free edge away from the contact promoting the
formation of new protrusions in this area. Focal adhesions form in
these new protrusions and stabilises them. Microtubule dynamics
increase at the contact site with an increase in growth and shrinkage
rates and microtubule catastrophe events. e The cells separate and
migrate away from each other: the cells continue migrating in the
direction of the newly formed protrusions away from the direction of
contact. The cell–cell adhesions disassemble and the cells final
separate
Molecular basis of contact inhibition of locomotion 1121
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Figure	1-9	Contact	inhibition	of	locomotion	type	classification	
(a)	 Type	 I	 CIL	 collisions	 comprise	 active	 repulsion	 and	movement	 away	 from	 the	
colliding	 cell.	 (b)	 Type	 II	 CIL	 collisions	 do	 not	 display	 repulsion,	 cells	 either	 cease	
movement	after	contact	or	are	randomly	deflected	form	the	colliding	cell.	Adapted	
from	Stramer	and	Mayor,	2016.	
1.3.2 Study	of	contact	inhibition	of	locomotion	-	assays	
As	described	in	the	section	before	(section	1.3.1)	CIL	behaviour	underlies	variability.	
To	 investigate	 and	 describe	 the	 CIL	 behaviour	 of	 a	 given	 cell	 population,	 use	 of	
multiple	assays	is	generally	required	to	describe	the	cellular	behaviour.	Over	recent	
years	 several	 approaches	 have	 been	 developed	 to	 study	 and	 understand	 CIL	
including	mixing,	radial	outgrowth,	kinematics	in	2D	and	1D.	In	the	following	section	
they	will	be	described	in	detail.	
Mixing	assay	
The	 first	 assay	 used	 to	 study	 CIL	 by	 Abercrombie	 is	 the	 so	 called	 mixing	 assay	
(Abercrombie	 and	 Heaysman,	 1954),	 sometimes	 also	 described	 as	 invasion	 or	
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explant	confrontation	assay.	Here	differently	marked	explant	cultures	are	plated	at	
a	 short	 gap	 between	 each	 other,	 the	 outgrowth	 of	 cells	 and	 their	 overlapping	
behaviour	was	used	as	readout	of	CIL.	Thus	when	cells	start	to	overlap	they	undergo	
a	CIL	response	and	cell	migration	from	the	explants	stops.	However	 in	the	case	of	
explants	with	 impaired	CIL,	 explants	will	 overlap	 and	 invade	each	other	 (Roycroft	
and	 Mayor,	 2016;	 Stramer	 and	 Mayor,	 2016).	 Abercrombie	 used	 this	 assay	 to	
describe	CIL	of	fibroblast	and	metastatic	sarcoma	cells,	whereby	the	latter	showed	
an	 impaired	 CIL	 response	 and	 the	 cancer	 cell	 explants	 were	 able	 to	 invade	 each	
other	(Abercrombie	and	Heaysman,	1954).	This	suggested	a	loss	of	CIL	in	metastatic	
sarcoma	 cells.	 Moreover	 this	 assay	 was	 also	 used	 to	 describe	 CIL	 responses	 in	
neural	crest	cell	explants	in	Xenopus	(Carmona-Fontaine	et	al.,	2008b;	Scarpa	et	al.,	
2015;	 Theveneau	 et	 al.,	 2010).	 A	 variation	 of	 this	 CIL	 test	 was	 developed,	 which	
analyses	instead	of	the	overlap	of	the	two	explant,	the	overlap	area	of	protrusions	
(Moore	et	al.,	2013;	Scarpa	et	al.,	2015).		
Radial	outgrowth	assay	
The	 next	 assay	 used	 to	 study	 CIL	 is	 the	 so-called	 radial	 outgrowth	 assay.	 If	 an	
explant	is	cultured	alone,	CIL	behaviour	will	lead	to	radial	dispersion.	Quantification	
of	 CIL	 dispersion	 is	 done	 by	measuring	 the	 distance	 between	 neighbouring	 cells,	
using	 Delaunay	 nearest	 neighbour	 equation	 (Carmona-Fontaine	 et	 al.,	 2008b;	
Nawrocki	Raby	et	al.,	2001;	Scarpa	and	Mayor,	2016;	Theveneau	et	al.,	2010).		
Kinematics	assay	2D	and	1D	
CIL	behaviour	in	single	cells	has	mostly	been	studied	using	2D	substrates	(Roycroft	
and	Mayor,	2016).	In	the	2D	Kinematics	assay,	cells	are	plated	in	a	2D	environment	
of	a	culture	dish,	or	analysed	 in	vivo	 in	cases	where	2D	dimensions	can	be	applied	
and	monitored	using	time-lapse	microscopy.	The	Individual	cells	migrate	randomly	
and	 stochastic	 collisions	 between	 them	are	 observed	 (Roycroft	 and	Mayor,	 2016;	
Stramer	 and	 Mayor,	 2016).	 This	 assay	 is	 a	 powerful	 way	 to	 describe	 many	
characteristics	of	changes	such	as	changes	in	velocity	and	acceleration	during	CIL,	as	
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well	as	the	angle	of	migration	after	contact	(Carmona-Fontaine	et	al.,	2008b;	Davis	
et	al.,	2012;	Davis	et	al.,	2015).	One	disadvantage	of	the	2D	Kinematics	assay	is	that	
cells	 can	 collide	 from	 different	 angles,	 such	 as	 front-on-front	 or	 front-on-side	 or	
even	front-back.	This	is	especially	problematic	as	it	is	known	for	long	that	front-on-
front	 collisions	 show	 a	 clear	 CIL	 behaviour,	 whereas	 other	 cell	 confrontations,	
where	 cell	 front	 lamellae	 do	 not	 get	 in	 contact,	 do	 not	 (Abercrombie	 and	 Dunn,	
1975;	 Davis	 et	 al.,	 2012).	 To	 circumvent	 this,	 a	 1D	 Kinematic	 collision	 assay	 was	
developed.	Here	migration	of	cells	is	restricted	using	striped	micropatterns,	so	more	
head-on-head	collisions	are	generated,	while	 the	angle	of	 repolarization	 is	 limited	
(Desai	et	al.,	2013;	Scarpa	et	al.,	2015).	Collision	in	the	1D	assay	can	lead	to	a	type	I	
CIL	response,	whereby	the	cells	repolarize	and	move	away	from	each	other,	or	just	
one	cell	is	repolarizing.	If	a	type	II	response	occurs,	the	cells	remain	in	contact	with	
each	other	(Stramer	and	Mayor,	2016)	
	
Figure	1-10	Methods	to	study	contact	inhibition	of	locomotion	
Different	methods	to	study	CIL	behaviour.	(a)	Mixing	assay	(also	called	invasion	or	
explant	 confrontation	 assay.	 (b)	 Radial	 outgrowth	 assay	 (also	 called	 dispersion	
assay).	(c)	Kinematics	in	2D.	(d)	Kinematics	in	1D.	t0	indicates	time	before	collision.	
tn	indicates	time	after	collision.	Adapted	from	Mayor	and	Streamer,	2016.	
the other as a substrate for its motility. In other cases, 
a heterotypic response may simply be subtly changed 
compared with the homotypic response, yielding only a 
slightly different type of CIL behaviour. Importantly, the 
ability of heterotypic collisions to produce non-mutual 
outcomes confers an added level of instructive power 
to the CIL process that can lead to emergent cellular 
behaviours during animal development (see the section 
‘Embryological functions of CIL’ below).
Stages of the CIL response
Before we can elucidate the mechanisms controlling CIL, 
it is important to understand the possible regulatory stages 
of the process. For the purpose of this Review, we divide 
the response into four stages, which have some basis from 
experimentation. This division is somewhat arbitrary 
because these steps temporally overlap. Furthermore, it 
is important to note that not all cells undergoing CIL will 
experience all of these behaviours. For example, the final 
Box 1 | Contact inhibition of locomotion assays
The variability in CIL behaviours makes it essential to choose the correct assay, with multiple assays typically required 
to fully describe the phenomenon. The currently available approaches for assaying CIL include:
Mixing assay
Two differentially labelled tissue explants are placed in culture at a short distance between each other, and the 
overlapping region resulting from the migratory outgrowth of both explants is quantified. When CIL responses are 
strong, cell migration from the explants ceases when one explant touches the other, whereas when CIL is impaired, 
an increase in overlap is observed25,27,31,49 (see the figure, part a). A variant of this assay is to quantify the overlapping 
of individual cell protrusions under higher magnification, allowing for more detailed analysis of cell behaviour27,48.  
It is also possible to quantify the overlap between cell nuclei1; however, decreasing the strength of CIL does not 
always lead to nuclear overlap, making this assay less sensitive to subtle effects.
Radial outgrowth
Explants of cells undergoing CIL radially disperse because this behaviour is the most efficient way for cells to spread 
(see the figure, part b). Cell dispersion can be quantified by measuring the distance between neighbouring cells upon 
explant outgrowth, as this distance increases in cells with strong CIL behaviour27.
Kinematics in 2D
Cells are cultured on a 2D substrate (or examined in vivo if 2D descriptions are relevant) and imaged by time-lapse 
imaging. During CIL, cells alter their motion, which results in changes in velocity and acceleration (see the figure, part c). 
Note that velocity and acceleration are vectors and therefore measure changes in both speed and direction. Care must 
be taken to compare these motions with the motion of freely moving cells to distinguish CIL-specific effects. As collisions 
occur in many orientations, it is also important to meaningfully pool data (for example, normalize to movement at the 
time of collision) otherwise one will observe a random collection of vectors. This assay is a powerful way to describe many 
aspects of the motion changes surrounding collisions25,26,59,98.
Kinematics in 1D
Cells are cultured on micropatterned stripes of extracellular matrix, and their migration is recorded (see the figure, part d). 
Compared with 2D kinematics, this approach increases the chance of collisions while limiting the degrees of freedom of 
motion, which eases interpretation. However, care must be taken t  choose an optimal width of the micropattern because 
migration can be greatly affected by this parameter99. There are a number of possible outcomes of collisions in 1D, which 
depend on the type and th  capacity of CIL response, including the following: repolarization and migration of the two cells 
away from each other; a non-mutual response with only one cell repolarizing; cells remain in contact; or cells migrate past 
or over each other23,73,100.  In the figure part d t0 denotes time before collision. tn denotes time after collision.
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b Radial outgrowth
c  Kinematics in 2D
d  Kinematics in 1D
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1.3.3 Molecular	mechanism	of	contact	inhibition	of	locomotion	
CIL	is	a	diverse	process	involving	four	steps	(see	section	1.3.1	and	Figure	1-8);	here	I	
will	 discuss	 the	molecular	 mechanisms	 and	 key	 components	 of	 the	 CIL	 response	
known	so	far.		
(1)	Cell-cell	contact		
The	formation	of	a	direct,	physical	contact	between	two	cells	 is	a	requirement	for	
CIL	 (Roycroft	 and	 Mayor,	 2016).	 Moreover	 it	 has	 been	 shown	 that	 an	 adhesive	
contact	between	two	colliding	cells	is	needed	to	build	up	membrane	tension	across	
the	area	of	contact	(Abercrombie	and	Ambrose,	1958;	Harris,	1973;	Heaysman	and	
Pegrum,	 1973).	 So	 far	 cadherin,	 Ephrin	 and	 the	 Robo-Slit	 cell-cell	 adhesion	
complexes	 have	 been	 shown	 to	 be	 involved	 in	 CIL	 (Stramer	 and	 Mayor,	 2016).	
Although	these	molecular	players	are	known	to	be	required	for	CIL,	they	are	not	of	
the	 same	 adhesion	 family,	 thus	 suggesting	 that	 CIL	 might	 work	 trough	 different	
mechanisms	(Roycroft	and	Mayor,	2016).		
Cadherins	 comprise	 a	 family	 of	 transmembrane	 glycoproteins,	 which	 build	 up	
calcium-dependent	 cell-cell	 adhesion.	 Classically	 cadherins	 were	 associated	 with	
regulation	of	the	actin	cytoskeleton	in	adherents	junction	of	epithelial	monolayers	
(Takeichi,	 1988).	However	more	 recent	 publications	 have	 suggested	 that	 the	 cell-
cell	 contact	 during	 CIL	 involves	 transient	 cadherin-dependent	 adhesion.	 It	 is	 not	
known	 why	 these	 adheres	 junctions	 are	 transient,	 compared	 to	 their	 epithelial	
counterpart.	 However,	 so	 far	 E-cadherin,	 N-cadherin	 and	 cadherin	 11	 have	 been	
shown	 to	be	 involved	 in	 the	CIL	 in	different	 cell	 types	during	 the	 cell-cell	 contact	
process	 (Becker	 et	 al.,	 2013;	 Bracke	 et	 al.,	 1997;	 Chen	 and	 Obrink,	 1991;	
Huttenlocher	 et	 al.,	 1998;	 Omelchenko	 et	 al.,	 2001;	 Scarpa	 and	 Mayor,	 2016;	
Theveneau	 et	 al.,	 2010).	 Moreover	 proteins	 involved	 in	 the	 cadherin-adherent	
junction	complex,	as	β-catenin,	α-catenin,	p120	and	vinculin,	have	been	found	to	be	
important	for	CIL	process	(Bracke	et	al.,	1997;	Gloushankova	et	al.,	1998;	Scarpa	et	
al.,	 2015).	 A	 recent	 publication	 in	Xenopus	neural	 crest	 cells	 found	 that	 a	 switch	
from	 E-cadherin	 to	 N-cadherin	 is	 required	 for	 the	 acquisition	 of	 CIL	 during	 EMT	
(Scarpa	 et	 al.,	 2015).	 They	 found	 that	 cells	 overexpressing	 E-cadherin	 remain	 in	
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contact	and	have	impaired	CIL	(Scarpa	and	Mayor,	2016).	A	role	of	E-cadherin	which	
has	 been	 described	 earlier	 in	 cell	 lines,	 where	 E-cadherin	 was	 been	 found	 to	
immobilizes	protrusive	activity	at	the	point	of	cell-cell	contact	in	cell	lines	(Chen	and	
Obrink,	1991).	However	N-cadherin	has	been	shown	to	be	required	for	neural	crest	
cell	 CIL,	 inhibition	 of	 N-cadherin	 using	 either	 Morpholino	 or	 blocking	 antibody,	
leading	to	an	impairment	of	CIL	behaviour	in	neural	crest	cells,	as	well	as	inhibition	
of	neural	crest	cell	migration	in	vivo	(Theveneau	et	al.,	2010).		
In	 general,	 Xenopus	 neural	 crest	 cells	 in	 a	 2D	 Kinematic	 assay	 show	 normal	 CIL	
behaviour,	 thus	 colliding	 cells	 collapse	 their	 protrusion,	 stop	 migrating	 and	 then	
repolarize	 and	 migrate	 away	 from	 each	 other	 (Carmona-Fontaine	 et	 al.,	 2008b).	
Once	 N-cadherin	 dependent	 actions	 are	 inhibited	 neural	 crest	 cells	 have	 an	
increased	 protrusive	 activity	 at	 the	 contact	 and	 fail	 to	 repolarize	 away	 from	 the	
contact.	 This	 suggested	 that	 N-cadherin	 might	 control	 a	 mechanism	 termed	
“contact-dependent	 polarity”	 (Theveneau	 et	 al.,	 2010).	 Apart	 from	 neural	 crest	
cells,	N-cadherin	requirement	during	CIL	has	been	implicated	in	different	cell	types	
as	 myoblasts	 and	 glial	 cells	 (Huttenlocher	 et	 al.,	 1998;	 Tanaka	 et	 al.,	 2012;	
Theveneau	 et	 al.,	 2010).	 However,	 the	 role	 of	N-cadherin	 in	 CIL	 seems	 not	 to	 be	
general,	 as	 depletion	 in	 Schwann	 cells	 has	 been	 suggested	 to	 enhance	 CIL	
(Letourneau	 et	 al.,	 1991).	 Furthermore	 Cadherin	 11	 is	 also	 essential	 for	 CIL	 in	
Xenopus	 neural	 crest	 cells.	 Inhibition	 of	 cadherin-11	 leads	 to	 impairment	 of	 CIL	
behaviour	and	neural	crest	cell	migration	in	vivo	(Becker	et	al.,	2013).		
Furthermore	 the	 Eph	 tyrosine	 kinase	 receptors	 and	 their	 transmembrane	 ephrin	
ligands	have	been	 linked	 to	 the	 initial	 cell	 contact	during	CIL.	The	EphA	and	EphB	
receptors	both	have	been	shown	to	be	required	 for	CIL	behaviour	 in	Cajal-Retzius	
cells	 and	 prostate	 cancer	 cells.	While	 both	 have	 shown	 to	 be	 important	 for	 CIL-
dependent	 dispersion	 of	 Cajal-Retzius	 neurons	 in	 the	mammalian	 cerebral	 cortex	
(Villar-Cerviño	et	al.,	2013).	EphA	has	been	shown	 to	be	 important	 for	homotypic	
CIL	amongst	prostate	cancer	cells	(Astin	et	al.,	2010;	Batson	et	al.,	2014).	Whereas	
EhpB	controls	 invasiveness	of	prostate	cancer	cells	by	 inhibition	of	heterotypic	CIL	
by	 suppression	 of	 CIL	 between	 prostate	 cancer	 cells	 and	 fibroblasts	 (Astin	 et	 al.,	
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2010).	Moreover	 EhpB	 signalling	 has	 been	 implicated	 in	 CIL	 in	 breast	 cancer	 cell	
lines,	where	it	was	able	to	dominate	given	EGF	chemotactic	cues	(Lin	et	al.,	2015).		
Next	to	Ephrin	signalling	the	repulsive	Slit-Robo	ligand-receptor	pair	has	been	linked	
to	CIL	cell	behaviour	 (Fritz	et	al.,	2015).	The	 ligand	slit	 is	normally	 secreted,	but	a	
membrane	bound	version	of	Slit2,	together	with	the	ROBO4	receptor,	was	recently	
found	to	be	employed	during	fibroblast	CIL	(Fritz	et	al.,	2015).	Interestingly	for	both,	
the	SLIT-ROBO	and	Eph-ephrin	receptor	ligand	system	have	been	shown	to	interact	
and	crosstalk	with	cadherins	(Rhee	et	al.,	2002;	Solanas	et	al.,	2011)	
Moreover	 the	 zyxin	 cell-cell	 adhesion	molecule	has	been	 reported	 to	be	 required	
for	haemocyte	CIL	in	Drosophila	development	(Davis	et	al.,	2012;	Davis	et	al.,	2015),	
although	 the	 molecular	 details	 of	 the	 zyxin	 cell-cell	 adhesion	 have	 not	 been	
investigated	yet.		
(2)	Protrusion	inhibition	at	the	contact	site	
Following	cell-cell	contact,	protrusion	formation	is	inhibited	at	the	contact	side.	This	
protrusive	inhibition	during	CIL	is	initiated	by	the	family	small	GTPases	which	drive	
cytoskeletal	reorganizations	(Roycroft	and	Mayor,	2016;	Stramer	and	Mayor,	2016).	
Rac1,	 RhoA	 and	Cdc42	 are	 the	 best-studied	members	 of	 the	GTPase	 family.	 Rac1	
and	Cdc42	are	necessary	for	actin	polymerization	in	the	lamellipodia	whereas	RhoA	
is	 required	 for	actomyosin	 regulation	and	 thus	 contraction	at	 the	back	of	 the	 cell	
(Ridley,	 2015)	 (for	more	 detailed	 description	 1.1.3	 Polarization	 of	migrating	 cells:	
Rho	GTPases).		
All	 three	members	 have	 been	 implicated	 in	 the	 CIL	 response	 (Astin	 et	 al.,	 2010;	
Carmona-Fontaine	et	al.,	2008b;	Fritz	et	al.,	2015;	Moore	et	al.,	2013;	Scarpa	et	al.,	
2015;	 Théveneau	 et	 al.,	 2007).	 In	Xenopus	 neural	 crest	 cells	 protrusive	 activity	 is	
repressed	by	inhibition	of	RAC1	in	a	N-cadherin	and	WNT/PCP	signalling	dependent	
way	(Carmona-Fontaine	et	al.,	2008a;	Moore	et	al.,	2013;	Theveneau	et	al.,	2010).	
Inhibition	 of	 N-cadherin,	 by	 either	 Morpholino	 or	 blocking	 antibody,	 leads	 to	
ubiquitous	 Rac1	 activity,	 a	 loss	 of	 protrusion	 inhibition	 at	 the	 contact	 in	Xenopus	
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neural	crest	cells	(Theveneau	et	al.,	2010).	Additionally,	ectopic	overexpression	of	E-
cadherin	in	neural	crest	cells	leads	to	an	increase	of	Rac1	activity	at	the	contact	site,	
resulting	 in	an	overlap	of	protrusions	and	 impairment	of	CIL	 (Scarpa	et	al.,	2015).	
However	 the	 exact	 molecular	 mechanism	 of	 N-cadherin	 dependent	 activation	 of	
RhoA	 and	 Rac1	 is	 not	 known,	 though	 some	 interactions	 have	 been	 reported.	 For	
example,	 p120-catenin	 binds	 to	 the	 intracellular	 domain	 of	 N-cadherin	 and	
regulates	 its	 turnover	 (Davis	 et	 al.,	 2003).	 Unbound	 cytosolic	 p120-catenin	 can	
increase	Rac1-mediated	protrusion	formation,	however	if	it	is	bound	to	N-cadherin,	
protrusion	formation	is	inhibited	(Grosheva	et	al.,	2001;	Noren	et	al.,	2000).	Hence	
during	 CIL	 N-cadherin	 could	 be	 sequestering	 p120-catenin	 and	 thus	 inhibiting	
activation	 of	 Rac1	 (Roycroft	 and	 Mayor,	 2016).	 Moreover,	 in	 neural	 crest	 cells	
overexpressing	E-cadherin,	Rac1	activity	is	increased	at	the	contact	in	a	p120-catinin	
dependent	manner	(Scarpa	et	al.,	2015).	
Furthermore	 the	 WNT/PCP	 pathway	 plays	 a	 major	 role	 in	 Rac1	 inhibition	 and	
activation	of	RhoA	at	the	site	of	contact	in	neural	crest	cell	CIL	(Carmona-Fontaine	
et	al.,	2008a;	Scarpa	et	al.,	2015;	Theveneau	et	al.,	2010).	After	collision	Wnt/PCP	
downstream	effectors	 including	Dishevelled,	Prickle1	and	Strabismus	are	 localized	
with	 the	receptor	Frizzled7	at	 the	site	of	contact,	whereby	 they	 inhibit	protrusion	
formation	 (Matthews	 et	 al.,	 2008;	 Mayor	 and	 Theveneau,	 2014).	 In	 detail,	 the	
triggering	of	the	Wnt/PCP	signal	leads	to	the	activation	of	RhoA	and	its	kinase	ROCK	
(Rho-associated	protein	kinase)	which	leads	to	contraction	of	protrusions	in	neural	
crest	 cell	 (Carmona-Fontaine	 et	 al.,	 2008a;	 Matthews	 et	 al.,	 2008).	 Furthermore	
Wnt/PCP	activity	 leads	to	 inhibition	of	Rac1	at	the	point	of	contact,	 followed	by	a	
protrusion	 collapse	 (Matthews	 et	 al.,	 2008;	 Scarpa	 et	 al.,	 2015;	 Theveneau	 et	 al.,	
2010).	The	 inhibition	of	Rac1	could	be	due	to	the	antagonistic	behaviour	between	
RhoA	and	Rac1,	where	 the	activation	of	one	 results	 in	 the	 inhibition	of	 the	other	
(Shoval	and	Kalcheim,	2012).	Nevertheless,	 the	exact	molecular	mechanism	of	the	
Rac1	 inhibition	 and	 RhoA	 activation	 remains	 to	 be	 solved.	 However	 the	 partition	
defective	3	homologue	(PAR3)	polarity	molecule	has	been	shown	to	be	localized	to	
the	 point	 of	 cell-cell	 contact	 during	 CIL,	where	 it	 inhibits	 the	 Rac1	 activator,	 Trio	
(Moore	et	al.,	2013).	Additionally,	 it	has	been	reported	that	Trio	 is	recruited	upon	
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cadherin-11	activation	at	the	cell	contact	and	this	inhibition	could	provide	a	method	
for	RhoA	activation	and	Rac1	 inhibition	upon	cell-cell	contact	 (Becker	et	al.,	2013;	
Kashef	et	al.,	2009).		
But	not	only	neural	crest	cells	require	RhoA/ROCK	activation	at	the	contact	site	for	
CIL	 response,	depletion	of	either	RhoA	or	ROCK	 in	chick	heart	 fibroblasts	 leads	 to	
inhibition	 of	 protrusive	 activity	 upon	 collision	 and	 thus	 CIL	 (Kadir	 et	 al.,	 2011).	
Correspondingly,	 CIL	 in	 pancreatic	 cancer	 cells	 is	 coordinated	 by	 EphA-mediated	
ROCK	 and	 RhoA	 activation	 at	 the	 contact	 site	 (Astin	 et	 al.,	 2010).	 In	 addition	 the	
impairment	of	Rac1	by	use	of	either	a	dominant	active	or	dominant	negative	form	
in	fibroblasts	leads	to	the	loss	of	CIL	behaviour	(Anear	and	Parish,	2012).	Besides,	it	
has	recently	been	reported	that	Rac1	activity	in	colliding	fibroblasts	is	controlled	by	
the	 GAP	 srGAP2	 (SLIT-ROBO	 Rho	 GTPase-activating	 protein	 2)	 in	 the	 overlapping	
protrusions	(Fritz	et	al.,	2015).	They	report	that	slit-robo	signalling	is	stimulated	in	
the	overlapping	protrusions	at	the	site	of	contact	causing	the	activation	of	srGAP2	
and	 thus	 inhibition	 of	 Rac1	 activity	 (Fritz	 et	 al.,	 2015).	 Likewise	 CIL	 between	 glial	
cells	 is	 regulated	by	 the	 suppression	of	Rac1,	mediated	by	 the	 inactivation	of	 the	
guanine	nucleotide	exchange	 factor	TIAM1	 (T-lymphoma	 invasion	and	metastasis-	
inducing	protein	1)	(Tanaka	et	al.,	2012).		
(3)	Repolarization	and	protrusion	formation		
The	 next	 key	 step	 during	 CIL	 is	 the	 repolarization	 away	 from	 the	 site	 of	 contact,	
involving	a	switch	of	the	front-rear	polarity.	Not	only	has	RhoA	to	be	activated	and	
Rac1	to	inhibited	at	the	contact,	a	new	leading	edge	opposing	the	contact	needs	to	
be	 formed,	 depending	on	 changes	 in	 adhesions,	 small	 Rho	GTPases	 activities	 and	
cytoskeletal	 changes	 (Roycroft	 and	Mayor,	 2016).	 In	 order	 to	 form	a	new	 leading	
edge,	increase	in	Rac1	activity	away	from	the	contact	is	required	for	the	formation	
of	new	protrusions	in	neural	crest	cells	(Scarpa	et	al.,	2015;	Theveneau	et	al.,	2010).	
FRET	 analysis	 of	 Rac1	 activity	 in	 Xenopus	 neural	 crest	 cells	 showed	 that	 Rac1	 is	
activated	 in	 the	 leading	 front	 of	 the	 cell,	 but	 upon	 cell-cell	 contact	 Rac1	 gets	
inhibited	at	the	contact	and	becomes	activated	away	from	the	contact	site	(Scarpa	
et	al.,	2015).	Moreover	localized	photoactivation	of	Rac1	at	the	free	edge	leads	to	
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extension	 of	 a	 protrusion	 formation	 and	 increased	 separation	 of	 cell-cell	 duplets	
(Scarpa	et	al.,	2015).	In	contrast,	the	photoactivation	of	a	dominant	negative	form	
inhibits	protrusion	formation	and	impairs	separation	of	a	cell-cell	duplet	in	Xenopus	
neural	 crest	 cells	 (Scarpa	et	 al.,	 2015).	Neural	 crest	 cell	 duplets	overexpressing	E-
cadherin	do	not	separate	after	colliding	due	to	an	increased	Rac1	activity	at	the	cell-
cell	 contact.	 However	 activation	 of	 photoactivatable	 Rac1	 away	 from	 the	 contact	
was	able	 to	 trigger	 separation,	 thus	 illustrating	 the	 importance	of	Rac1	activity	 in	
the	leading	edge	for	repolarization	(Roycroft	and	Mayor,	2016;	Scarpa	et	al.,	2015).		
Not	only	changes	in	Rac1	polarity,	but	also	microtubule	remodeling	has	been	shown	
to	be	required	for	switch	of	cell	repolarization	during	CIL	(Kadir	et	al.,	2011;	Moore	
et	 al.,	 2013;	 Nagasaki	 et	 al.,	 1992).	 In	 general,	 in	 a	 migrating	 cell,	 microtubules	
strengthen	 polarity	 and	 are	 stabilized	 in	 the	 front	 of	 the	 cell	 (Bershadsky	 et	 al.,	
1991;	 Glasgow	 and	 Daniele,	 1994).	 After	 cell	 collision	 of	 neural	 crest	 cells	
microtubules	at	the	site	of	contact	show	an	increase	in	microtubule	catastrophe	at	
the	 contact	 site	 during	 CIL	 (Moore	 et	 al.,	 2013).	 This	 increase	 of	 dynamic	
microtubule	 after	 collision	 has	 been	 shown	 to	 be	 essential	 for	 CIL	 (Batson	 et	 al.,	
2013;	 Kadir	 et	 al.,	 2011;	Moore	 et	 al.,	 2013;	 Stramer	 et	 al.,	 2010).	 As	mentioned	
before	 in	Xenopus	neural	 crest	 cells,	 this	dynamic	action	of	microtubules	 requires	
the	cell	polarity	protein,	Par3	(Moore	et	al.,	2013).	Par3	concentrates	to	the	cell–cell	
contact	upon	 collision	where	 it	 stimulates	microtubule	 catastrophe	 (Moore	et	 al.,	
2013).	 The	 microtubule	 catastrophe	 in	 neural	 crest	 cells	 is	 trigged	 through	 the	
inhibition	of	the	GEF	Trio	and	following	inhibition	of	Rac1	(Moore	et	al.,	2013).	Also	
in	 Drosophila	 haemocytes	 microtubule	 catastrophe	 is	 required	 for	 a	 normal	 CIL	
response	 (Stramer	 et	 al.,	 2010).	 Additionally	 it	 has	 been	 shown	 that	microtubule	
bundles	 of	 two	 colliding	 haemocytes	 align	 before	 they	 collapse	 (Stramer	 et	 al.,	
2010).		
(4)	Cell	separation	and	migration	away	from	the	collision	
The	 next	 step	 of	 CIL,	 after	 repolarization,	 is	 the	 separation	 of	 the	 cells	 and	 the	
migration	 away	 from	 the	 colliding	 cell.	 So	 far	 the	 sequence	 of	 events	 during	
repolarization,	protrusion	formation	and	separation	during	CIL	has	not	resolved	yet	
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(Stramer	 and	 Mayor,	 2016).	 In	 Drosophila	 haemocytes	 and	 chick	 fibroblasts	 the	
protrusion	 collapse	 at	 the	 cell-cell	 contact,	 precedes	 the	 repolarization	 and	 new	
protrusion	formation	away	from	the	contact	(Abercrombie,	1978;	Abercrombie	and	
Ambrose,	1958;	Davis	et	al.,	2015).	Though,	 in	Xenopus	neural	crest	cells,	the	new	
protrusion	formation,	and	thus	repolarization	precedes	the	loss	of	cell-cell	contact.	
Moreover	 the	 repolarization	 and	 protrusion	 formation	 have	 been	 implicated	 to	
generate	the	tension	needed	for	cell	separation	in	neural	crest	cells	(Scarpa	et	al.,	
2015).	Since	Abercrombie	1958	it	has	been	thought	that	tension	build-up	across	the	
contacting	 lamellae	 could	 be	 essential	 for	 the	 cell	 separation	 (Abercrombie	 and	
Ambrose,	 1958;	 Davis	 et	 al.,	 2015;	 Harris,	 1973;	 Heaysman	 and	 Pegrum,	 1973).	
Nevertheless,	 it	 remains	 unsolved	 how	 this	 tension	 is	 established	 and	 if	 it	 is	
sufficient	 for	 cell	 separation.	 Furthermore	 how	 cell	 separation	 is	 started	 remains	
controversial.	 Its	 been	 suggested	 that	 it	 could	 be	 triggered	by	 the	 endocytosis	 or	
disassembly	of	adhesion	complexes	between	the	cells	 (Roycroft	and	Mayor,	2016;	
Scarpa	 et	 al.,	 2015).	 However	 it	 is	 also	 possible	 that	 high	 tension	 build	 up	 by	
activation	of	RhoA/ROCK	and	microtubule	disassembly	at	 the	contact	 leads	 to	 the	
cell	separation	(Astin	et	al.,	2010;	Carmona-Fontaine	et	al.,	2008a;	Kadir	et	al.,	2011;	
Matthews	et	al.,	2008;	Moore	et	al.,	2013;	Roycroft	and	Mayor,	2016;	Stramer	et	
al.,	 2010).	 In	 neural	 crest	 cells	 the	 cell-cell	 adhesion	 is	 not	 perturbed	 if	 cell	
protrusion	formation	is	inhibited	away	from	the	contact	(Scarpa	et	al.,	2015).	Thus	
suggesting	that	neural	crest	cells	first	need	to	separate	before	the	cell-cell	adhesion	
is	disassembled.	Moreover,	as	mentioned	before	Scarpa	et	al.	 (2015)	showed	that	
forced	protrusion	formation	by	photoactivatable	Rac1	in	E-cadherin	overexpressing	
cells	is	sufficient	to	separate	cell	neural	crest	cell	duplets.	This	suggests	that	neural	
crest	 cell	 separation	 is	 mainly	 regulated	 by	 the	 repolarization	 and	 subsequent	
tension	 build	 up	 across	 the	 membrane,	 then	 disassembly	 of	 cell-cell	 adhesion	
complexes.	
After	 repolarization	 and	 separation	 the	 final	 step	 in	 CIL	 program	 is	 the	migration	
away	 from	 the	 contact	 site.	 To	 allow	 this	 migration	 a	 reorganization	 of	 cell-
substrate	 traction	 stresses,	 via	 the	 modification	 of	 focal	 adhesions	 (Stramer	 and	
Mayor,	 2016).	 For	 example,	 in	 Drosophila	 CIL-driven	 macrophage	 dispersion,	
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integrin,	responsible	to	link	the	focal	adhesion	to	the	migration	substrate,	has	been	
shown	 to	 be	 required	 for	 normal	 development	 (Comber	 et	 al.,	 2013).	 In	Xenopus	
neural	crest	cells	focal	adhesion	reorganization	during	CIL	has	been	observed.	Cells	
undergoing	CIL	 reduce	 their	 focal	 adhesions	 at	 the	 cell-cell	 contact	 (Scarpa	et	 al.,	
2015;	Theveneau	et	al.,	2013),	which	could	lead	to	a	change	in	cell-matrix	traction	
stresses	 away	 from	 the	 contact,	 and	 finally	 cause	 movement	 away	 from	 the	
colliding	partner.	However,	Abercrombie	did	not	see	any	changes	in	focal	adhesion	
before	 cell	 separation	 during	 chick	 embryonic	 fibroblast	 CIL	 (Abercrombie	 and	
Dunn,	1975).	This	might	imply	that	focal	adhesion	changes	during	CIL	could	be	cell-
type	dependent	(Stramer	and	Mayor,	2016).	
1.3.4 Contact	inhibition	in	embryonic	development	
CIL	has	been	implicated	more	recently	in	embryonic	processes.	It	has	emerged	that	
it	is	not	only	a	cell-cell	interaction	in	vitro,	but	can	instruct	development	within	cell	
populations	 in	 vivo	 (Stramer	 and	 Mayor,	 2016).	 Recent	 developments	 of	 in	 vivo	
imaging	have	brought	CIL	into	the	attention	of	embryonic	development.	Processes	
such	 as	 cellular	 dispersion,	 cellular	 tilling	 and	 collective	 migration	 have	 been	
connected	to	CIL	(Roycroft	and	Mayor,	2016;	Stramer	and	Mayor,	2016)	and	will	be	
discussed	 in	 detail	 in	 this	 section	 with	 specific	 emphasis	 on	 neural	 crest	 cell	
development	(see	also	Figure	1-11).	
Contact	inhibition	of	locomotion	and	cellular	dispersion	
Abercrombie	(1962)	first	described	the	ability	of	CIL	to	disperse	a	cell	cluster	as	
	“Negative	taxis…	to	promote	movement	into	space	where	contact	
inhibition	does	not	operate”		
Dispersion	of	cells	via	CIL	has	been	widely	described	in	cell	culture	(see	also	section	
1.3.2	 radial	 outgrowth;	 Stramer	 and	Mayor,	 2016).	More	 recently,	 in	 vivo	 and	 in	
vitro	studies	of	Cajal-Retzius	cells	described	their	CIL	response	to	be	necessary	for	
their	 spreading	 throughout	 mammalian	 cerebral	 cortex	 (Figure	 1-11	 a;	 Villar-
Cerviño	et	al.,	2013).	Cajal-Retzius	are	 induced	 in	distinct	regions	of	the	brain	and	
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spread	 throughout	 the	 cerebral	 cortex	 and	 control	 the	 development	 of	 cortical	
layers	by	regulating	migration	of	other	neuronal	cells.	Thus	inhibition	of	CIL	in	Cajal-
Retzius	cells	 leads	to	cell	clustering	and	thus	severe	impairment	of	cerebral	cortex	
development.	 The	 Cajal-Retzius	 CIL-dependent	 dispersion	 was	 found	 to	 be	
regulated	by	Eph/ephrin	signalling	(Villar-Cerviño	et	al.,	2013).	
Contact	inhibition	of	locomotion	and	cellular	tiling	
Cellular	 tilling	describes	 the	 cell	 dispersion	during	embryogenesis	where	 cells	 end	
up	in	a	highly	organized	pattern.	This	process	can	be	regulated	by	CIL,	as	shown	for	
the	 homogenous	 Drosophila	 macrophage	 dispersion	 (Figure	 1-11	 b;	 Davis	 et	 al.,	
2012;	Davis	et	al.,	2015).	Analysis	with	live	imaging	and	computational	modelling	in	
the	 Drosophila	 embryo	 revealed	 that	 macrophage	 evenly	 spaced	 dispersion	 is	
regulated	 by	 CIL.	 The	 distinction	 between	 the	 above	 mentioned	 CIL	 driven	
dispersion	of	Cajal-Retzius	and	tilling	of	macrophages,	could	be	related	to	the	more	
precise	coordinated	CIL	 in	the	latter	(Davis	et	al.,	2015;	Stramer	and	Mayor,	2016;	
Villar-Cerviño	 et	 al.,	 2013).	 Davis	 et	 al.	 2015	 showed	 that	 precise	 repulsion	 and	
patterning	involves	the	coordination	of	intracellular	forces	during	the	CIL	response	
in	 vivo.	 This	 CIL	 tilling	 is	 orchestrated	 by	 the	 cell-cell	 adhesions	 and	 subsequent	
action-myosin	networks	drive	the	uniform	dispersion	of	the	CIL	response	(Davis	et	
al.,	2015).	
Contact	inhibition	of	locomotion	and	collective	cell	migration	
Contact	 inhibition	as	discussed	before	 (1.1.3	Contact	 inhibition	of	 locomotion	and	
collective	migration)	 has	 been	 shown	 to	 be	 necessary	 for	 collective	migration	 of	
neural	crest	cells	(Figure	1-11	c;	Carmona-Fontaine	et	al.,	2008b;	Moore	et	al.,	2013;	
Theveneau	 et	 al.,	 2010).	 Not	 only	 has	 CIL	 behaviour	 of	 neural	 crest	 cells	 been	
described	in	vitro.	Live-imaging	in	vivo	experiments	have	revealed	that	Xenopus	and	
zebrafish	 neural	 crest	 cells	 undergo	 a	 CIL	 response	 during	 their	 migration	
comparable	 to	 those	 observed	 in	 culture	 (Carmona-Fontaine	 et	 al.,	 2008b;	
Theveneau	et	al.,	2010).	Different	experiments	showed	that	impairment	of	CIL	leads	
to	inhibition	of	Xenopus	neural	crest	cell	collective	movement	in	vivo	(Moore	et	al.,	
2013;	Scarpa	et	al.,	2015;	Theveneau	et	al.,	2010).			
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A	 number	 of	molecules	 have	 been	 found	 to	 be	 regulating	 this	 process,	 including	
Wnt/PCP	pathway	and	N-cadherin	 (Carmona-Fontaine	et	al.,	2008b;	Theveneau	et	
al.,	 2010).	 For	 example	 N-cadherin	 based	 adherents	 junctions	 between	 cells	 are	
crucial	 for	 CIL	 in	Xenopus	 cranial	 neural	 crest	 cells	 (Theveneau	et	 al.,	 2010).	 If	N-
cadherin	 is	 inhibited,	using	a	Morpholino	or	blocking	antibody,	protrusions	are	no	
longer	 repressed	 at	 the	 cell-cell	 contact	 and	 CIL	 is	 impaired	 in	 vitro	 and	 in	 vivo	
(Theveneau	 et	 al.,	 2010).	 The	 presence	 of	 E-cadherin	 however	 suppresses	 CIL	
(Scarpa	et	al.,	2015).	The	switch	between	the	CIL-suppressive	cadherin	(E-cadherin)	
and	 the	 CIL-supportive	 cadherin	 (N-cadherin),	 has	 been	 recently	 described	 has	 a	
requirement	for	EMT	program.	The	restrain	of	protrusions	via	CIL	together	with	the	
chemokine	 cue	 SDF-1,	 from	 the	 placodes,	 is	 thought	 to	 give	 the	 neural	 crest	 cell	
population	polarity	and	admits	collective	migration	 (Theveneau	et	al.,	2010).	Thus	
the	 authors	 termed	 CIL	 response	 in	 a	 neural	 crest	 cell	 streams	 also	 “contact-
dependent-polarity”	(Theveneau	et	al.,	2010).	
CIL	 does	not	only	occur	homotypically	 between	neural	 crest	 cells,	 heterotypic	CIL	
response	 between	 neural	 crest	 cells	 and	 the	 underlying	 placodes	 have	 also	 been	
described	 essential	 for	 collective	migration	 (Figure	 1-11;	 Theveneau	 et	 al.,	 2013).	
Placodes	 are	 the	 source	 of	 the	 chemokine	 SDF-1	 and	 attract	 neural	 crest	 cells.	
Though	the	placodal	cells	respond	with	a	CIL	reaction	to	neural	crest	cells,	triggering	
a	mechanism	termed	“chase-and-run”.	Whereby	neural	crest	cells	are	attracted	to	
the	 placodal	 cells,	 which	 in	 turn	 migrate	 away	 (Theveneau	 et	 al.,	 2013).	 The	
interplay	of	CIL	and	chemotaxis	might	be	a	 common	 thing,	as	a	 similar	behaviour	
has	also	been	reported	in	breast	melanoma	in	vitro	(Lin	et	al.,	2015).	
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Figure	1-11	Contact	inhibition	in	vivo	
(a)	 CIL	 regulated	 cell	 dispersion	 of	 Cajal-Retzius	 cells	 during	mammalian	 cerebral	
cortex	development,	similar	to	radial	outgrowth	from	an	explant.	(b)	Cellular	tilling	
of	 Drosophila	 macrophages	 is	 controlled	 by	 precise	 CIL	 responses.	 (c)	 Collective	
migration	of	neural	crest	cells	 is	regulated	by	homotypic	CIL	 interactions,	together	
with	 Co-attraction.	 (D)	 The	 movement	 of	 neural	 crest	 cells	 is	 also	 regulated	 by	
heterotypic	CIL	between	neural	crest	cells	and	placodal	cells,	in	a	mechanism	where	
the	neural	crest	cells	“chase”	towards	the	placodes	(triggered	by	SDF-1	chemotaxis),	
leading	 the	placodes	 to	 “run”	 (triggered	by	CIL)	away.	Adapted	 from	Stramer	and	
Mayor,	2016.	
1.4 Hypothesis		
1.4.1 Hypothesis	background	
The	 receptor	 tyrosine	 kinase	 pathway	 Platelet-derived	 growth	 factor	 (PDGF)	 has	
been	implicated	in	EMT	during	cancer	invasion	(Eckert	et	al.,	2011;	Jechlinger	et	al.,	
2006a;	Thiery	and	Sleeman,	2006)	and	it	is	essential	for	the	correct	development	of	
several	neural	crest	cell	derivatives	 (Morrison-Graham	et	al.,	1992;	Soriano,	1997;	
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Tallquist	 et	 al.,	 2003).	 Perturbations	 of	 PDGFRα	 signalling	 in	mouse	 and	 zebrafish	
lead	 to	 severe	 defects	 in	 cranial	 neural	 crest	 cell	 derived	 tissues,	 suggesting	
developmental	role	of	PDGFRα	signalling	in	neural	crest	cell	development	towards	
its	 craniofacial	 targets	 (Eberhart	 et	 al.,	 2008;	 He	 and	 Soriano,	 2013;	 Morrison-
Graham	 et	 al.,	 1992;	 Soriano,	 1997;	 Tallquist	 et	 al.,	 2003).	 However,	 the	 specific	
mechanism	by	which	 PDGF	 controls	 the	 formation	 of	 neural	 crest	 cell	 derivatives	
has	 not	 been	 completely	 elucidated,	 as	 evidence	 suggest	 it	 is	 involved	 in	 cell	
migration	and	proliferation	(Eberhart	et	al.,	2008;	He	and	Soriano,	2013;	Smith	and	
Tallquist,	2010).		
1.4.2 Hypothesis	
Thus,	I	am	proposing	the	following	hypothesis:		 
“PDGF-A/PDGFRα	signalling	controls	collective	migration	of	neural	
crest	cell	migration	in	Xenopus	laevis” 
In	order	to	test	this	hypothesis	the	following	questions	will	be	addressed:		
1.	Are	the	ligand	PDGF-A	and	its	receptor	PDGFRα	expressed	in	neural	
crest	cells	during	Xenopus	laevis	development?	
2.	Is	PDGF-A/PDGFRα	signalling	required	for	neural	crest	cell	migration	
in	vivo	and	in	vitro?	
3.	What	are	the	cellular	activities	controlled	by	PDGF-A/PDGFRα	
signalling	during	neural	crest	cell	migration?		
4.	Which	are	the	downstream	targets	of	PDGF-A/PDGFRα	signalling	that	
are	required	for	neural	crest	cell	migration?	
5.	What	are	the	signalling	pathways	downstream	of	the	PDGF-
A/PDGFRα	signalling	response	during	neural	crest	cell	migration?	 	
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Chapter	2 Experimental	Procedures	
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2.1 Embryological	and	Histological	Procedures	 
2.1.1 In	vitro	fertilization	and	embryo	collection	of	Xenopus	laevis	embryos	
Xenopus	laevis	were	obtained	from	Portsmouth	Animal	Facility,	UK	and	Nasco,	USA.	
Ovulation	 was	 induced	 with	 100	 units	 of	 gonadotropic	 hormone	 (pregnant	mare	
serum	gonadotropin	hormone	PMSG;	Intervet)	2-5	days	before	the	experiment	and	
with	500	units	of	human	chorionic	gonadotropin	hormone	(Chorulon;	 Intervet)	16	
hours	 before	 the	 experiment.	 During	 egg	 laying	 females	 were	 held	 in	 modified	
ringer	solution	 (MMR:	100	mM	NaCl,	2	mM	KCl,	1	mM	MgS04,	2	mM	CaC2,	5	mM	
Hepes,	 0.1	 mM	 EDTA,	 pH	 7.6)	 at	 17-18	 °C,	 conserving	 the	 mature	 oocytes	
inactivated	until	fertilisation.	Male	Xenopus	laevis	were	culled	by	anaesthetizing	in	
0.5	%	Tricaine	 solution	 for	minimum	of	40	minutes,	 followed	by	decapitation	and	
pithing.	 Testes	 were	 dissected	 and	 kept	 in	 Leibovitz	 L-15	 medium	 (Invitrogen,	
11415-064)	with	added	streptomycin	(5	μg	mL-1,	Sigma,	85886)	at	4	°C	for	up	to	4	
days.	The	Oocytes	were	collected	in	a	petri	dish	excessive	MMR	was	removed	and	
fertilised	 with	 homogenized	 testes	 tissue.	 After	 an	 incubation	 period	 of	 15-30	
minutes,	NAM1/10	(normal	amphibian	medium	1/10:	11	mM	NaCa,	0.2	mM	KCl,	0.1	
mM	Ca(NO3)2,	0.1	mM	MgS04,	10	μM	EDTA,	0.2	mM	NaH2PO4,	0.1	mM	NaHCO3,	pH	
7.5,	50	μg	mL-1	streptomycin)	was	applied	to	the	fertilisation.	After	approximately	2	
hours	 cortical	 rotation	 and	 the	 first	 division	 of	 the	 embryo	 was	 observed.	
Subsequently	 the	 embryos	were	dejellied	by	 incubation	 in	 2	%	 L-cysteine	 (Sigma)	
solution	 for	5-10	minutes. Embryos	were	kept	at	14.5	 °C	 in	NAM1/10	and	 staged	
according	 to	Nieuwkoop	 and	 Faber	 (1967)	 normal	 table	 of	Xenopus	development	
table. 
2.1.2 Microinjection	of	Xenopus	laevis	embryos	
Xenopus	laevis	embryos	were	injected	using	a	Narishige	IM300	microinjector	under	
a	 LeicaMZ6	 or	 a	 Nikon	 SMZ645	 dissecting	microscope.	 Needles	 were	made	 from	
borosilicate	glass	capillaries	(Intracel,	01-001-	06)	with	0.58	mm	inner	diameter	by	
pulling	the	capillaries	on	a	Narishige	PC-10	puller	set	to	2	step	mode;	with	the	first	
step	 regulated	 to	 86	 %	 capacity	 and	 second	 step	 regulated	 to	 99	 %	 capacity.	
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Subsequently	needles	were	calibrated	using	an	eyepiece	graticule	to	inject	a	volume	
of	 5	 nL	 or	 10	 nL	 per	 injection.	 The	 needles	 were	 filled	 with	 the	 solution	 to	 be	
injected,	 such	 as	 mRNA,	 DNA	 or	 antisense	 Morpholinos	 (see	 Table	 2-1	 List	 of	
injected	mRNA	and	Morpholinos)	and	embryos	were	 injected	at	either	4-cell	or	8-
cell	 stage	 in	a	3	%	polysucrose	 (Sigma)	solution	 in	NAM	3/8	 (40.7	mM	NaCa,	0.74	
mM	KCl,	0.37	mM	Ca(NO3)2,	0.37	mM	MgSO4,	37	μM	EDTA,	0.37	mM	NaH2PO4,	0.1	
mM	NaHPO4,	pH	7.5,	50	μg	mL-1	streptomycin)	at	17	°C.	Fluorescein-dextran	(FDX;	
Invitrogen,	D1821,	20	ng/10	nL	 injection)	or	Rhodamine-dextran	 (RDX;	 Invitrogen,	
D1824,	 20	 ng/10	 nL	 injection)	 were	 used	 as	 tracers	 if	 needed.	 For	 injection	 of	
Morpholinos	and	mRNAs	the	neural	crest	cells	were	targeted	by	injection	at	the	8-
cell	 stage,	 into	 the	 dorsal	 animal	 blastomere	 and	 the	 ventral	 animal	 blastomere	
(Figure	2-1).	Following	injection	the	embryos	were	left	 in	Ficoll	solution	for	1	hour	
to	 overnight	 at	 14.5	 °C,	 before	 being	 transferred	 to	 NAM	 1/10.	 Embryos	 were	
generally	developed	at	14.5	°C	although	temperature	could	be	varied	from	14	°C	–	
18	°C	to	alter	the	timing	of	development	and	experiments.	
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Figure	2-1	mRNA	and	Morpholino	neural	crest	targeting	injection	scheme	
(A)	 8-cell	 stage	 Xenopus	 laevis	 embryo	 animal	 view.	 (B)	 8-cell	 Xenopus	 laevis	
embryo	 dorso-lateral	 view.	 (A,	 B)	 For	 injection	 of	 Morpholinos	 and	 mRNAs	 the	
neural	 crest	 cells	 were	 targeted	 by	 injection	 at	 the	 8-cell	 stage	 into	 the	 dorsal	
animal	 blastomere	 and	 the	 ventral	 animal	 blastomere	 (red	 crosses).	 (C)	 Xenopus	
laevis	embryo	stage	16	Neural	crest	cell	target	region	at	stage	18	depicted	in	blue	
(images	from	Nieuwkoop	et	al.,	1994)	
	
ventral	
dorsal	
animal	
vegetal	
a	animal	view	(8-cell)	 b	dorso-lateral	view	(8-cell)		
c	dorsal	view	(stage	16)	
anterior	
posterior	
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Table	2-1	List	of	injected	mRNA	and	Morpholinos	
Construct	 Name	 Plasmid	
Amount	(total/	10	
nL	injection	
concentration)	
membrane	RFP mRFP	mRNA	
pCS2+	
(Theveneau	
et	al.,	2010)	
300	pg/	30	ng	μL-1	
membrane	GFP	 mGFP	mRNA	
pCS2+	
(Theveneau	
et	al.,	2010)	
300	pg/	30	ng	μL-1	
nuclear	H2B	RFP	 nRFP	mRNA	
pCS2+	
(Theveneau	
et	al.,	2010)	
300	pg/	30ng	μL-1	
life	actin	
mCherry		 liveActin	
pCS2+	
(Scarpa	et	
al.,	2015)	
300	pg/	30	ng	μL-1	
Xenopus	laevis	
PDGFRαw37	 dom.	neg.	PDGFRα	mRNA	 pALTER-1	(Ataliotis	et	al.,	1995)	 300	pg/	30	ng	μL-1	
zebrafish	ph-AKT-
GFP	 ph-AKT-GFP	mRNA	
pCS2+	
(Montero	et	
al.,	2003)	
500	pg/	50	ng	μL-1	
zebrafish	PI3K-
p110-CAAX	 PI3K-CAAX	mRNA	
pCS2+	
(Montero	et	
al.,	2003)	
300	pg/	30	ng	μL-1	
mouse	PDGF-A		 mouse	PDGF-A	mRNA	
pGEM-1	
(Fruttiger	et	
al.,	1999)	
200	pg/	20	ng	μL-1	
mouse	PDGFRα	 mouse	PDGFRα	mRNA	 pGEM-1	(IMAGE	ID	
5704645)	
300	pg/	30	ng	μL-1	
Chick	N-cadherin-
GFP	 N-cadherin	mRNA	
pCS2+	
(Scarpa	et	
al.,	2015)	
500	pg/	50	ng	μL-1	
PDGFRα	
Morpholino	 PDGFRa	MO	mRNA	 -	 16	ng/	16	μg	μL
-1	
PDGF-A	
Morpholino	 PDGF-A	MO	mRNA	 -	 16	ng/	16	μg	μL
-1	
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2.1.3 Microdissection	and	neural	crest	cells	culture		
Microdissection	 was	 performed	 as	 previously	 described	 (Theveneau	 et	 al.,	 2010)	
Briefly,	 neural	 crest	 cells	 were	 microdissected	 with	 help	 of	 an	 eyebrow	 knife	 at	
stage	17	from	Xenopus	 laevis	embryos	 in	3/8	NAM	(40.7	mM	NaCa,	0.74	mM	KCl,	
0.37	 mM	 Ca(NO3)2,	 0.37	 mM	MgSO4,	 37	 μM	 EDTA,	 0.37	 mM	 NaH2PO4,	 0.1	 mM	
NaHPO4,	pH	7.5,	50	μg	mL-1	 streptomycin)	at	17	 °C.	Before	 the	 start	of	dissection	
the	vitelline	membrane	was	removed	with	the	help	of	forceps	and	the	embryo	was	
placed	 at	 14.5	 °C	 for	 at	 least	 15	 minutes	 to	 heal.	 To	 fix	 the	 embryos	 during	
dissection,	embryos	were	embedded	into	plasticine	and	the	ectoderm,	superficial	to	
the	 neural	 crest,	 cells	 was	 removed.	 Subsequently	 the	 neural	 crest	 cells	 were	
dissected	and	transferred	to	a	plastic	dish	containing	Danilchick’s	Medium	(DFA,	53	
mM	 NaCl,	 	5	 mM	 Na2CO3,	4.5	 mM	 K-Gluconate,	 32	 mM	 Na-Gluconate,	 1	 mM	
MgSO4,		 1	mM	CaCl2,	 	0.1	%	BSA,	 pH	 8.3	,	 50	 μg	mL
-1	 streptomycin).	Neural	 crest	
explants	 were	 further	 dissected	 into	 small	 clusters	 and	 plated	 on	 a	 fibronectin-
coated	dish.	Dishes	were	coated	using	10	μg	mL-1	or	50	μg	mL-1	fibronectin	(Sigma)	
for	 plastic	 or	 glass	 dishes,	 respectively.	 For	 single	 cell	 experiments	 the	 explants	
were	 fully	dissociated	 in	calcium	and	magnesium	free	DFA	 for	3-5	minutes	before	
culturing	 on	 fibronectin-coated	 dishes	 in	 normal	 DFA.	 Cells	 and	 explants	 were	
incubated	 for	 at	 least	 20-30	 minutes	 before	 imaging.	 Plastic	 dishes	 (single	 well:	
Falcon	 50	 x	 9	 mm;	 4-well:	 ThermoFischer	 multidish)	 and	 glass	 bottomed	 dishes	
(Greiner	 bio-one	 35	 mm	 4	 compartments	 or	 FluoroDish	 35	 mm)	 and	 coverslips	
(Academy	Dia.	13,	0.13-0.16	mm	thick)	were	incubated	with	fibronectin	for	1	hour	
at	 37	 °C	 prior	 to	 plating.	 After	 coating	with	 fibronectin,	 the	 dishes	were	washed	
with	1x	PBS	and	subsequently	blocked	with	0.1	%	bovine	serum	albumin	(BSA)	in	1x	
PBS	for	15-30	minutes	at	37	°C.	Afterwards	the	dishes	were	washed	again	with	1x	
PBS	before	DFA	was	added	and	the	dishes	were	cooled	to	17	°C.	
2.1.4 Whole	mount	in	situ	hybridisation		
In	situ	hybridisation	was	performed	as	described	previously	reported	(Fawcett	and	
Klymkowsky,	2004;	Harland,	1991).	If	not	stated	otherwise	steps	were	performed	at	
room	temperature.	 In	 short,	embryos	were	 fixed	at	 the	 required	stage	 in	MEMFA	
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(100	mM	MOPS,	 1	mM	MgSO4,	 2	mM	 EGTA,	 3.7	 %	 formaldehyde)	 for	 1	 hour	 at	
room	temperature	or	over	night	at	4	°C.	After	fixation	embryos	were	dehydrated	in	
100	%	methanol	with	3	washes	for	5	min	and	subsequently	stored	at	-20	°C	for	up	
to	 2	month.	 To	 start	 the	 in	 situ	 hybridisation	 the	 fixed	 embryos	were	 rehydrated	
with	 successive	 washes	 of	 5	 minutes	 each,	 of	 75	 %	 methanol	 in	 1x	 PBS,	 50	 %	
methanol	 in	1	x	PBS,	25	%	methanol	 in	1	x	PBS.	Followed	by	3	washes	 in	1	x	PBS.	
Subsequently	embryos	were	bleached	in	bleaching	buffer	(20	%	H202,	2.5	%	saline-	
sodium	 citrate	 buffer	 (20	 x	 SSC:	 3	M	NaCl,	 0.3	M	 tri-sodium	 citrate,	 pH	7.0),	 5	%	
formamide)	for	approximately	20	minutes	in	the	dark.	Embryos	were	then	washed	3	
times	 in	1	x	PBS	and	fixed	again	 in	3.7	%	formaldehyde	in	1	x	PBS	for	30	minutes,	
followed	by	3	washes	in	1	x	PBS.	Embryos	were	then	transferred	into	hybridisation	
buffer	(50	%	formamide,	5	x	SSC,	1	x	Denhardt's	solution,	1	mg	mL-1	ribonucleic	acid,	
100	 μg	 mL-1	 heparin,	 0.1	 %	 CHAPS,	 10	 mM	 EDTA,	 0.1	 %	 Tween-20,	 pH	 5.5)	 and	
incubated	at	65-68	 °C	 for	30-60	minutes.	Afterwards	 the	hybridisation	buffer	was	
replaced	hybridisation	buffer	containing	digoxigenin-labelled	probe	at	65-68	°C	and	
the	embryos	were	incubated	over	night.	After	over	night	hybridisation,	the	embryos	
were	 washed	 in	 a	 series	 of	 washes	 at	 65-68	 °C	 for	 10	 minutes	 each:	 washing	
solution	1	(50	%	formamide,	10	%	20	x	SSC,	0.1	%	Tween-20);	washing	solution	2	(25	
%	 formamide,	 10	 %	 20	 x	 SSC,	 0.1	 %	 Tween-20);	 washing	 solution	 3	 (12.5	 %	
formamide,	 10	 %	 20	 x	 SSC,	 0.1	 %	 Tween-20);	 washing	 solution	 4	 (2x	 SSC,	 0.1	 %	
Tween-20).	Followed	by	a	last	wash	in	washing	solution	5	(0.2	x	SSC,	0.1	%	Tween-
20)	for	30	minutes	at	65-68	°C.	All	solutions	and	buffers	used	up	to	this	point	were	
made	with	autoclaved	DEPC-treated	water	(0.1	%	diethylpyrocarbonatein	in	ddH2O)	
to	prevent	RNase	contamination	and	thus	degradation	of	the	probe.	Embryos	were	
then	washed	twice	with	1x	PBS	and	equilibrated	for	blocking	with	3	washes	 in	1	x	
MAB	 (maleic	acid	buffer	100	mM	maleic	acid,	150	mM	NaCl,	0.1	%	Tween-20,	pH	
7.6).	Followed	by	blocking	 in	2	%	BMBR	(Boehringer	Mannheim	Blocking	Reagent;	
Roche,	11096176001)	 in	1	x	MAB	for	2	hours	or	at	4	°C	over	night.	Embryos	were	
incubated	 overnight	 at	 4	 °C	 with	 an	 anti-digoxigenin-alkaline	 phosphatase	 (AP)	
conjugated	antibody	(Roche,	11093274910)	in	a	dilution	of	1:3000	in	2	%	BMBR	in	1	
x	 MAB.	 Subsequently	 embryos	 were	 washed	 5	 times	 in	 1	 x	 MAB	 buffer	 for	 30	
minutes	each.	Embryos	were	then	equilibrated	to	AP	buffer	(100	mM	NaCl,	50	mM	
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MgCl2,	100	mM	Tris-HCL	pH	9.8,	0.1	%	Tween-20)	with	3	washes	each	15	minutes.	
Followed	 by	 developing	 the	 colorimetric	 reaction	 in	 the	 dark	 using	 75	 μg	mL-1	 5-
bromo-4-chloro-3-indoyl-phosphate	(Roche,	11585002001)	and	150	μg	mL-1	4-nitro	
blue	 tetrazolium	 chloride	 (Roche,	 11383213001).	 The	 reaction	 was	 stopped	 by	 3	
washes	in	1	x	PBS	and	background	staining	was	removed	by	20	minutes	incubation	
in	100	%	methanol.	Embryos	were	then	fixed	in	3.7	%	formaldehyde	in	1vx	PBS	and	
stored	 at	 room	 temperature	 until	 they	 were	 photographed.	 The	 ribonuclease	
probes	used	 in	this	thesis	were	against	Xenopus	 laevis	Snail2	 (Mayor	et	al.,	1995),	
Xenopus	 laevis	 Twist	 (Hopwood	et	 al.,	 1989),	Xenopus	 laevis	 PDGFRα	 (Ataliotis	 et	
al.,	1995)	and	Xenopus	laevis	PDGF-A	(Nagel	et	al.,	2004).	
2.2 Molecular	biology	and	biochemistry	
2.2.1 Amplification	of	plasmid	DNA	clones	
Plasmid	 DNA	 was	 amplified	 by	 transforming	 50-100	 ng	 of	 DNA	 into	 heat	 shock	
competent	Escherichia	Coli	of	the	DH5α	strain	(Invitrogen).	Briefly,	DNA	was	added	
to	 the	 30	μL	 bacteria	 cells	 suspension	on	 ice	 and	 incubated	 for	 30	minutes.	 Cells	
were	heat	shocked	for	45	seconds	at	42	°C	and	subsequently	incubated	on	ice	for	2	
minutes.	Then	500	μL	of	LB	broth	(20	g	L-1	LB	Broth,	Sigma)	was	added	and	bacteria	
were	incubated	for	1	hour	at	37	°C.	Following	100	μL	of	the	bacteria	culture	were	
spread	on	to	a	preheated	LB	agar	plate	with	Ampicillin	(37	g	L-1	LB	Agar,	Sigma;	100	
μg	mL	 -1	 Ampicillin)	 and	 incubated	over	 night	 at	 37	 °C.	 Colonies	were	picked	 and	
amplified	 in	 50-100	 mL	 of	 LB	 broth	 supplemented	 with	 50	 μg	 mL-1	 Ampicillin	
overnight	 in	 a	 shacking	 incubator	 at	 37	 °C.	 Following	 plasmid	 DNA	 was	 purified	
using	a	Plasmid	Midiprep	Kit	(Qiagen).	DNA	was	re-suspended	in	100	μL	of	nuclease	
free	 H20	 (Ambion)	 and	 subsequently	 quantified	 using	 a	 Nanodrop	
Spectrophotometer	NDL2000.		
2.2.2 Synthesis	of	mRNA	for	microinjection		
For	sense	mRNA	synthesis,	plasmid	DNA	was	linearized	by	restriction	digest	at	a	3'	
restriction	 site	 with	 an	 appropriate	 restriction	 endonuclease.	 A	 restriction	 digest	
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with	a	total	volume	of	100	μL,	containing	10	μg	plasmid	DNA,	10	μL	10x	buffer	and	1	
μL	(10	Units)	of	enzyme	in	nuclease	free	H20	(Ambion),	was	incubated	for	2	hours	at	
37	 °C.	 Digested	 plasmid	was	 purified	 using	Qiaquick	 PCR	 Purification	 kit	 (Qiagen)	
and	 concentration	 of	 purified	 digested	 plasmid	 was	measured	 using	 a	 Nanodrop	
spectrophotometer	NDL20001.	1	μg	purified	3'	linearized	plasmid	DNA	was	used	to	
transcribe	synthetic	capped	mRNA	with	the	SP6	or	T7	Ambion	mMessage	Machine	
kit	 according	 to	 manufacturers	 instructions	 (Invitrogen,	 AM1340	 and	 AM1344	
respectively).	To	degrade	template	DNA	1	μL	of	the	reaction	mixture	was	replaced	
with	1	μL	of	Turbo	DNase	 (2	Units,	Ambion)	and	 the	mixture	was	 incubated	 for	a	
further	30	minutes	at	37	°C.	The	mRNA	was	purified	using	the	RNeasy	kit	following	
manufactures	instructions	(Qiagen,	74104)	and	resuspended	in	30	μL	nuclease	free	
H2O	 (Ambion).	 RNA	 concentration	 was	 measured	 using	 the	 Nanodrop	
spectrophotometer	 NDL20001	 and	 the	 efficiency	 of	 mRNA	 synthesis,	 DNase	
digestion	 and	 quality	 of	 mRNA	 transcript	 was	 evaluated	 by	 agarose	 gel	
electrophoresis.	 Therefore,	 1	 μL	 of	 linearized	 plasmid	 DNA,	 1	 μL	 of	 transcription	
mixture	before	addition	of	DNase,	1	μL	of	purified	 sense	mRNA	were	 run	on	1	%	
agarose	(Fisher	Scientific,	BP1356-100)	gel	in	TAE	(20	mM	acetic	acid,	1	mM	EDTA,	
40	mM	Tris,	pH	7.6).	For	mouse	PDGF-A	mRNA	transcription	mouse	PDGF-A	pGEM-1	
(Fruttiger	 et	 al.,	 1999)	 was	 linearized	 with	 PvuII	 and	 transcribed	 with	 SP6	 RNA	
polymerase.	For	transcription	of	mouse	PDGFRα	mRNA	the	mouse	PDGFRα	pYX-Asc	
plasmid	 (IMAGE	 consortium,	 5704645)	 was	 linearized	 with	 PacI	 and	 mRNA	 was	
transcribed	using	RNA	T7	polymerase.	For	N-cadherin	mRNA	transcription	the	chick	
N-cadherin-GFP	pCS2+	plasmid	was	linearized	with	NotI	and	mRNA	was	transcribed	
using	Sp6	RNA	polymerase.	For	ph-AKT-GFP	mRNA	transcription	ph-AKT-GFP	pCS2+	
plasmid	(Montero	et	al.,	2003)	was	 linearized	with	NotI	and	was	transcribed	using	
Sp6	 RNA	 polymerase.	 For	 dominant	 negative	 PDGFRα	 mRNA	 the	 PDGFRαw37	
pGHE2	(Ataliotis	et	al.,	1995)	plasmid	was	linearized	NheI	and	was	transcribed	using	
T7	 RNA	 polymerase.	 For	 PI3K-CAAX	 mRNA	 transcription	 PI3K-p110-CAAX	 pCS2+	
plasmid	(Montero	et	al.,	2003)	was	 linearized	with	NotI	and	was	transcribed	using	
Sp6	 RNA	 polymerase.	 All	 restriction	 enzymes	 and	 buffers	were	 all	 obtained	 from	
Promega.	
	 80	
2.2.3 Synthesis	of	mRNA	probe	for	in-situ	hybridisation		
For	in	vitro	transcription	of	labelled	antisense	RNA,	plasmid	DNA	was	linearized	at	a	
5'	restriction	site	with	the	appropriate	restriction	enzyme.	Plasmids	were	linearized	
and	 purified	 as	 described	 before	 (see	 section	 2.2.2	 Synthesis	 of	 mRNA	 for	
microinjection)	Antisense	RNA	 transcription	mix	 (total	Volume	20	μL)	 contained	1	
μg	of	linearized	DNA,	4	μL	of	5	x	buffer	(Promega),	2	μL	of	10	x	DTT	(Promega),	2	μL	
of	DIG	RNA	Labelling	Mix	 (Roche,	11277073910),	0.5	μL	of	 ribonuclease	 inhibitors	
(Promega)	 and	 1	 μL	 of	 appropriate	 RNA	 polymerase	 (SP6,	 T3,	 T7;	 10-20	 Units,	
Promega).	 This	 transcription	 reaction	 mix	 was	 incubated	 at	 37	 °C	 for	 2	 hours.	
Following	1	μL	of	 the	 reaction	mix	was	 replaced	with	1	μL	of	DNase	 (1,000	Units;	
Promega)	to	degrade	the	plasmid	DNA	template	for	30	minutes	at	37	°C.	The	mRNA	
was	 purified	 using	 the	 RNeasy	 kit	 following	 manufactures	 instructions	 (Qiagen,	
74104)	 and	 resuspended	 in	 20	 μL	 nuclease	 free	 H2O	 (Ambion).	 The	 efficiency	 of	
mRNA	synthesis,	DNase	digestion	and	quality	of	mRNA	transcript	was	evaluated	by	
agarose	 gel	 electrophoresis	 as	 described	 before	 (see	 section	 2.2.2	 Synthesis	 of	
mRNA	 for	microinjection).	 Probes	were	 diluted	 in	 hybridisation	 buffer	 to	working	
concentrations	see	Table	2-2	List	of	antisense	in	situ	hybridisation	probes.	
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Table	2-2	List	of	antisense	in	situ	hybridisation	probes	
	
2.2.4 Immunostaining	 
Immunofluorescence	staining	of	neural	crest	cell	explant	culture	was	performed	as	
previously	 described	 (Theveneau	 et	 al.,	 2010).	 In	 short,	 neural	 crest	 cell	 explants	
plated	 on	 glass	 coverslips	 (Academy	Dia.	 13,	 0.13-0.16	mm	 thick)	 and	 allowed	 to	
spread	for	at	least	2	hours.	Subsequently,	the	neural	crest	cell	explants	were	fixed	
in	 4	%	paraformaldehyde	 (PFA;	 Sigma,	 P6148)	 in	 1	 x	 PBS	 for	 30	minutes	 at	 room	
temperature,	and	then	washed	3	x	in	1	x	PBS	and	permeabilised	in	0.1	%	Triton-X-	
100	 in	1	x	PBS	for	10	minutes.	After	washing	the	explants	thoroughly	 in	PBS,	they	
were	blocked	in	blocking	buffer	(3	%	fetal	calf	serum	(FCS),	5	%	BSA	in	1	x	PBS)	for	
30	 minutes.	 The	 primary	 antibody	 (see	 Table	 2-3	 List	 of	 primary	 antibodies	 for	
immunostaining)	was	diluted	in	blocking	buffer	(3	%	fetal	calf	serum	(FCS),	5	%	BSA	
in	1	x	PBS)	and	incubated	over	night	at	4	°C	in	a	humidity	chamber.	The	next	day	the	
explants	were	washed	3	x	in	1	x	PBS	and	the	secondary	antibody	(see	Table	2-4	List	
of	 secondary	 antibodies	 immunostaining)	 in	 blocking	 buffer	 was	 incubated	 for	 1	
hour	at	room	temperature.	1	μg	mL-1	DAPI	(4',6-	diamidino-2-phenylindole;	Sigma,	
D9542)	 and	 1	 μg	 mL-1	 phallodin	 tetramethylrhodamin-b-isothiocyanate	 (PhR;	
Antisense	
Probe	 Plasmid	
Restriction	
Enzyme		
Transcription	
polymerase	
Working	
concentration		
Twist	
Twist-pCS2+	
(Hopwood	et	al.	
1989)		
SmaI	 T7	 1000	ng	mL-1	
Slug	
Slug	pSP72	
(Mayor	et	al.	
1995)	
Kpn	 T7	 800	ng	mL-1	
PDGF-A	
PDGF-A	pGHE2	
(Nagel	et	al.	
2004)	
NotI	 T7	 1000	ng	mL-1	
PDGFRα	
PDGFRα	pGHE2	
(Ataliontis	et	al.	
1995)	
NotI	 T7	 1000	ng	mL-1	
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P1951)	 were	 incubated	 together	 with	 the	 secondary	 antibody	 if	 appropriate.	
Following	 the	 incubation	 samples	 were	 3	 x	 washed	 in	 1	 x	 PBS	 and	 mounted	 in	
Mowiol	(Sigma,	81381).		
Table	2-3	List	of	primary	antibodies	for	immunostaining	
Antibody	 Species	 Working	conc.	 Producer	
N-cadherin		 rat	 6	μg	mL-1	 DSHB,	MNCD-2	
E-cadherin	 mouse	 1.2	μg	mL-1	 DSHB,	5D3	
PDGFRα	 rabbit	 1:500	 Cell	signalling,	9271		
	
Table	2-4	List	of	secondary	antibodies	immunostaining	
Antibody	 Species	 Working	conc.	 Producer	
Anti-Mouse	IgG	Alexa	
Flour	488	 goat	 1:500	
Life	Technologies,	
A-11017	
Anti-Rat	IgG	Alexa	
Flour	488	 donkey	 1:500	
Life	Technologies,	
A-21208	
Anti-Rabbit	IgG	Alexa	
Fluor	488	 goat	 1:500	
Life	Technologies,	
A-11034	
Anti-Rabbit	IgG	Alexa	
Fluor	647	 donkey	 1:500	
Life	Technologies,		
A-31573	
	
	
2.2.5 Morpholinos	
Morpholinos	were	obtained	from	GeneTools.	Morpholinos	against	PDGF-A	(PDGF-A	
MO;	 8ng,	 5’-AGAATCCAAGCCCAGATCCTCATTG-3’;	 Nagel	 et	 al.,	 2004)	 and	 new	
designed	Morpholino	against	PDGFRα	 (16ng,	5’-TGCCCTCATGGCAGGCATCATGGAC-
3’).	 Mouse	mRNA	mismatches	 for	 rescue	 experiments	 are	 underlined.	 Equimolar	
concentrations	 of	 standard	 control	 Morpholino	 (Control	 MO;	 3'-	
ATATTTAACATTGACTCCATTCTCC	-	5')	was	used.		
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2.2.6 Inhibitors	
Pharmacological	inhibitors	were	all	solubilized	in	DMSO	(Sigma)	see	Table	2-5	List	of	
pharmaceutical	 inhibitors	 for	 an	 overview.	 For	 all	 experiments	 DMSO	 controls,	
comparable	 to	 the	 amount	 of	 DMSO	 added	 with	 the	 inhibitor,	 were	 used.	 For	
example,	as	a	control	for	10	μL	mL-1	of	AG1296	(diluted	in	DMSO),	10	μL	mL-1	DMSO	
were	used	as	a	control.	For	in	vivo	experiments	inhibitors	were	applied	at	stage	15-
16	and	the	embryos	were	allowed	to	develop	until	stage	25	before	proceeding	to	in	
situ	hybridization	or	western	blot.	For	 in	vitro	experiments	 inhibitors	were	applied	
to	 neural	 crest	 cells	 after	 an	 initial	 attachment	 phase	 of	 20-30	minutes	 and	 then	
incubated	 for	1	hour	before	 imaging	or	addition	of	PDGF-AA	protein	 (50	ng	mL-1	;	
Peprotech).	
Table	2-5	List	of	pharmaceutical	inhibitors	
Name	 Inhibitor	of	 Company	 Working	conc.	
AG1296	 PDGFR	 Merck	Millipore,	658551	 in	vivo	20	μM	
LY294002	 PI3K	 Cell	Signaling,	9901	
in	vivo	40	μ	M	
in	vitro	5	μM	
MK-2206	 AKT	 Axon,	1684	
in	vivo	100	μM	
in	vitro	5	μM	
UO126	 MAPK	 Cell	Signaling,	9903	 in	vivo	100	μM	
	
	
2.2.7 RT-PCR	
RNAs	were	extracted	from	neural	crest	cell	explants	or	ventral	non-neural	crest	cell	
tissue	 dissections	 using	 RNeasy	 Mini	 kit	 (Qiagen).	 Amount	 of	 purified	 RNA	 was	
measured	 using	 the	 Nanodrop	 spectrophotometer	 NDL20001.	 From	 the	 purified	
RNA	cDNA	libraries	were	reverse-transcribed	using	ImProm	II	Reverse	transcription	
kit	 (Promega,	 A3800)	 and	 PCR	 machine	 Eppendorf	 mastercycler	 Personal.	 cDNA	
libraries	were	 transcribed	according	 to	manufactures	 instructions,	using	a	 reverse	
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transcriptase	reaction	mix	and	a	reverse	transcriptase	cycle	program	as	described	in	
Table	 2-7	 and	 Table	 2-8,	 respectively.	 Subsequently	 PCR	 was	 performed	 using	
GoTaq	G2	Hot	Start	Polymerase	(Promega,	M7401)	using	a	10	μL	reaction	mix	(see	
Table	2-9).	PCR	cycles	were	analysed	in	pilot	experiments.	PCR	reactions	were	run	
with	95	°C	15	seconds,	temperature	dependent	on	primer	pair	30	seconds,	72	°C	30	
seconds	cycle	program	started	by	a	95	°C	5	minutes	denaturation	and	finished	with	
a	72	°C	5	minutes	elongation	period,	see	Table	2-6	Reverse	transcriptase	PCR	Primer	
and	Program.	10	μL	of	RT-PCR	were	run	on	2	%	agarose	(Fisher	Scientific,	BP1356-
100)	gel	in	TAE	buffer	(20	mM	acetic	acid,	1	mM	EDTA,	40	mM	Tris,	pH	7.6).	
	
Table	2-6	Reverse	transcriptase	PCR	Primer	and	Program	
Name	 Primer	forward/reverse	 Cycle	 Reference	
PDGF-A	
5’-GGAATGCACGTGTACAGCAA-3’	 60°C,	
32x	
Damm	and	
Winkelbauer	
2011	
5’-CGGGAATGTAACATGGCGTA-3’	
PDGFRα	
5’-CTCGCAAATGCCACTACAGA-3’		 60°C,	
30x	5’-CCACAAGGTGT-CATTGTTGC-3’	
ODC	
5’-GTCAATGATGGAGTGTATGGATC-	3’		 60°C,	
25x	5’-TCCATTCCGCTCTCCTGAGCAC-3’	
Sox9	
5’-AACAGGAGTTCCATCAATCCCC-	3’	 55°C,	
30x	
Monsoro-
Burq	et	al.,	
2003	5’-CTTTTGCTAAACCCCGTGTCAC-	3’	
Sox2	
5’-CCACACGCCGCCTCGATGT-	3’	 55°C,	
27x	
Sugiura	et	al.,	
2004	5’-TCAGCCCCCAGCCTCTTGC-	3’	
Keratin	
5’-CACCAGAACACAGAGTAC-	3’	 55°C,	
25x	
Wilson	and	
Melton,	1994	5’-CAACCTTCCCATCAACCA-	3’	
Brachyury	
5’-GGATCGTTATCACCTCTG-	3’		 55°C,	
27x	
Kuriyama	et	
al.,	2014	5’-GTGTAGTCTGTAGCAGCA--	3’	
	
	
Table	2-7	Reverse	transcriptase	reaction	mix	
RT	Mix	 Total	RNA	 500	ng	
	Oligo	DT	 1	μL	
Up	to	5	μL	with	nuclease	free	H2O	
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Enzyme	
Mix	
50	mM	Mg	Cl2	 4	μL	
10	mM	dNTPs	 1	μL	
RNasin	40	u	μL-1	 0.5	μL	
Improm	II	(200	u	
μL	-1)	 1	μL	
Up	to	15	μL	with	nuclease	free	H2O	
Table	2-8	Reverse	transcriptase	cycle	program	
Addition	of	RT	Mix	
	 Temperature	 Time	
Denaturation	 65	°C	 5	minutes	
Cooling	 4	°C	 ∞	
Addition	of	Enzyme	Mix	
Annealing	 25	°C	 5	minutes	
Extension	 42	°C	 60	minutes	
Inactivation	RT	 70	°C	 15	minutes	
Cooling	 4	°C	 ∞	
	
	
	
Table	2-9	RT-PCR	PCR	reaction	Mix	
	
	
PCR	Mix	 cDNA	 1-2	μL	
5x	Buffer	 2	μL	
10	mM	dNTPs	 0.2	μL	
25	mM	Mg	Cl2	 0.2	μL	
forward	primer	(10	μM)	 0.2	μL	
reverse	primer	(10	μM)	 0.2	μL	
GoTaq	Polymerase	(5	u	
μL-1)	 1	μL	
Up	to	10	μL	with	nuclease	free	H2O	
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2.2.8 Western	blot	
For	 immunoblotting,	 cells	were	 lysed	 in	a	 lysis	buffer	 containing	100	mM	Tris-HCl	
(pH	8.0),	1	%	Triton	X-100,	0.01	%SDS,	complete	Mini	protease	inhibitor	(Roche)	and	
PhosphoStop	phosphatase	 inhibitor	 (Roche).	20-25	neural	crest	cell	explants	 in	15	
μL	lysis	buffer	per	lane,	or	1	embryo	in	20	μL	lysis	buffer.	The	Protein	fraction	was	
isolated	 by	 centrifugation	 (13,200	 rpm,	 4	 °C)	 in	 two	 rounds	 for	 whole	 embryo	
lysates.	Neural	crest	lysates	were	further	processed	without	the	protein	purification	
step.	 The	 appropriate	 amount	 of	 4x	 SDS	 Sample	 Buffer	 (Millipore	 70607-3)	 was	
added	to	the	lysate	and	boiled	at	95	°C	for	3	minutes.	Protein	lysates	were	analysed	
by	 SDS-PAGE	 using	 4	 to	 12	%	 Bis-Tris	 gels	 (NuPAGE;	 Invitrogen),	 and	 subsequent	
transfer	 onto	 Invitrolon	 polyvinylidene	 difluoride	 membranes	 (Invitrogen).	
Membranes	were	blocked	with	5	%	non-fat	dry	milk	and	0.1	%	Tween-20	in	1	x	PBS	
for	 1	 hour	 at	 room	 temperature,	 before	 being	 probed	with	 the	 primary	 antibody	
(see	Table	2-10)	by	overnight	incubation	at	4	°C,	followed	by	incubation	for	1	hour	
at	 room	 temperature	 with	 a	 horseradish	 peroxidase-linked	 secondary	 antibody	
(Table	 2-11)	 and	 detection	 using	 ECL	 reagent	 (Luminata	 Forte	 Western	 HRP	
Substrate,	Milipore).	Band	intensity	was	measured	by	scanning	of	films	and	analysis	
by	densitometry	using	Image	J	(NIH).		
	
Table	2-10	List	of	primary	antibodies	for	western	blot	
Antibody	 Species	 Working	concentration	 Producer	
PDGFRα	 rabbit	 1:2000	 Cell	Signaling,	3164	
pAKT	Ser437	 rabbit	 1:2000	 Cell	Signaling,	9271	
panAKT	(total	AKT)	 rabbit	 1:2000	 Cell	Signaling,	4691	
GAPDH-HRP	 goat	 1:2000	 Santa	Cruz,	sc20357	
N-cadherin	 rat	 380	ng	mL-1	 DHSB,	MNCD-2	
E-cadherin	 mouse	 60	ng	mL-1	 DHSB,	5D3	
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Table	2-11	List	of	secondary	antibodies	for	western	blot	
Antibody	 Species	 Working	concentration	 Producer	
Anti-rabbit	IgG-HRP	 goat	 1:10,000	 Santa	cruz,	sc-2004	
Anti-rat	IgG-HRP	 goat	 1:10,000	 Santa	cruz,	sc-2006	
Anti-mouse	IgG-HRP	 goat	 1:10,000	 Santa	cruz,	sc-2005	
	
	
2.3 Microscopy	and	imaging	
2.3.1 Time	lapse	imaging	of	neural	crest	cells	
Neural	 crest	cells	 cultured	on	 fibronectin-coated	plastic	dishes	 (single	well:	50	x	9	
mm	 Falcon	 351006;	 4-well:	 Thermo	 Scientific	 179830)	 and	 were	 imaged	 using	 a	
compound	upright	 or	 inverted	microscopes.	 Images	were	 taken	on	 either	 upright	
compound	microscopes	with	motorised	stages,	either	a	DM550B	Leica	Microscope	
with	 a	 DFC	 300FX	 Leica	 camera,	 a	 DMRXA2	 Leica	Microscope	with	 a	 Hamamatsu	
Digital,	Nikon	camera,	a	Nikon	Eclipse	80i	with	a	Hamamatsu	ORCA	05G	camera	or	
inverted	 compound	 microscope	 with	 motorised	 stage,	 a	 Olympus	 1X70	 with	 a	
Hamamatsu	 ORCA	 05G	 camera.	 All	 imaging	 was	 performed	 in	 a	 temperature	
regulated	environment	at	approximately	18	°C.	Cells	were	imaged	using	a	10	x	or	20	
x	lens.		Images	were	acquired	every	3-5	minutes,	dependent	on	the	experiments	for	
up	to	10-20	hours	using	either	the	Las	AF	or	the	SimplePCI6	software.	Images	were	
exported	as	.avi	or	.lif	files	and	analysed	as	appropriate	using	the	ImageJ	software	
(Schneider	et	al.,	2012).		
2.3.2 Confocal	microscopy	of	neural	crest	cells	
For	confocal	 imaging	of	 living	cells,	neural	crest	cells	were	cultured	on	fibronectin	
coated	glass	bottom	dishes	(single	well:	world	precision	instrument	Inc.	FD35-100;	
4-well:	 Greiner	 bio-one	 627870).	 Images	 were	 acquired	 using	 a	 PerkinElmer	
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UltraVIEW	Vox	Spinning	Disk	system	mounted	on	a	Nikon	Ti	Eclipse	microscope	for	
high	time	resolution	imaging.	Neural	crest	explants	were	 imaged	with	a	frequency	
of	10	to	30	seconds	performing	Z-stacks	of	a	thickness	of	1	μm	using	Nikon	60X	oil	
immersion	lenses.	Acquired	images	were	exported	as	TIFF	files	and	further	analysed	
using	the	Image	J	free	software.		For	imaging	of	fluorescently	immunostained	neural	
crest	 cell	 explants,	 either	 an	 Olympus	 Fluoview	 1000	 or	 a	 Leica	 SPE1	 confocal	
microscope	 were	 used,	 with	 a	 60	 x	 or	 a	 63	 x	 oil	 immersion	 lens,	 respectively.	
Imaging	conditions	were	adjusted	according	to	the	characteristics	of	the	specimen.		
	
2.4 Analysis	
2.4.1 In	vivo	migration	assay 
For	 the	 analysis	 of	 in	 vivo	 neural	 crest	 cell	migration	 in	 situ	hybridization	 for	 the	
neural	crest	cell	marker	Twist	was	performed	at	stage	25	on	Xenopus	embryos	(see	
section	2.1.4	Whole	mount	in	situ	hybridisation).	Embryos	were	injected	with	either	
mRNAs	 or/and	 Morpholinos	 at	 one	 side	 of	 the	 embryo	 and	 labelled	 with	
fluorescein-dextran	(FDX	Invitrogen	D1821)	or	rhodamine	dextran	(RDXL	Invitrogen	
D1824).	Injected	embryos	and	control	embryos	were	developed	until	approximately	
stage25,	 and	 processed	 for	 in	 situ	 hybridization.	 Images	 of	 both	 sides	 of	 the	
embryo,	 injected	 and	 uninjected,	 were	 taken	 with	 Leica	 MZFLIII	 Fluorescence	
Stereomicroscope	with	a	 Leica	DFC420	using	 the	 Leica	 IM50	 Image	Manager.	 The	
length	 of	 the	 dorso-ventral	 (D-V)	 neural	 crest	 cell	migration	was	measured	 using	
Twist	marker	 in	 ImageJ	 of	 both	 sides	 of	 the	 embryo,	 the	 injected	 and	 uninjected	
side.	 Thus	 in	 vivo	 Migration	 (%)	 was	 calculated	 ratio	 of	 injected	 side	 to	 the	
uninjected	 side	 per	 embryo.	 In	 order	 to	 control	 for	 variations	 the	measurements	
were	 repeated	 three	 times	 for	 each	 embryo	 and	 the	 average	 calculated.	 For	
embryos	incubated	with	inhibitors,	neural	crest	cell	migration	was	estimated	by	the	
average	 proportion	 of	 D-V	 distance	 of	 a	 control	 population	 (>	 15	 embryos)	
compared	to	the	average	of	the	inhibitor	treated	embryo	population.	Following	this	
control	 embryos	 were	 treated,	 with	 either	 mRNA	 or	 Morpholino	 injection,	 or	
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inhibitors	the	migration	value	calculated	by	the	experimental	data	should	approach	
1.	
	
Figure	2-2	Neural	Crest	migration	measurement	scheme	
Lateral	head	view	of	stage	25	Xenopus	laevis		embryo.	A=	anterior;	P=	posterior;	D=	
dorsal;	 V=	 ventral;	 inj=	 injected;	 uninj=	 uninjected;	 d=	 distance.	 Neural	 crest	
streams	depicted	in	purple.	
	
mRNA	or/and	Morpholino	
	In	vivo	migration	=		 D-V	distance	injected	side/D-V	distance	
uninjected	side	
Inhibitor	treatment	
	In	vivo	migration	=		 average	D-V	distance	inhibitor	treated	
embryos/average	D-V	distance	inhibitor	treated	
embryos	head	length		
D	
V	
A	 P	
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2.4.2 Single	cell	motility	assay	 
For	neural	crest	cells	single	cell	motility	assays	nuclear	RFP	injected	neural	crest	cell	
explants	were	dissociated	(see	section	2.1.3	Microdissection	and	neural	crest	cells	
culture	)	 and	 allowed	 to	 attach	 for	 30	 minutes.	 Neural	 crest	 cell	 clusters	 were	
imaged	 as	 described	before	 (see	 section	 2.3.1	 Time	 lapse	 imaging	of	 neural	 crest	
cells),	with	a	compound	epifluorescence	microscope	at	a	magnification	of	20	x	for	8	
hours	and	a	3-5	minutes	frame	rate.	Individual	cells	nuclei	were	tracked	for	5	hours	
using	the	ImageJ	Manual	Tracking	plug-in	and	cells	that	contacted	another	cell	were	
not	 included	 in	 the	 analysis.	 Following	 the	 cell	 tracks	 were	 analysed	 using	 the	
ImageJ	Chemotaxis	 tool	plug-in	and	speed	and	directionality	of	cell	migration	was	
extracted.	The	Cell	speed	by	the	plug	in	is	estimated	based	on	the	equation	speed=	
dx/dt.	The	distance	travelled	(dx)	within	a	period	of	time	(dt	corresponding	to	the	
time	between	two	frames)	was	calculated	using	the	ImageJ	plug-in	Chemotaxis	Tool	
using	 the	 coordinates	 dx,	 dy	 from	 the	 cell	 tracks.	Directionality	was	 calculated	 as	
the	 euclidean	 or	 accumulated	 distance	 between	 the	 start	 and	 end	 point	 of	
migration	divided	by	the	actual	distance	migrated	(Figure	2-3).	The	average	speed	
and	 directionality	 was	 calculated	 per	 cell,	 from	 which	 the	 average	 velocity	 and	
persistence	of	any	given	population	was	calculated.		
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Figure	2-3	Directionality	calculation	scheme	
Directionality	 was	 calculated	 as	 the	 euclidean	 distance	 or	 accumulated	 distance	
between	the	start	and	end	point	of	migration	(daccum)	divided	by	the	actual	distance	
(dt)	migrated.	
	
2.4.3 Chemotaxis	assay	
The	 chemotaxis	 assay	 was	 performed	 as	 previously	 described	 (Theveneau	 et	 al.,	
2010).	 Briefly,	 heparin	 acrylic	 beads	 (Sigma	 H5263,	 Adar	 Biotech	 6024-1)	 were	
incubated	with	1	μg	mL-1	purified	human	stromal	cell-derived	factor-1	(Sdf1)	protein	
overnight.	Sdf1-beads	of	a	similar	diameter	(150–200	mm)	were	 immobilized	on	a	
fibronectin-	coated	dish	using	silicone	grease	(VWR,	6366082B)	and	neural	crest	cell	
explants	were	plated	at	between	250	and	500	mm	away	from	the	bead	and	left	to	
attach	for	20-30	minutes.	Neural	crest	cell	clusters	were	imaged	as	described	before	
(see	 section	 2.3.1	 Time	 lapse	 imaging	 of	 neural	 crest	 cells)	 with	 a	 compound	
epifluorescence	microscope	at	a	magnification	of	10	x	for	15	hours	and	a	5	minutes	
frame	rate.	After	 imaging	 the	 image	was	 rotated	so	 the	y-axis	of	 the	 images	goes	
through	the	SDF-1	bead	at	the	top	and	the	neural	crest	cell	cluster	at	the	bottom.	
To	calculate	the	Chemotaxis	 Index,	 individual	cells	nuclei	were	tracked	for	5	hours	
using	the	ImageJ	Manual	Tracking	plug-in.	Following	the	tracks	were	analysed	with	
the	ImageJ	Chemotaxis	tool	plug-in	and	the	chemotaxis	index	was	extracted,	which	
resembles	the	net	displacement	of	a	cell	divided	by	the	distance	travelled	by	each	
cell.	 Thus,	 with	 a	 chemotaxis	 index	 of	 1	 the	 cell	 moves	 directly	 towards	 the	
chemotactic	cue	and	with	a	chemotaxis	 index	of	-1	that	the	cells	move	away	from	
the	chemotactic	source.		
2.4.4 Dispersion	assay	
For	 dispersion	 assays	 nuclear	 RFP	mRNA	 injected	 neural	 crest	 cell	 explants	 were	
plated	 on	 a	 plastic	 dish	 for	 20-30	minutes	 to	 settle	 before	 imaging.	When	 using	
inhibitors	 (see	 section	 2.2.6	 Inhibitors),	 they	 were	 incubated	 60	 minutes	 before	
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recombinant	PDGF-AA	protein	 (50	ng	mL	 -1	;	Peprotech)	addition.	Neural	crest	cell	
clusters	were	imaged	as	described	before	(see	section	2.3.1	Time	lapse	imaging	of	
neural	crest	cells),	with	a	compound	epifluorescence	microscope	at	a	magnification	
of	 10	 x	 for	 20	 hours	 and	 a	 10	minutes	 frame	 rate.	 Cells	within	 the	 explant	were	
tracked	using	their	nuclear	marker	and	cell	dispersion	was	analysed	by	the	average	
triangle	 area	 between	 cells	 calculated	 using	 Delaunay	 triangulation	 algorithm	 as	
described	before	(Carmona-Fontaine	et	al.,	2011;	Nawrocki	Raby	et	al.,	2001)	using	
a	ImageJ	dispersion	tool	plugin	developed	in	the	lab	by	András	Szabó.	The	Delaunay	
algorithm	connects	each	cell	 (nucleus)	 in	a	cluster	with	 its	closest	 two	neighbours	
and	 determines	 the	 triangle	 area	 between	 them.	 The	 average	 triangle	 area	 per	
cluster	was	used	as	readout	of	cell	dispersion	and	calculated	12	hours	after	imaging	
had	 started.	 In	 order	 to	 control	 for	 variations	 between	different	 experiments	 the	
average	 triangle	 areas	 were	made	 relative	 to	 the	 average	 area	 of	 control	 at	 the	
same	time	point.		
2.4.5 Single	cell	collision	assay	
For	analysis	of	single	cell	collisions,	neural	crest	cells	derived	from	embryos	injected	
with	membrane	GFP	and	nuclear	RFP	were	dissociated	and	plated	on	a	fibronectin	
coated	plastic	dish.	Neural	crest	cell	clusters	were	imaged	as	described	before	(see	
section	 2.3.1	 Time	 lapse	 imaging	 of	 neural	 crest	 cells)	 with	 a	 compound	
epifluorescence	microscope	at	a	magnification	of	20	x	for	10	hours	with	a	3	minutes	
frame	 rate.	 The	 time	 of	 CIL	 collision	 was	 measured. The	 start	 (t0)	 of	 a	 cell-cell	
collision	event	was	classified	as	the	first	frame	in	which	a	contact	between	the	two	
colliding	cells	could	be	observed.	The	end	(tend)	of	the	collision	was	defined	as	the	
last	frame	of	contact	between	the	two	colliding	cells.	Cell	collisions,	which	exceeded	
60	 minutes,	 were	 considered	 as	 adhesion	 events.	 The	 average	 ratio	 of	 CIL	 cell	
collision	time	per	experiment	population	was	calculated	for	comparison. 
2.4.6 Explant	Invasion	assay	
For	 Explant	 Overlap	 Assays,	 as	 previously	 described	 (Carmona-Fontaine	 et	 al.,	
2008b),	 neural	 crest	 cell	 clusters	 differentially	 labelled	 with	 fluorescein-dextran	
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(FDX	Invitrogen	D1821)	or	rhodamine	dextran	(RDXL	Invitrogen	D1824)	were	plated	
close	 to	 each	 other	 and	 imaged	 on	 a	 10	 x	 magnification	 on	 a	 compound	
epifluorescence	microscope	for	10	hours	and	a	frame	rate	of	10	minutes.	To	analyse	
the	extent	of	overlap	between	two	differentially	labelled	neural	crest	cell	explants,	
.avi	or	 .lif	movies	were	 imported	 into	 ImageJ.	Red	and	green	channels	were	 split,	
converted	 to	 8-bit	 and	 each	 of	 them	 thresholded	 to	 obtain	 a	 binary	 image.	
Thresholded	images	of	both	channels,	red	and	green,	were	then	merged.	The	frame	
showing	the	maximum	overlap	 (characterized	by	the	area	of	overlap	between	the	
red	and	green	channels)	was	identified	and	the	overlap	area	was	normalized	as	the	
ratio	between	 the	area	of	overlap	between	 the	 two	explants	 and	 the	area	of	 the	
smallest	of	the	two.	 
2.4.7 Analysis	of	cell-cell	adhesion	protein 
To	determine	the	 levels	of	 the	endogenous	cadherin	complex	proteins	at	 the	cell-
cell	 junction,	 neural	 crest	 cells	 clusters	 were	 plated	 on	 fibronectin	 coated	 glass	
coverslips	 and	 allowed	 to	 spread	 for	 at	 least	 2	 hours	 before	 fixation	 and	
immunostaining	 (see	 section	 2.2.4	 Immunostaining).	 For	 quantitation,	 confocal	
stacks	were	acquired	 (see	 section	2.3.2	Confocal	microscopy	of	neural	 crest	 cells)	
and	then	analysed	on	ImageJ.	A	maximum	projection	of	the	Stacks	was	carried	and	
to	measure	the	 intensity	profile	a	straight	segment	of	10	μm	in	 length	was	traced	
across	each	cell-cell	 junction	and	the	 intensity	profile	(grey	values)	retrieved	using	
the	Plot	Profile	function	of	ImageJ.	The	measured	plot	intensity	was	normalised	to	
the	intensity	profile	of	the	cell	cytoplasmic	region.	 
2.4.8 Analysis	of	ph-AKT-GFP	distribution	
For	ph-GFP	analysis	neural	crest	cell	explants	 injected	with	ph-AKT-GFP	and	either	
membrane	RFP	or	liveActin	RFP,	were	plated	on	4-well	glass	petri	dishes	in	750	μL	
DFA	and	allowed	to	attach	for	at	least	20	minutes.	Images	were	acquired	using	a	60	
x	oil-immersion	lens	using	the	Vox	Spinning	Disk	system	for	10	minutes	with	a	frame	
rat	of	10-30	seconds	 (see	section	2.3.2	Confocal	microscopy	of	neural	 crest	 cells).	
PDGF-AA	 protein	 (200	 ng	mL-1)	was	 applied	 diluted	 in	 250	 μL	 DFA,	 giving	 a	 final	
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concentration	of	PDGF-AA	(50	ng	mL-1),	after	5	minutes	of	 the	start	of	 the	 image	
acquisition	 without	 stopping	 the	 image	 acquisition.	 To	 analyse	 ph-AKT-GFP	
membrane	localization	.tif	files	were	imported	into	ImageJ.	A	maximum	projection	
of	the	Stacks	was	carried	out	and	to	measure	the	intensity	profile	a	segmented	line	
(width	2	pixel)	was	drawn	at	the	cell	boarder,	visualized	by	mRFP	or	liveActin	RFP.	
The	 measured	 grey	 value	 intensity	 was	 normalised	 to	 the	 grey	 value	 intensity	
profile	 of	 the	 cell	 cytoplasmic	 region.	 ph-AKT-GFP	 membrane	 localization	 was	
analysed	every	15	seconds	for	10	minutes.	
2.4.9 Protrusion	analysis	
For	 protrusion	 analysis	 neural	 crest	 cell	 explants,	 injected	 with	 nuclear	 RFP	 and	
membrane	GFP,	were	plated	on	glass	petri	dishes	and	monitored	using	a	60	x	oil-
immersion	lens	using	the	Vox	Spinning	Disk	system	for	10	minutes	with	a	frame	rate	
of	 10	 seconds	 (see	 section	 2.3.2	 Confocal	 microscopy	 of	 neural	 crest	 cells).	
Protrusions	were	defined	as	the	regions	devoid	of	vitelline	platelets	and	measured	
in	ImageJ	every	30	seconds	for	a	total	of	10	minutes	and	the	average	area	per	cell	
over	10	minutes	period	was	calculated.	
2.4.10 Statistical	Analysis	
Significant	 differences	 between	 two	 data	 sets	 were	 considered	 different	 (null	
hypothesis	 rejected).	 Data	 sets	 (expect	 Western	 blot	 data)	 were	 analysed	 as	
follows:	 Normality	 was	 evaluated	 by	 Kolmogorov-Smirnov’s	 test,	 d’Agostino	 and	
Pearson’s	test	using.	Data	set	were	treated	normal	distributed	if	found	so	by	all	two	
tests.	 Normal	 distributed	 data	 was	 compared	 using	 Student’s	 t-test	 (two-tailed,	
unequal	variances)	or	using	one-way	ANOVA	with	a	Dunnett’s	multiple	comparisons	
post-test.	 Data	 sets	 that	 were	 found	 not	 to	 follow	 normal	 distribution	 were	
compared	 using	 Mann-Whitney’s	 test	 or	 a	 non-	 parametric	 ANOVA	 in	 Prism5	
(GraphPad).	 Normalised	 western	 blot	 data	 was	 analysed	 by	 one-way	 ANOVA	
followed	 by	 Student	 Newman-Keuls	 test	 for	 multiple	 comparison	 differences.	 All	
analysis	was	performed	in	Prism5	(GraphPad).	
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Chapter	3 Results	 	
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3.1 Co-expressed	PDGFRα	and	PDGF-A	are	required	for	neural	crest	cell	
migration	in	vivo	and	in	vitro	
3.1.1 PDGF-A	and	PDGFRα	are	co-expressed	in	Xenopus	laevis	neural	crest	cells	
During	 late	 neural	 crest	 cell	 migration	 in	 mouse,	 Zebrafish	 and	 Xenopus	 PDGF	
receptor	alpha	(PDGFRα)	and	its	corresponding	ligand	PDGF-A	have	been	reported	
to	be	expressed	in	neural	crest	cells	and	surrounding	tissues,	respectively	(Ho	et	al.,	
1994;	Liu	et	al.,	2002a;	Liu	et	al.,	2002b;	Orr-Urtreger	and	Lonai,	1992;	Takakura	et	
al.,	 1997).	 To	 address	whether	 the	 receptor	 and	 ligand	 have	 the	 same	 reciprocal	
expression	pattern	during	onset	and	early	neural	crest	cell	migration,	I	first	analysed	
the	expression	of	the	receptor	(PDGFRα)	and	its	corresponding	ligand	PDGF-A	by	in	
situ	hybridization.	Both	expression	patterns	were	compared	 to	either	neural	 crest	
cell	induction	marker	Slug	(Figure	3-1	A)	or	migrating	neural	crest	cell	marker	Twist	
(Figure	 3-1	 B,	 C).	 Interestingly,	 in	 this	 comparative	 approach	 I	 found	 both,	 ligand	
and	receptor,	to	be	expressed	in	pre-migratory	(Figure	3-1	D	and	G)	and	migrating	
neural	crest	cells	(Figure	3-1	E,	F	and	H,	I).	To	validate	that	both	receptor	and	ligand	
are	 expressed	 in	 neural	 crest	 cells,	 I	 performed	RT-PCR	 of	micro-dissected	 neural	
crest	cell	tissue.	Consistent	with	the	previous	data,	RT-PCR	analysis	showed	specific	
expression	of	both,	PDGF-A	and	PDGFRα,	in	neural	crest	cells	but	not	in	non-neural	
crest	cell	tissue	(Figure	3-2).		
To	 further	 verify	 this	 I	 performed	 immunostaining	 and	 western	 blot	 analysis	 of	
neural	crest	cell	explants	for	the	PDGFRα	protein.	 In	 line	with	the	expression	data	
(Figure	 3-1	 and	 Figure	 3-2)	 I	 observed	 the	 PDGFRα	 protein	 in	 neural	 crest	 cell	
explants	with	both	methods	(Figure	3-3	A,	B;	control	lane).		
To	deplete	the	levels	of	PDGFRα,	for	further	experimental	approaches,	a	translation	
blocking	ATG	 anti-sense	Morpholino	 oligonucleotide	 (PDGFRα	MO),	was	 designed	
(see	 experimental	 procedures	 2.2.5	Morpholinos).	 To	 verify	 the	 specificity	 of	 the	
new	Morpholino	 I	 tested	 its	depletion	capabilities	by	 immunoblotting	of	 	PDGFRα	
MO	 injected	 neural	 crest	 cell	 lysates	 against	 PDGFRα.	 This	 MO	 showed	 high	
efficiency	 to	 reduce	 the	 protein	 levels	 by	 western	 blot	 (Figure	 3-3	 B,C).	 Taken	
together	these	data	suggests	that	both	the	receptor	PDGFRα	and	ligand	PDGF-A	are	
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expressed	 in	pre-migratory	and	migratory	neural	 crest	 cells.	 Further	 I	was	able	 to	
verify	effective	depletion	of	PDGFRα	by	use	of	an	antisense	Morpholino.		
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Figure	 3-1	 PDGF-A	 and	 PDGFRα	 are	 expressed	 in	 pre-migratory	 and	 migrating	
neural	crest	cells		
(A-I)	 Whole	 mount	 in	 situ	 hybridisation	 of	 Xenopus	 embryos	 at	 neural	 crest	 cell	
induction	stage	18	(lateral	view,	scale	bar	500	μm)	and	neural	crest	cell	migration	
stage	 24	 (lateral	 head	 region,	 scale	 bar	 1	mm).	 (A)	 neural	 crest	 induction	marker	
Slug.	 (B)	 neural	 crest	 migration	 marker	 Twist.	 (D-F)	 PDGF-A	 and	 (G-I)	 PDGFRα	
expression.	Grey	asterisk	marks	the	eye;	arrows	indicate	neural	crest	cell	migration;	
(C-F)	line	in	(B)	indicates	level	of	frontal-lateral	section,	cranial	left	and	caudal	right,	
yellow	lines	outline	neural	crest	cell	streams.		
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Figure	3-2	RT-PCR	of	microdissected	neural	crest	cells	for	PDGF-A	and	PDGFRα	
RT-PCR	 analysis	 of	 PDGF-A	 and	 PDGFRα	 expression	 in	 stage	 18	 neural	 crest	 cell	
tissue	 and	 control	 whole	 embryo,	 Sox9	 neural	 crest	 marker,	 Sox2	 neural	 plate	
marker,	 Brachyury	 mesoderm	 marker,	 e-Keratin	 epidermis	 marker,	 ODC	 lane	
loading	control.,	-RT	lane	DNA	contamination	control	.		
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Figure	3-3	PDGFRα	is	expressed	in	neural	crest	cells		
(A)	Immunostaining	of	neural	crest	cell	explants	against	PDGFRα	(green),	Phalloidin	
(red),	 DAPI	 (blue).	 Scale	 bars	 as	 indicated.	 Yellow	 box	 indicates	 zoom	 in.	 (B)	
Western	blot	analysis	of	PDGFRα	protein	using	neural	crest	cell	explants	lysates	of	
control,	 PDGF-AA	 treated	 (50ng	 mL-1	 for	 60min)	 or	 PDGFRα	 MO	 injected	 neural	
crest	cells.	(C)	Band	intensity	normalized	to	loading	control,	bar	graph	shows	mean	
and	 s.d.,	 statistical	 analysis	 used	 one-way	 ANOVA	 followed	 by	 Student	 Newman-
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Keuls	test,	data	from	three	 independent	experiments.	Control	versus	PDGF-A	n=3,	
nsP=0.874;	control	versus	PDGFRα	n=3,	***P=	0.0006;	AU=	arbitrary	units.	 	
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3.1.2 PDGF-A/PDGFRα	signalling	is	required	for	neural	crest	cell	migration	
In	section	3.1.1	I	established	that	both	the	receptor	(PDGFRα)	and	the	ligand	(PDGF-
A)	are	expressed	in	neural	crest	cells.	To	address	whether	inhibition	of	either	has	an	
effect	on	neural	crest	cell	migration	in	vivo	I	perturbed	the	signalling	pathway	using	
three	 different	 treatments:	 First,	 a	 previously	 published	 ATG	 site	 antisense	
Morpholino	 against	 PDGF-A	 (PDGF-A	 MO,	 Nagel	 et	 al.,	 2004).	 Second,	 a	 new	
designed	Morpholino	against	PDGFRα	(PDGFRα	MO,	see	section	3.1.1).	Third,	mRNA	
of	 a	 dominant	 negative	 form	 of	 the	 PDGFRα,	 PDGFRαw37,	 which	 has	 a	mutated	
glutamate	 residue	 converted	 to	 a	 lysine.	 This	 mutation	 prevents	
autophosphorylation	 of	 the	 Tyrosine	 37	 (W37)	 and	prevents	 autophosphorylation	
of	 the	 receptor	 (Ataliotis	 et	 al.,	 1995).	 Both	Morpholinos	 and	 dominant	 negative	
mRNA	were	injected	at	the	late	8-cell	stage	into	two	dorsal	blastomeres,	in	order	to	
target	 neural	 crest	 cell	 tissue	 on	 one	 side	 of	 embryo	 and	 to	minimise	 secondary	
effects	on	other	tissues.	The	effect	on	neural	crest	cell	migration	was	analysed	by	in	
situ	hybridization	against	the	neural	crest	cell	marker	Twist	at	stage	25.	To	evaluate	
the	 effect	 on	 neural	 crest	 cell	migration,	 the	 length	 of	 the	 2nd	 hyoid	 stream	was	
compared	 between	 the	 un-injected	 and	 injected	 side	 of	 the	 embryo.	 All	 three	
different	treatments,	PDGFRα	MO,	PDGFRα	MO	and	PDGFRαw37	mRNA,	showed	a	
significant	inhibition	of	neural	crest	cell	migration	in	vivo	(Figure	3-4	A,	B	and	C).		
PDGFRα	expression	has	been	 reported	 to	be	a	downstream	target	of	early	neural	
crest	cell	progenitor	transcription	factors	Pax3	and	Zic1	(Bae	et	al.,	2013).	Therefore	
I	addressed	whether	the	 impairment	of	neural	crest	cell	migration	by	depletion	of	
PDGFRα	signalling	could	be	due	to	an	effect	 in	neural	crest	cell	migration	and	not	
neural	 crest	 cell	 induction.	 To	 investigate	 this	 I	 performed	 in	 situ	 hybridisation	of	
the	 neural	 crest	 cell	 induction	 marker	 Slug	 on	 unilateral	 injected	 embryos	 with	
PDGF-A	MO,	PDGFRα	MO	and	PDGFRαw37	mRNA.	 Importantly,	 the	 same	 level	of	
reduction	of	PDGFRα	or	PDGF-A	which	affected	neural	crest	cell	migration,	did	not	
affect	the	neural	crest	cell	specification	marker	slug	(Figure	3-5	A,	B).	This	suggests	a	
specific	 mechanism	 of	 PDGF	 signalling	 during	 migration	 without	 affecting	 neural	
crest	cell	induction.		
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The	use	of	antisense	Morpholinos	has	been	recently	criticised	due	to	its	possibility	
of	off-target	effects	(Kok	et	al.,	2015;	Schulte-Merker	and	Stainier,	2014).	To	verify	
the	 specificity	 of	 both	 receptor	 and	 ligand	 anti-sense	 Morpholinos	 I	 co-injected	
mouse	 mRNA,	 which	 had	 at	 least	 5	 mismatches	 to	 the	 Xenopus	 laevis	 target	
sequence	(see	methods	section	2.2.5),	together	with	the	Morpholino	at	8-cell	stage.	
Subsequently	the	effect	on	neural	crest	cell	migration	was	analysed,	as	before,	by	in	
situ	 hybridisation	 against	 neural	 crest	 cell	 marker	 Twist	 at	 stage	 25.	 For	 both	
Morpholinos	 (PDGF-A	MO	and	PDGFRα	MO)	co-injection	of	mouse	mRNA	rescued	
neural	crest	cell	migration	back	to	wild	type	levels	(Figure	3-6	A-D).	Taken	together,	
these	data	show	that	specific	inhibition	of	PDGF-A	and	PDGFRα	impairs	neural	crest	
cell	migration,	suggesting	a	requirement	of	PDGF-A/PDGFRα	signalling	during	neural	
crest	cell	migration	in	vivo.	
	 104	
	
	
Figure	3-4	PDGF-A/PDGFRα	inhibition	impairs	collective	neural	crest	cell	migration	
in	vivo.		
(A)	Schematic	whole	mount	Twist	in	situ	hybridisation	of	Xenopus	laevis	embryo	
stage	25;	anterior	(A)	to	the	left,	posterior	(P)	to	the	right,	dorsal	(D)	up	and	ventral	
(V)	down.	The	three	neural	crest	cell	streams,	1st	mandibular,	2nd	hyoid	and	3rd	
brachial	are	shown.	(B)	Whole	mount	in	situ	hybridisation	of	Twist	neural	crest	cell	
migration	marker,	scale	bar	1	mm.	Red	arrow	indicates	2nd,	(hyoid)	neural	crest	cell	
stream,	grey	asterisk	indicates	eye.	(C)	Analysis	of	neural	crest	cell	migration	(%)	for	
control	n=30,	dominant	negative	(dn)	mRNA	(PDGFRαw37)	n=51,	PDGF-A	MO	n=47,	
PDGFRα	MO	n=28	embryos,	from	three	independent	experiments.	Control	versus	
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dominant	negative	mRNA	***P<0.0001;	Control	versus	PDGF-A	MO	***P<0.0001	;	
control	versus	PDGFRα	MO	***P<0.0001.	Bar	graph	for	neural	crest	cell	migration	
shows	distance	of	2nd	(hyoid)	neural	crest	cell	stream	migration	of	injected	side	
normalized	to	uninjected	control	side.	Bar	graph	indicates	mean	and	s.e.m.,	
statistical	analysis	using	one-way	ANOVA	with	a	Dunnett’s	multiple	a	comparisons	
post-test.	
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Figure	3-5	PDGF-A/PDGFRα	inhibition	might	not	affect	neural	crest	cell	induction	
(A)	 In	 situ	 hybridization	 of	 Slug	 neural	 crest	 cell	 induction	 marker,	 dorsal	 view,	
anterior	(A)	to	the	top	and	posterior	(P)	to	the	bottom,	uninjected	side	to	the	 left	
and	 injected	side	 to	 the	 right.	Red	arrow	 indicates	side	of	 injection,	 scale	bar	500	
μm.	 (B)	 Neural	 crest	 cell	 induction	 phenotype	 analysis.	 Strong	 phenotype=	 Slug	
neural	crest	marker	not	or	only	faintly	visible	on	injected	side	compared	to	control	
side.	Mild	 phenotype=	 lower	 Slug	 neural	 crest	marker	 compared	 to	 control	 side.	
Control	MO	n=	15,	dominant	negative	(dn)	mRNA	n=15,	PDGF-A	MO	n=15,	PDGFRα	
MO	n=15.	 	
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Figure	3-6	PDGF-A	and	PDGFRα	Morpholino	rescue.		
(A,	 B)	Whole	mount	 in	 situ	 hybridization	 against	Twist	neural	 crest	 cell	migration	
marker.	 Red	 arrow	 indicates	 2nd	 (hyoid)	 neural	 crest	 cell	 stream,	 grey	 asterisk	
indicates	eye,	scale	bar	1	mm.	(A,	C)	PDGF-A	MO	 in	vivo	rescue	with	control	n=20,	
PDGFRα	MO	n=36,	mouse	PDGFRα	mRNA	n=22,	PDGFRα	MO	and	mouse	PDGFRα	
mRNA	n=41	embryos.	Control	versus	PDGF-A	MO	***P>0.0001,	control	versus	PDGF-
A	mRNA	nsP=0.9995,	control	versus	PDGF-A	MO	and	PDGF-A	mRNA	nsP=0.7303.	(B,	
D)	PDGFRα	MO	in	vivo	rescue	with	control	n=30,	PDGF-A	MO	n=24,	mouse	PDGF-A	
mRNA=28,	PDGF-A	MO	and	mouse	PDGF-A	mRNA	n=27.	Control	versus	PDGFRα	MO	
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***P<0.0001;	control	versus	PDGFRα	mRNA	nsP=0.1919;	control	versus	PDGFRα	MO	
and	PDGFRα	mRNA	nsP=0.9557.	All	Bar	graphs	for	neural	crest	cell	migration	show	
distance	 of	 2nd	 (hyoid)	 neural	 crest	 cell	 stream	 migration	 on	 injected	 side	
normalized	 to	 uninjected	 control	 side.	 All	 bar	 graphs	 indicates	 mean	 and	 s.e.m.,	
statistical	 analysis	 using	 one-way	 ANOVA	 with	 a	 Dunnett’s	 multiple	 comparisons	
post-test.	 	
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3.1.3 PDGF-A/PDGFRα	signalling	controls	neural	crest	cell	dispersion	in	vitro	
In	 section	3.1.2	 I	 showed	 that	PDGF-A/PDGFRα	 inhibition	 impairs	neural	 crest	 cell	
migration	 in	vivo.	 Following	 this	 the	next	question	 I	 addressed	was,	what	 are	 the	
cellular	activities	controlled	by	PDGF	during	neural	crest	cell	migration?	
To	investigate	how	inhibition	of	PDGF	signalling	could	negatively	 impact	on	neural	
crest	cell	migration	I	analysed	the	following	possible	cellular	behaviours	in		in	vitro	
assays:	
• cell	motility	
• chemotaxis	
• cell	dispersion.		
Due	to	the	cohesive	properties	of	Xenopus	laevis	neural	crest	cells,	it	is	possible	to	
dissect	the	cranial	neural	crest	cells	before	they	start	migration	and	culture	them	in	
vitro	(Alfandari	et	al.,	2010).	PDGF	signalling	has	been	shown	to	be	essential	for	cell	
motility	 during	 embryonic	 development	 in	 many	 different	 model	 organisms	
including	the	mouse,	frog,	zebrafish,	and	sea	urchin	(Andrae	et	al.,	2008b)	.	Hence,	I	
first	 addressed	whether	 neural	 crest	 cell	migration	 impairment	 is	 due	 to	 possible	
changes	in	neural	crest	cell	motility.		
For	 this,	nuclear	 labelled	neural	crest	cells	were	dissociated,	plated	on	fibronectin	
coated	dishes	and	single	cell	migration	was	monitored	using	time-lapse	microscopy.	
Cell	tracking	and	analysis	of	cell	motility	parameters	did	not	reveal	any	difference	in	
cell	speed	between	PDGFRα	MO	injected	and	control	neural	crest	cells	(Figure	3-7	
A,	B).	However,	analysis	of	cell	directionality,	a	measurement	of	how	directional	a	
cell	migrates,	revealed	inhibition	od	directionality	in	PDGFRα	MO	injected	cells.	This	
shows	that	inhibition	of	PDGFRα	does	not	affect	cell	motility	of	single	cells,	but	their	
directional	 movement	 and	 suggests	 that	 inhibition	 of	 collective	 cell	 migration	 by	
PDGFRα	depletion	might	not	be	due	to	an	effect	on	neural	crest	cell	motility.	
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It	 is	 known	 that	 directional	 migration	 of	 neural	 crest	 cells	 is	 controlled	 by	
chemotaxis	towards	the	chemokine	SDF-1	(Belmadani,	2005;	Olesnicky	Killian	et	al.,	
2009;	Theveneau	et	al.,	 2010).	 I	 investigated	whether	 the	 loss	of	neural	 crest	 cell	
migration	after	 inhibition	of	PDGFRα	 is	caused	by	a	defect	of	chemotaxis	 towards	
the	chemokine	SDF-1.	PDGFRα	MO	injected	explants	were	plated	in	close	proximity	
to	SDF-1	protein-coated	beads	and	their	migratory	behaviour	was	analysed	by	time-
lapse	 microscopy.	 Cell	 tracking	 analysis	 of	 chemotaxing	 clusters	 revealed	 no	
difference	 in	 the	 migration	 towards	 the	 SDF-1	 source	 between	 the	 PDGFRα	
depleted	explants	and	the	control	cells	(Figure	3-8	A,	B;	Movie	1).	This	indicates	that	
the	 effect	 of	 PDGF-A/PDGFRα	 depletion	 on	 neural	 crest	 cell	 migration	 is	 not	 a	
consequence	of	disturbed	SDF-1	chemotaxis.		
Another	 possibility	 for	 the	 impaired	 migration	 of	 the	 neural	 crest	 cells	 could	 be	
defects	 during	 EMT.	 To	 assess	 the	 potential	 influence	 of	 PDGF	 signalling	 during	
EMT,	 the	behaviour	during	neural	 crest	 cell	 dispersion	was	used	as	 an	EMT	 read-
out.	Fluorescently	 labelled	neural	crest	cell	clusters	were	monitored	by	time-lapse	
microscopy	and	dispersion	was	quantified	using	Delaunay	 triangulation	of	 the	cell	
nuclei	 (Carmona-Fontaine	 et	 al.,	 2011;	 Nawrocki	 Raby	 et	 al.,	 2001).	 Inhibition	 of	
either	PDGF-AA	or	PDGFRα	signalling	by	Morpholino	injection	reduced	neural	crest	
cell	 dispersion	 dramatically.	 Thus,	 confirming	 our	 previous	 observation	 that	 both	
PDGFRα	MO	and	PDGF-AA	are	 co-expressed	by	neural	 crest	 cells	 and	 functionally	
active	 in	 these	 cells	 (Figure	 3-9	 C,E	 and	 G;	 Movie	 2).	 Moreover,	 addition	 of	 the	
ligand	PDGF-AA	to	the	culture	media	further	 increased	cell	dispersion	of	wild	type	
neural	crest	cells	 (Figure	3-9	A,	B	and	G;	Movie2).	Concentration	 for	dispersion	of	
PDGFRα	 MO,	 PDGF-A	 MO	 and	 PDGF-AA	 protein	 was	 determined	 by	 titration	
experiments	(Figure	3-10	A,	B	and	C).	Following	these	experiments	8	ng	of	PDGFRα	
MO,	 16ng	 PDGF-A	 MO	 and	 50	 ng	 mL-1	 PDGF-AA	 protein	 where	 used.	 To	 test	
whether	inhibition	of	PDGF-A	MO	and	PDGFRα	MO	is	specific,	PDGF-AA	protein	was	
added	to	the	Morpholino	injected	neural	crest	cell	explants.	The	addition	of	PDGF-
AA	protein	was	only	able	to	partially	rescue	the	inhibition	of	PDGF-A	MO	dispersion,	
but	not	PDGFRα	MO	treated	cells	 (Figure	3-9	D,	F	and	G).	Thus	showing	again	the	
specificity	and	effectivity	of	 the	pathway	 inhibition	using	the	PDGF-A	and	PDGFRα	
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Morpholinos.	 Taken	 together,	 I	 show	 that	 PDGF-A/PDGFRα	 signalling	 inhibition	
does	 not	 affect	 neural	 crest	 cell	 motility,	 nor	 chemotaxis	 towards	 SDF-1,	 but	
regulates	neural	crest	cell	dispersion.	 	
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Figure	3-7	PDGFRα	does	not	affect	single	cell	motility.		
(A)	Images	showing	tracks	of	nuclear	(nuc)	RFP	injected	cells	over	30min,	scale	bar	
50µm.	(B)	Analysis	of	neural	crest	cell	motility	(Speed	(µm	seconds-1))	in	control	and	
PDGFRα	MO	injected	single	cells,	control	n=202,	PDGFRα	MO=228	cells	from	three	
independent	 experiments,	 scatter	 blot	 median	 and	 interquartile	 range,	 statistical	
analysis	 using	 Mann-Whitney’s	 test;	 control	 versus	 PDGFRα	MO	 nsP=0.1069;	 	 (C)	
Analysis	 of	 neural	 crest	 cell	 persistence/directionality	 in	 control	 and	 PDGFRα	MO	
injected	single	cells,	control	n=100,	PDGFRα	MO=114	cells	from	three	independent	
experiments,	 scatter	blot	median	and	 interquartile	 range,	 statistical	analysis	using	
Mann-Whitney’s	test;	control	versus	PDGFRα	MO	*P=0.00091.	
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Figure	3-8	PDGFRα	signalling	is	not	required	for	SDF-1	chemotaxis.	
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(A)	Representative	 images	of	chemotaxing	clusters	at	 t=0min	and	 t=300min,	 scale	
bar	100µm.	 (B)	Chemotaxis	assay	analysis	 showing	Forward	migration	 index	 (FMI)	
with	SDF1	bead	 (control	n=47,	PDGFRα	MO	n=50)	and	PBS	control	beads	 (control	
n=50,	 PDGFRα	 MO	 n=50);	 box	 and	 whisker:	 box	 and	 median	 are	 ±	
25th/75thpercentile,	 whiskers	 are	 min.	 and	 max.,	 statistical	 analysis	 using	 ANOVA	
with	 a	 Dunnett’s	 multiple	 comparisons	 post-test;	 control	 (SDF-1	 bead)	 versus	
PDGFRα	 MO	 (SDF-1	 bead)	 nsP=0.9995;	 control	 (SDF-1	 bead)	 versus	 control	 (PBS	
bead)	***P<0.0001;	control	(PBS	bead)	versus	PDGFRα	MO	(PBS	bead	)	nsP=0.3975.	
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Figure	3-9	PDGF-A/PDGFRα	required	for	neural	crest	cell	dispersion.	
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(A-F)	PDGF	signalling	dispersion	with	nuclear	RFP	mRNA	(nucRFP)	explants,	example	
images	 of	 movies	 at	 t=0min	 and	 t=720min,	 scale	 bar	 100µm	 and	 Delaunay	
triangulation	examples	at	t=720min.	(G)	Average	Delaunay	triangulation	area	(	μm2)	
of	 control=43,	 PDGF-AA	 protein	 (50ng	 mL-1)	 n=31,	 PDGF-A	 MO	 n=18,	 PDGF-AA	
MO&PDGF-A	protein	n=13,	PDGFRα	MO	n=30,	PDGFRα	MO&PDGF-AA	protein	n=29	
explant	clusters	from	at	least	three	independent	experiments.	Box	and	whisker:	box	
and	 median	 are	 ±	 25th/75thpercentile,	 whiskers	 are	 min.	 and	 max.,	 statistical	
analysis	using	Kruskal-Wallis	Anova	with	Dunnett’s	multiple	comparisons	post-test;	
control	versus	PDGF-A	protein	 ***P<0.0001;	control	versus	PDGF-A	MO	 *P=0.0217;	
control	 versus	 PDGFRα	MO	 **P=0.0052;	 PDGF-A	MO	 versus	 PDGF-A	MO&PDGF-A	
protein	**P=0.0059;	PDGFRα	MO	versus	PDGFRα	MO&PDGF-A	protein	nsP=0.9956.	
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Figure	3-10	PDGFRα	MO,	PDGF-A	MO	and	PDGF-AA	protein	dispersion	titration	
(A)	 PDGFRα	 MO	 titration	 (0	 ng,	 8	 ng,	 16	 ng	 and	 24	 ng)	 analysed	 by	 delauney	
triangulation	[μm2]	at	720	min.	(B)	PDGF-A	MO	titration	(0	ng,	8	ng,	16	ng	and	24	
ng)	 analysed	 by	 delauney	 triangulation	 [μm2]	 at	 720	 min.	 (C)	 PDGF-AA	 protein	
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titration	(0	ng	mL-1,	25	ng	mL-1,	50	ng	mL-1	and	100	ng	mL-1)	analysed	by	delauney	
triangulation	[μm2]	at	720	min.	
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3.2 PDGF-A/PDGFRα	controls	N-cadherin	dependent	contact	inhibition	of	
locomotion	
3.2.1 PDGF-A/PDGFRα	controls	cell-cell	adhesion	via	N-Cadherin	regulation	
In	 the	 section	 3.1.3	 I	 established	 that	 PDGF-A/PDGFRα	 signalling	 is	 controlling	
dispersion,	an	EMT	property,	in	vitro.	One	of	the	hallmarks	of	EMT	transition	is	the	
change	in	cell-cell	adhesion	from	epithelial	to	mesenchymal	character	(Thiery	et	al.,	
2009).	Specifically	a	switch	from	E-cadherin	to	N-cadherin	 is	 linked	to	EMT	(Thiery	
et	al.,	2009)	and	has	also	been	has	been	recently	connected	to	neural	crest	cell	EMT	
(Scarpa	et	al.,	2015).	Therefore,	I	investigated	whether	PDGF	signalling	inhibition	is	
affecting	 cell-cell	 adhesion.	 To	 address	 this	 I	made	 use	 of	 a	 previously	 published	
cell-cell	sorting	assay	(Carmona-Fontaine	et	al.,	2011;	Moore	et	al.,	2013;	Scarpa	et	
al.,	 2015).	 The	 cell	 sorting	 assay	 provides	 a	 readout	 of	 differences	 in	 cell-cell	
adhesion	properties	between	two	cell	populations.	Differently	micro-dissected	and	
labelled	 neural	 crest	 cells	 populations	 were	 dissociated,	 mixed	 and	 allowed	 to	
reaggregate	 in	 an	 agarose	 coated	 dish	 over	 night.	 The	 read	 out	 is	 given	with	 the	
mixing	capabilities	of	both	populations.	If	the	cell-cell	adhesion	properties	between	
the	two	groups	are	the	similar,	the	cell	populations	stay	mixed,	if	they	are	different	
cell	groups	sort	out	 into	two	distinct	populations	 in	the	aggregate	(Figure	3-11	A).	
After	mixing	PDGFRα	MO	injected	neural	crest	cells	with	control	neural	crest	cells	
we	 observed	 that	 re-aggregated	 cell	 populations	 grouped	 themselves	 into	 two	
distinct	 populations	 (Figure	 3-11	B),	 in	 contrast	 to	 the	 control	 cells,	which	 stayed	
mixed	(Figure	3-11	B).	This	experiment	might	suggest	a	role	of	PDGFRα	signalling	in	
cell-cell	adhesion.		
As	mentioned	 above	 one	 of	 the	 key	 families	 involved	 in	 cell-cell	 adhesion	 is	 the	
cadherin	protein	family	(Thiery	et	al.,	2009)	and	it	has	been	recently	shown	that	a	
switch	 from	 E-	 to	 N-cadherin	 is	 essential	 for	 neural	 crest	 cell	 EMT	 (Scarpa	 et	 al.,	
2015).	Therefore	I	first	investigated	the	impact	of	PDGFRα	signalling	on	N-Cadherin	
and	E-Cadherin	levels	in	neural	crest	cells	by	western	blot.	Neural	crest	cell	explants	
were	 micro-dissected	 and	 immunoblotted	 against	 N-cadherin	 and	 E-cadherin.	
Surprisingly,	we	observed	a	reduction	of	N-Cadherin	protein	 levels	 in	PDGFRα	MO	
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injected	 neural	 crest	 cells,	 but	 no	 significant	 change	 in	 E-Cadherin	 levels	 (Figure	
3-12	A,	B).	To	verify	the	effect	of	PDGFRα	depletion	on	N-	and	E-cadherin	 levels,	 I	
performed	 immunofluorescence	 staining	 in	 PDGFRα	 depleted	 neural	 crest	 cells.	
Immunofluorescence	 against	 N-cadherin	 or	 E-cadherin	 were	 imaged	 by	 confocal	
microscopy	and	analysed	by	measuring	grey	value	intensity	levels	over	the	cell-cell	
border.	 Consistent	 with	 my	 previous	 data,	 I	 observed	 a	 specific	 decrease	 in	
fluorescently	labelled	N-cadherin	(Figure	3-13	A,	B),	but	not	E-cadherin	(Figure	3-14	
A,	 B)	 after	 PDGFRa	 MO	 injection.	 Interestingly,	 N-cadherin	 levels	 were	 similarly	
diminished	 after	 PDGF-A	 MO	 treatment	 (Figure	 3-13	 A,	 B).	 Furthermore	
overexpression	of	the	PDGF-A	ligand,	led	to	an	increase	in	N-cadherin	levels	(Figure	
3-13	A,	B).		
Taken	 together,	 the	 data	 in	 this	 chapter	 lead	 to	 the	 suggestion	 that	 PDGFRα	
signalling	might	control	neural	crest	cell	migration,	at	least	 in	vitro,	by	a	change	in	
cell-cell	adhesion.	Further	I	show	that	the	change	in	cell-cell	adhesion	could	be	due	
to	a	downregulation	of	N-cadherin	levels	in	PDGFRa	MO	explants.	
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Figure	 3-11	 Cell-Cell	 Sorting	 assay:	 PDGFRα	 MO	 in	 neural	 crest	 cells	 show	
adhesion	differences	
(A)	 Schematic	 representation	 of	 cell-cell	 sorting	 assay	 adapted	 from	 Carmona-
Fontaine	 et	 al.,	 2011	 (B,C)	 Example	 confocal	 projections	 of	 differentially	 labelled	
control	 (B)	 and	 PDGFRα	 injected	MO	 (C)	 neural	 crest	 cell	 aggregates.	 Example	 of	
two	independent	experiments,	scale	bar	50µm.		
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Figure	3-12	PDGFRα	depletion	affects	N-cadherin	level	by	western	blot	
(A)	 Immunoblot	against	N-cadherin	and	E-cadherin	protein	from	of	control,	PDGF-
AA	protein	(50ng	mL-1	for	60min)	and	PDGFRα	MO	injected	neural	crest	cell	explant	
lysates	(B)	Band	intensity	normalized	to	loading	control,	bar	graph	shows	mean	and	
s.d.,	 statistical	 analysis	 used	one-way	ANOVA	 followed	by	 Student	Newman-Keuls	
test,	data	from	three	independent	experiments.	N-cadherin:	Control	versus	PDGF-A	
protein	 nsP=0.9985;	 control	 versus	 PDGFRα	 MO	 **P=0.0040;	 E-cadherin:	 control	
versus	 PDGF-A	 protein	 nsP=0.1721;	 control	 versus	 PDGFR	 α	 MO	 nsP=0.0537;	 AU=	
arbitrary	units.	
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Figure	3-13	Immunostaining:	PDGFRα	signalling	regulates	N-cadherin	level	
(A,C)	 Immunostaining	against	N-cadherin	 (A,	green),	DAPI	 (blue)	of	control,	PDGF-
AA	protein	 treated	 (50ng	mL-1	for	180min),	PDGF-A	MO	and	PDGFRα	MO	 injected	
neural	crest	cells.	Scale	bar	20	μM.	 (B,D)	Analysis	of	pixel	 intensity	across	cell-cell	
contact	(0	μm),	normalized	to	average	cell	background	level.	Data	points	represent	
mean	 with	 s.e.m.,	 statistical	 analysis	 using	 one-way	 ANOVA	 with	 a	 Dunnett’s	
multiple	 comparisons	 post-test.	 Control	 n=118,	 PDGFRα	 MO	 n=61,	 PDGF-A	 MO	
n=50,	PDGF-AA	mRNA	n=50;	control	versus	PDGFRα	MO	***P<0.0001;	control	versus	
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PDGF-A	MO	***P<0.0001;	control	versus	PDGF-AA	mRNA	***P<0.0001.	AU=	arbitrary	
units.		
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Figure	3-14	Immunostaining	E-cadherin:	PDGFRα	signalling	perturbation	does	not	
affect	E-cadherin	level	
Immunostaining	 against	 E-cadherin	 (A,	 green),	 DAPI	 (blue)	 of	 control,	 PDGF-AA	
protein	 treated	 (50ng	 mL-1	 for	 180min),	 PDGF-A	 MO	 and	 PDGFRα	 MO	 injected	
neural	crest	cells.	Scale	bar	20	μm.	 (B,D)	Analysis	of	pixel	 intensity	across	cell-cell	
contact	(0	μm),	normalized	to	average	cell	background	level.	Data	points	represent	
mean	 with	 s.e.m.,	 statistical	 analysis	 using	 one-way	 ANOVA	 with	 a	 Dunnett’s	
multiple	 comparisons	 post-test.	 E-cadherin:	 control	 n=445,	 PDGFRα	 MO	 n=137,	
PDGF-AA	protein	n=256.	nsP>0.05,	AU=	arbitrary	units.	
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3.2.2 N-cadherin	dependent	CIL	is	regulated	by	PDGF-A/PDGFRα	signalling	
So	 far,	 I	 found	 that	 inhibition	of	PDGF-AA/PDGFRα	changes	 cell-cell	 adhesion	and	
specifically	 decreases	 the	 levels	 of	 N-cadherin	 protein	 at	 the	 cell-cell	 contact	
(section	3.2.1).	The	next	question	asked	was:	How	can	this	decrease	in	N-cadherin	
be	 related	 to	 reduced	 cell	 dispersion?	 Blocking	 N-cadherin	 leads	 to	 a	 loss	 of	 CIL	
behaviour	in	neural	crest	cells	(Theveneau	et	al.,	2010).	Hence,	I	hypothesized	that	
the	decreased	dispersion	in	PDGFRα	MO	explants	(Fig.3	E,	F)	could	be	due	to	a	N-
cadherin	dependent	loss	of	CIL.	It	 is	well	established	that	a	cell	cluster	undergoing	
CIL	will	disperse	(Davis	et	al.,	2015;	Scarpa	et	al.,	2015;	Stramer	and	Mayor,	2016;	
Villar-Cerviño	 et	 al.,	 2013),	 conversely	 the	 depletion	 of	 CIL	 behaviour	 causes	 an	
inhibition	 of	 dispersion,	 as	 observed	 in	 PDGF-A	 MO	 and	 PDGFRα	 MO	 explants	
(Figure	3-9;	Movie	2).		
To	further	investigate	whether	CIL	is	impaired	in	a	PDGFRα	depletion	background	I	
used	two	different	assays	to	test	for	a	change	in	CIL;	first	a	single	cell	based	collision	
assay	 (or	 2D	 kinematic	 assay)	 and	 second	 an	 explant	 invasion	 assay	 (Carmona-
Fontaine	et	al.,	2008b;	Moore	et	al.,	2013;	Scarpa	et	al.,	2015).		
First,	when	 two	 cells	 undergoing	 CIL	 collide	 they	 remain	 briefly	 in	 contact	 before	
they	move	away	from	each	other.	However,	if	CIL	is	impaired	the	two	colliding	cells	
remain	in	contact	for	longer	time.	We	measured	the	time	that	pairs	of	colliding	cells	
remain	 together	 as	 an	outcome	of	CIL	 (Stramer	 and	Mayor,	 2016,	 Figure	3.13	B).	
PDGFRα	 depleted	 and	 control	 dissociated	 single	 cells	 were	 plated	 on	 fibronectin	
coated	dishes	and	their	behaviour	was	monitored	using	time-lapse	microscopy.	Our	
results	show	that	cells	expressing	the	PDGFRα	MO	remain	 in	contact	much	 longer	
compared	to	control	cells,	indicating	impairment	in	the	CIL	response	(Figure	3-15	A).		
Second,	PDGFRα	depletion	was	analysed	by	its	capability	to	invade.	When	two	cell-
explants	that	exhibit	CIL	are	confronted,	they	do	not	overlap;	on	the	other	hand	an	
overlapping	between	adjacent	 explants	 is	 an	 indication	of	 CIL	 deficiency	 (Stramer	
and	Mayor,	 2016).	 Two	 neural	 crest	 cell	 explants	 fluorescently	 labelled	with	 two	
distinct	 tracers	were	cultured	at	a	 short	distance	and	 their	behaviour	analysed	by	
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time-lapse	 microscopy.	 The	 overlapping	 area	 between	 them	 was	 analysed	 as	
readout	 of	 CIL	 deficiency	 (Figure	 3-16	 A).	 This	 assay	 showed	 that	 while	 control	
explants	 did	 not	 overlap,	 PDGFRα	 deficient	 explants	 showed	 a	 clear	 overlapping	
(Figure	3-16	B,	C).	This	indicates	a	striking	reduction	in	CIL	response.		
In	 order	 to	 undergo	 CIL	 and	 move	 away	 from	 each	 other	 cells	 must	 be	 able	 to	
change	their	polarity	upon	cell	contact.	This	change	 in	contact-dependent	polarity	
has	 been	 linked	 to	 N-cadherin	 dependent	 cell	 adhesion	 (Scarpa	 et	 al.,	 2015;	
Theveneau	et	al.,	2010).	To	assess	whether	inhibition	of	PDGFRα	changes	polarity	in	
neural	 crest	 cells	 we	 measured	 the	 protrusion	 area	 as	 readout	 in	 Morpholino	
injected	 explants.	 We	 found	 a	 reduced	 protrusion	 size	 in	 PDGFRα	 MO	 injected	
explants	(Figure	3-17),	suggesting	a	change	in	polarity.	Taken	together,	this	further	
supports	the	hypothesis	that	PDGFRα	MO	depletion	impairs	CIL	in	neural	crest	cell	
migration.		
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Figure	3-15	PDGFRα	required	for	contact	inhibition	of	locomotion	
(A,B)	 Single	 cell	 collision	 assay	 representing	 CIL	 time	 between	 first	 contact	 and	
separation,	 also	 considered	 as	 the	 stability	 of	 the	 contact.	 PDGFRα	MO	 explants	
have	 impaired	CIL,	 control-control	 CIL	 events	 n=58	 and	PDGFRα	MO-PDGFRα	MO	
events	n=63,	bar	graph	shows	mean	and	s.d.,	from	three	independent	experiments,	
statistical	analysis	by	two-way	ANOVA	followed	by	Bonferroni	post-tests;	0-15	min	
data	bin	control	versus	PDGFRα	MO	***P<0.0001;	16-30	min	data	bin	control	versus	
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PDGFRα	MO	nsP=0.9999;	31-45	min	data	bin	control	versus	PDGFRα	MO	nsP=0.9999;	
45-60	min	data	bin	control	versus	PDGFRα	MO	***P=0.0003.	
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Figure	3-16	PDGFRα	depleted	neural	crest	cells	are	able	to	invade	each	other	
(A)	Schematic	representation	of	 invasion	assay.	RDX	(rhodamine-dextran)	and	FDX	
(fluorescein-dextran)	where	used	as	tracers.	CoA	(co-attraction)	attracts	two	neural	
crest	cluster.	There	is	little	to	none	to	very	little	overlap	between	two	neural	crest	
clusters	 with	 wild	 type	 CIL	 behaviour,	 if	 there	 is	 diminished	 CIL	 neural	 crest	 cell	
clusters	 overlap.	 (B)	 Thresholded,	 brightfield	 and	 fluorescent	 images	 of	 explant	
invasion	assay,	scale	bar	100µm.	(C)	Overlap	percentage	between	two	neural	crest	
cell	explants	of	control-control	explants	n=52,	PDGFRα-PDGFRα	MO	explants	n=59,	
from	 three	 independent	 experiments.	 Scatter	 blot	 represents	 median	 with	
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interquartile	 range,	 statistical	 analysis	 used	 Mann-Whitney’s	 test;	 control	 versus	
PDGFRα	***P<0.0001.	
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Figure	3-17	PDGFRα	depletion	affects	protrusion	formation	
(A)	Free	edge	protrusion	area	 (defined	as	the	regions	devoid	of	vitelline	platelets;	
labelled	in	white)	confocal	projections,	scale	bar	30	μM.	(B)	Protrusion	area	analysis	
(	μm2)	of	control	n=51,	PDGF-AA	(50ng	mL-1)	n=34,	PDGFRα	MO	n=41	cells,	scatter	
blot	 represents	median	with	 interquartile	 range,	 statistical	 analysis	by	unpaired	 t-
test	with	Welch’s	corrections;	control	versus	PDGFRα	MO	*P=0.0281.	
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3.3 PI3K/AKT	signalling	downstream	of	PDGFRα	during	neural	crest	cell	
migration	
3.3.1 PDGF-A/Rα	controls	neural	crest	cell	migration	via	PI3K/AKT	pathway	
In	the	previous	sections	(3.1	and	3.2)	I	describe	that	PDGF-A/PDGFRα	is	required	for	
neural	 crest	 cell	migration	 in	 vivo.	 Further,	 I	 have	 shown	 that	 PDGFRα	 depletion	
leads	 to	 impairment	of	dispersion	 in	vitro	and	that	 this	 inhibition	could	be	due	to	
reduction	of	N-cadherin	dependent	CIL.		
Next	I	tried	to	elucidate	the	possible	downstream	signalling	pathway/s,	which	could	
mediate	 this	 response.	 It	 is	 known	 that	 PDGF	 can	 activate	 several	 signalling	
pathways,	 such	 as	 PI3K,	 MAPK,	 PKC,	 JAK-STAT,	 and	 Src	 (Demoulin	 and	 Essaghir,	
2014).	 Studies	 in	 mouse	 and	 zebrafish	 during	 craniofacial	 neural	 crest	 cell	
migration,	 showed	 PI3K	 signalling	 as	 the	 main	 downstream	 effector	 of	 PDGF	
signalling	(Klinghoffer	et	al.,	2001;	Vasudevan	et	al.,	2015).	To	test	the	contribution	
of	PI3K	as	a	downstream	component	of	PDGFRα	signalling	 I	made	use	of	 the	AKT	
pleckstrin	 homology	 (ph)	 domain	 biosensor	 ph-AKT-GFP	 (Montero	 et	 al.,	 2003).	
Activation	 of	 PI3K	 results	 in	 the	 addition	 of	 a	 phosphate	 molecule	 to	
phosphoinositides,	 generating	phosphatidylinositol	 3,4,5-trisphosphate	 (PIP3).	 The	
PH	 domain	 has	 a	 high	 and	 specific	 affinity	 for	 PIP3	 and	 therefore	 ph-AKT-GFP	
translocates	 to	 the	 plasma	 membrane	 upon	 binding	 PIP3.	 Thus,	 a	 GFP	 intensity	
change	from	the	cytosolic	to	membrane	bound	form	is	used	as	a	read-out	of	PI3K	
pathway	 activation.	 The	 ph-AKT-sensor	 was	 exogenously	 expressed,	 by	 mRNA	
injection	 and	 PI3K/AKT	 activity	 was	 monitored	 the	 by	 high-time	 resolution	
microscopy	in	micro-dissected	neural	crest	cells.	
Strikingly,	 the	 treatment	 of	 PH-AKT-GFP	 expressing	 cells	 with	 PDGF-AA	 protein	
induced	 a	 clear	 increase	 in	 the	membrane	GFP	 intensity,	 compared	 to	 untreated	
neural	crest	cells	(Figure	3-18	A-D;	Movie	3).	As	a	positive	control	I	co-injected	ph-
AKT-GFP	 mRNA	 with	 a	 dominate	 active	 from	 of	 PI3K	 kinase	 (PI3K-p110-CAAX)	
mRNA,	 which	 resulted	 in	 a	 strong	 membrane	 GFP	 response	 without	 PDGF-AA	
protein	 addition	 (Figure	 3-19	 A,	 C).	 This	 suggests	 that	 PI3K/AKT	 signalling	 acts	
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downstream	of	the	PDGF-A	ligand.	To	verify	that	the	observed	response	acts	via	the	
receptor	PDGFRα,	I	treated	ph-AKT-GFP	and	PDGFRα	Morpholino	injected	cells	with	
PDGF-AA	protein,	which	led	to	no	membrane	localization	(Figure	3-19	B,	C).		
To	further	examine	the	role	of	PI3K/AKT	signalling	I	tested	for	endogenous	pathway	
activation	 by	 western	 blot	 against	 phosphorylated	 AKT	 (pAKT).	 Treatment	 with	
PDGF-AA	 protein	 led	 to	 an	 increase	 in	 AKT	 phosphorylation	 in	 neural	 crest	 cells,	
whereas	PDGFRα	MO	led	to	a	slight,	but	not	significant,	decrease	in	pAKT	levels	(	
Figure	 3-20	 A,	 B).	 This,	 so	 far,	 suggests	 an	 involvement	 of	 PI3K/AKT	 signalling	
downstream	 of	 PDGF-A/PDGFRα	 signalling.	 But	 the	 question	 remains	 whether	
PI3K/AKT	 signalling	 is	 involved	 in	 PDGF-A/PDGFRα	 mediated	 neural	 crest	 cell	
migration?	
To	 interfere	 with	 PI3K/AKT	 signalling	 in	 vivo	 and	 in	 vitro	 I	 used	 small	
pharmacological	molecule	inhibitors	against	PDGFR	(AG1296),	PI3K	(LY294002)	and	
AKT	 (MK2206)	 (Figure	 3-21	 A).	 As	 a	 control	 for	 the	 specificity	 in	 targeting	 the	
PI3K/AKT	pathway,	I	also	included	treatment	of	the	unrelated	MAPK/ERK	signalling	
pathway	by	use	of	the	MEK	inhibitor	(UO126).		
Treatment	of	PDGFR,	PI3K	and	AKT	inhibitors	in	vivo	led	to	inhibition	of	neural	crest	
cell	migration	(Figure	3-21	B,	C)	supporting	our	earlier	findings.	No	significant	effect	
of	MAPK	 inhibition	on	neural	crest	cell	migration	was	detected	 (Figure	3-21	B,	C).	
This	 indicates	 a	 role	 for	 PI3K/AKT	 signalling	 in	 neural	 crest	 cell	 migration	 in	 vivo	
supporting	our	earlier	findings	with	the	ph-AKT-GFP	inhibitor.	
To	 investigate	 a	 possible	 effect	 on	 CIL	 I	 investigated	 the	 effect	 of	 PI3K/AKT	
pharmacological	 inhibition	 on	 neural	 crest	 cell	 explants	 dispersion,	 which	 is	
considered	as	an	assay	for	CIL	(Stramer	and	Mayor,	2016).	PI3K	(LY294002)	and	AKT	
(MK-2206)	 inhibitor	 treatment	 alone	 led	 to	 an	 inhibition	 of	 neural	 crest	 cell	
dispersion	 (Figure	 3-22	 Fig.	 7	 B,	 C	 and	 I:	 black	 bars).	 Surprisingly,	 also	 treatment	
with	the	MAPK	inhibitor	showed	a	reduction	in	neural	crest	cell	dispersion	despite	
showing	no	effect	neural	crest	cell	migration	in	vivo	(Figure	3-22	D,	I:	black	bars).		
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As	some	of	these	inhibitors	could	also	affect	other	pathways	present	in	the	neural	
crest	 cells,	 different	 to	 the	 one	 activated	 by	 PDGF-AA,	 I	 continued	 to	 use	 the	
inhibitors	 after	 treating	 the	 neural	 crest	 cell	 clusters	 with	 PDGF-AA	 protein.	 As	
previously	 shown,	 treatment	 of	 neural	 crest	 cell	 with	 PDGF-AA	 leads	 to	 cell	
dispersion	 (Figure	 3-9	 A,	 B).	 However,	 this	 dispersion	 was	 dramatically	 impaired	
when	PDGF-AA	 treated	 cells	were	 co-incubated	with	PI3K	 and	AKT	 inhibitors,	 but	
not	with	the	MAPK	inhibitor	(Figure	3-22	F-H	and	I:	grey	bars).	These	results	show	
that	PDGF-AA	promotes	cell	dispersion	in	a	PI3K/AKT	manner,	but	independent	on	
MAPK,	which	 is	 consistent	with	 the	 effect	 of	 the	 inhibitors	 of	 these	 pathways	 on	
neural	crest	cell	migration	in	vivo.	To	verify	the	efficacy	of	the	inhibitors	at	the	used	
concentration	I	performed	Immunoblotting	for	pAKT	on	inhibitor	treated	embryos.	
This	 confirmed	 a	 decrease	 after	 PDGFR	 inhibitor	 treatment	 (Figure	 3-23	 A,	 D),	
similar	to	inhibitor	treatment	of	PI3K	and	AKT	(Figure	3-23	C,	E	and	F).		
Taken	together,	both	the	analysis	of	the	ph-AKT-GFP	biosensor	and	dissection	of	the	
downstream	pathway	with	pharmacological	 inhibitors	strongly	suggest	 that	PDGF-
A/PDGFRα	 controls	 neural	 crest	 cell	 migration	 and	 dispersion	 via	 the	 PI3K/AKT	
signalling	pathway.	 	
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Figure	 3-18	 PDGF-AA	 addition	 leads	 to	 ph-AKT	 translocation	 to	 the	 plasma	
membrane	
(A-C)	 Confocal	 projections	 of	Ph-AKT-GFP	mRNA	 injected	 neural	 crest	 cell	 images	
from	t=0sec	and	t=425sec	movies.	Scale	bar	20	μM.	 (A,D)	Time	course	 (10min)	of	
stills	 at	 cell	membrane,	 displaying	membrane	 localization	 after	 PDGF-AA	 addition	
50ng	mL-1	and	 (A,C)	No	PDGF-AA	protein	addition	control.	 (B,D)	PDGF-AA	protein	
50ng	mL-1	addition	at	300sec	after	start.	Heat	map	images	depict	pixel	count,	with	
red	high	pixel	count	and	blue	with	low	pixel	count.	(E)	Analysis	of	ph-AKT-GFP	pixel	
intensity	 at	 membrane	 normalized	 to	 cytoplasmic	 ph-AKT-GFP	 level	 over	 time	
(seconds).	PDGF-AA	protein	addition	control	n=12,	no	PDGF-AA	addition	control	n=7	
cells,	 from	 three	 independent	 experiments,	 line	 graph	 represents	mean	 and	 s.d.,	
AU=	arbitrary	units.	 	
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Figure	 3-19	 dominant	 active	 PI3K	 and	 PDGFRα	 inhibition	 and	 ph-AKT	
translocalisation	
(A,	 B)	Confocal	projections	of	Ph-AKT-GFP	mRNA	 injected	neural	 crest	cell	 images	
from	 t=0sec	 and	 t=425sec	 movies	 with	 PDGF-AA	 protein	 50	 ng	 mL-1	 addition	 at	
300sec	after	start.	Scale	bar	20	μM.	(A)	Additional	PI3K-CAAX	mRNA	injected	neural	
crest	 cells	 (lower	 panel).	 (B)	 Additional	 PDGFRα	 MO	 injected	 neural	 crest	 cells	
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treated.	 (C)	 Analysis	 of	 ph-AKT-GFP	 pixel	 intensity	 at	 membrane	 normalized	 to	
cytoplasmic	 ph-AKT-GFP	 level	 over	 time	 (seconds).	 PDGFRα	MO	 n=11,	 PI3K-CAAX	
n=10	 cells,	 from	 three	 independent	 experiments,	 line	 represents	mean	 and	 error	
bars	are	s.d.,	AU=	arbitrary	units.		 	
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Figure	3-20	PDGFRα	depletion	decreased	phosphorylated	AKT	in	neural	crest	cells	
(A)	Western	blot	analysis	of	pAKT	(Ser437)	using	neural	crest	cells	explants	lysates	
control,	 PDGF-AA	 protein	 (50	 ng	 mL-1	 for	 60	 min)	 or	 injected	 with	 PDGFRα	MO.	
Dissection	 scheme	 adapted	 from	 Nieuwkoop	 et	 al.,	 1994.	 (B)	 Band	 intensity	
normalized	to	total	AKT	control,	bar	graph	shows	mean	and	s.d.,	statistical	analysis	
by	 one-way	 ANOVA	 followed	 by	 Student	 Newman-Keuls	 test,	 from	 three	
independent	experiments;	control	versus	PDGF-A	protein	*P=0.0318;	control	versus	
PDGFRα	Mo	nsP=0.9957.	
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Figure	 3-21	 PI3K	 and	 AKT	 pharmacological	 inhibition	 impairs	 neural	 crest	 cell	
migration	in	vivo	
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(A)	 Scheme	 illustrating	 PDGF-PI3K-AKT	 signalling	 axis.	 Signalling	 is	 activated	 upon	
PDGF	 ligand/PDGF	 receptor	 binding,	 inducing	 receptor	 dimerization	 and	
subsequent	 autophosphorylation.	 PI3K	 gets	 activated,	 leading	 to	 the	
phosphorylation	 of	 phosphoinositol	 (PI)	 residues	 in	 the	 plasma	 membrane,	
converting	PIP2	to	PIP3.	Downstream	effector	kinase	AKT	binds	(with	its	pleckstrin	
homology	(ph)	domain)	to	PIP3	residues	and	gets	activated.	(B)	 In	situ	of	 inhibitor	
treated	embryos	stage	14	 to	stage	24.	DMSO	control,	AG1296	 (20	μM),	LY294002	
(40	μM),	MK-2206	 (100	μM),	UO126	 (100	μM),	scale	bar	100	μm.	 (C)	neural	crest	
cell	 migration	 normalised	 to	 control	 average	 of	 each	 experiment.	 DMSO	 control	
n=256,	 AG1296	 n=101,	 LY294002	 n=40,	 MK-2206	 n=106,	 UO126	 n=68	 embryos,	
from	 three	 independent	 experiments.	 Scale	 bar	 1	mm.	 Bar	 graph	 indicates	mean	
and	 sem.,	 statistical	 analysis	 by	one-way	ANOVA	 followed	by	Dunnett’s	 post-test;	
DMSO	 control	 versus	 AG1296	 ***P<0.0001;	 DMSO	 control	 versus	 LY294002	
***P<0.0001;	DMSO	control	versus	MK-2206	**P=0023;	DMSO	control	versus	UO126	
nsP=0.999.	
	 143	
	
	
	
Figure	3-22	neural	crest	cell	dispersion	and	small	molecule	inhibition	of	PI3K/AKT	
signalling	
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(A-H)	Delaunay	triangulation	examples	of	small	molecule	inhibitor	treated	explants	
and	their	effect	on	PDGF-AA	(50	ng	mL-1	)	induced	dispersion,	t=720	min.	(I)	Average	
triangulation	area	normalized	to	control	of	each	experiment,	control	n=92,	control	
and	PDGF-AA	protein	n=55,	LY294002	5	μM	n=21,	MK-2206	5	μM	n=16,	UO126	25	
μM	n=14,	LY294002	5	μM	and	PDGF-AA	n=25,	MK-2206	5	μM	and	PDGF-AA	protein	
n=35,	UO126	25	μM	and	PDGF-AA	n=19	explants,	PDGF-AA	concentration	used	for	
all	conditions	50	ng	mL-1.	Bar	graphs	 indicate	mean	and	s.d.,	statistical	analysis	by	
one-way	ANOVA	 followed	by	Dunnett’s	 post-test;	DMSO	 control	 versus	 LY294002	
***P<0.0001;	 DMSO	 control	 versus	 MK-2206	 ***P=0.0002;	 DMSO	 control	 versus	
UO126	 ***P=0.0001;	 DMSO	 control	 versus	 LY294002	 and	 PDGF-AA	 protein	
**P=0.0015;	 DMSO	 control	 versus	 MK-2206	 and	 PDGF-AA	 protein	 ***P<0.0001;	
DMSO	control	versus	UO126	and	PDGF-AA	protein	nsP<0.9999.		
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Figure	3-23	pharmacological	 inhibition	leads	to	reduction	of	phosphorylated	AKT	
by	western	blot	
(A-C)	Western	blot	against	pAKT	using	lysates	of	whole	embryos	treated	with	small	
molecule	inhibitors	stage	14	to	stage	24.	(A)	AG1296	(20	μM),	(B)	LY294002	(40	μM)	
and	 (C)	 MK-2206	 (100	 μM)	 showed	 decrease	 of	 AKT	 activation	 upon	 inhibitor	
treatment.	(D-E)	Band	intensity	of	pAKT	normalized	to	total	AKT	control,	bar	graph	
indicates	mean	 and	 s.d.	 of	 three	 independent	 experiments,	 statistical	 analysis	 by	
one-way	 ANOVA	 followed	 by	 Student	 Newman-Keuls	 test;	 DMSO	 control	 versus	
AG1296	 ***P<0.0001;	 DMSO	 control	 versus	 LY294002***P<0.0001;	 DMSO	 control	
versus	MK-2206	***P<0.0001.	AU=	arbitrary	units.	
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3.3.2 N-cadherin	dependent	CIL	is	regulated	via	PI3K/AKT	signalling	downstream	
of	PDGF-A/PDGFRα	signalling	
It	 is	 well	 established	 that	 a	 cell	 cluster	 undergoing	 CIL	will	 disperse	 (Davis	 et	 al.,	
2015;	 Scarpa	 et	 al.,	 2015;	 Stramer	 and	Mayor,	 2016;	 Villar-Cerviño	 et	 al.,	 2013),	
conversely	 the	 depletion	 of	 CIL	 behaviour	 causes	 an	 inhibition	 of	 dispersion,	 as	
observed	in	PDGF-A/	PDGFRα	MO	explants	(Figure	3-9,	Movie	4).	To	assess	whether	
this	observed	inhibition	of	dispersion	is	due	to	a	lack	of	N-cadherin,	I	co-injected	N-
cadherin	mRNA	together	with	 the	PDGFRα	MO.	Strikingly,	 co-injection	of	PDGFRα	
MO/N-cadherin	mRNA	rescued	the	dispersion	inhibition	phenotype	of	PDGFRα	Mo	
explants	 (Figure	3-24	A-E,	Movie	4).	 This	 suggests	 that	 PDGF-A/PDGFRα	 signalling	
controls	N-cadherin	dependent	CIL	in	neural	crest	cells.		
Finally,	 I	 investigated	 whether	 the	 N-cadherin	 regulation,	 that	 I	 have	 shown	 is	
controlled	 by	 PDGF-A/PDGFRα	 (Figure	 3-12	 and	 Figure	 3-13),	 is	 also	 PI3K/AKT	
dependent.	For	this	embryos	were	treated	with	either	a	PDGF	receptor	inhibitor	or	
a	PI3K	inhibitor	from	stage	14	to	stage	24	and	N-cadherin	levels	were	analysed	by	
western	 blot.	 Similar	 to	 the	 inhibition	 with	 the	 PDGFRa	 MO	 (Figure	 3-12),	
pharmacological	 inhibition	of	the	PDGF	receptor	by	AG1296	led	also	to	a	decrease	
of	N-cadherin	protein	levels.	In	line	with	our	previous	observation,	inhibition	of	PI3K	
kinase	signalling	also	decreased	N-cadherin	protein	levels	(Figure	3-25	A,	B).		
In	conclusion,	 these	 results	 suggest	 that	 the	 tissue-intrinsic	PDGF-A/PDGFRα-PI3K-
AKT	 signalling	pathway	controls	N-cadherin	 levels,	which	are	essential	 for	CIL	and	
hence	collective	neural	crest	cell	migration.	
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Figure	3-24	N-cadherin	mRNA	co-injection	rescues	PDGFRα	dispersion	inhibition		
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(A-D)	N-cadherin	mRNA	and	PDGFRα	MO	dispersion	stills	of	nuclear	RFP	mRNA	at	
t=0	 min	 and	 t=720	 min	 and	 Delaunay	 triangulation	 at	 t=720	 min.	 (E)	 Average	
triangulation	 area	 at	 720	min	 normalized	 to	 control	 average	 of	 each	 experiment,	
control	 n=41,	 PDGFRα	 MO	 n=19,	 N-cadherin-GFP	 mRNA	 n=23,	 N-cadherin-GFP	
mRNA	and	PDGFRα	MO	n=23	explants,	scale	bar	100	µm.	Box	and	whisker:	box	and	
median	are	±	25th/75thpercentile,	whiskers	are	min.	and	max.,	statistical	analysis	by	
one-way	 ANOVA	 followed	 by	 Dunnett’s	 post-test;	 control	 versus	 PDGFRa	 MO	
**P=0.0041;	 control	 versus	 N-cadherin	 mRNA	 nsP=0.1603;	 control	 versus	 PDGFRa	
MO	nsP=0.4041.	AU=	arbitrary	units.		
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Figure	3-25	PI3K	inhibition	decreases	N-cadherin	protein	level	
(A,B)	Western	blot	for	N-cadherin	using	lysates	of	whole	embryos	treated	with	small	
molecule	 inhibitors	 AG1296	 (20	 μM)	 LY294002	 (40	 μM)	 showed	 decrease	 of	 N-
cadherin	 level	upon	PDGFR	(AG1296)	and	PI3K	(LY294002)	 inhibitor	treatment.	(B)	
Band	 intensity	 of	 N-cadherin	 normalized	 to	 loading	 control,	 bar	 graph	 indicate	
mean	and	s.d.	of	at	least	three	independent	experiments,	statistical	analysis	by	one-
way	ANOVA	followed	by	Student	Newman-Keuls	test;	control	DMSO	versus	AG1296	
**P=0.0093;	control	versus	LY294002	*P=0.002	;	AU=	arbitrary	units.	
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Chapter	4 Discussion	
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4.1 Model	overview	
In	this	thesis	I	investigate	the	role	of	PDGF	signalling	during	collective	cranial	neural	
crest	 migration	 in	 Xenopus	 lavis.	 I	 show	 that	 PDGFRα	 and	 its	 ligand	 PDGF-A	 are	
expressed	 in	 pre-migratory	 and	 migrating	 cranial	 neural	 crest	 cells.	 Inhibition	 of	
either	PDGF-A	or	PDGFRα	 impairs	neural	 crest	migration	 in	vivo	 and	dispersion	of	
neural	crest	clusters	in	vitro.	I	find	that	this	deficiency	in	migration	and	dispersion	is	
caused	 by	 the	 impairment	 of	 N-cadherin	 dependent	 CIL.	 CIL	 is	 a	 fundamental	
property	 of	 collective	 neural	 crest	 cell	 migration	 which	 has	 been	 shown	 to	 be	
acquired	 in	neural	crest	cells	during	EMT	by	a	switch	to	N-cadherin	 (Scarpa	et	al.,	
2015).	Moreover	 I	 find	PI3K/AKT	as	a	downstream	effector	of	the	PDGFRα	cellular	
response.		
This	 body	 of	work	 supports	 the	 following	 novel	model	 for	 PDGF	 signalling	 during	
cranial	 neural	 crest	 migration	 in	 Xenopus	 laevis.	 PDGFRα	 and	 its	 corresponding	
ligand	 are	 expressed	 on	 neural	 crest	 cells.	 This	 leads	 to	 the	 autocrine	 or	 at	 least	
tissue-autonomous	 regulation	 of	 CIL	 during	 neural	 crest	 EMT	 by	 PDGF	 signalling.	
This	CIL	response	is	controlled	by	PDGF	signalling	via	regulation	of	N-cadherin	levels	
in	a	PI3K/AKT	signalling	pathway	dependent	way.	This	proposed	model	shows	PDGF	
signalling	 as	 a	 essential	 effector	 for	 the	 acquirement	 of	 CIL	 capability	 during	
Xenopus	laevis	neural	crest	EMT.		
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Figure	4-1	Model	Overview	
Schematic	 representation	of	 PDGF	 signalling	model	 in	Xenopus	 laevis	neural	 crest	
cell	migration.	Red	indicates	polarity	change	from	a	more	epithelial	static	polarity	to	
a	front-rear	polarity	during	EMT.	Square	shows	zoom	in.	
	
	
4.2 PDGF-A/PDGFRα	signalling	is	required	for	neural	crest	migration	in	Xenopus	
laevis	
Many	different	 signalling	pathways	have	been	 reported	 to	be	 required	 for	 neural	
crest	migration.	Here,	 I	 give	 the	 first	 report	 of	 the	 role	 PDGF	 during	 neural	 crest	
migration	 in	Xenopus	 laevis.	 I	 show,	 that	 the	PDGF-A	 ligand	and	PDGFRα	receptor	
are	both	expressed	in	pre-migratory	and	migrating	neural	crest.	Consistent	with	my	
data,	 expression	 of	 PDGFRα	 has	 been	 reported	 to	 be	 neural	 crest	 cell	 specific	 in	
mouse,	 zebrafish	 and	Xenopus,	 previously	 (Ho	 et	 al.,	 1994;	 Liu	 et	 al.,	 2002b;	Orr-
Urtreger	 and	 Lonai,	 1992).	 However,	 different	 to	 our	 finding	 that	 PDGF-A	 is	
expressed	 in	 Xenopus	 cranial	 neural	 crest	 cells,	 the	 expression	 PDGF-A	 in	 other	
animal	models	has	so	far	been	attributed	only	to	the	neural	crest	cell	surrounding	
tissues	 in	 later	 cranial	neural	 crest	 cell	migratory	 stages	and	 in	 trunk	neural	 crest	
cells	(Ho	et	al.,	1994;	Liu	et	al.,	2002a;	Orr-Urtreger	and	Lonai,	1992).	In	support,	of	
PDGF-A	being	produced	by	the	neural	crest	cells,	I	show	that	depletion	of	PDGF-A	in	
the	neural	crest	by	a	Morpholino	inhibited	neural	crest	cell	dispersion	in	vitro,	in	a	
condition	 where	 the	 only	 possible	 source	 of	 PDGF	 are	 the	 neural	 crest	 cells	
themselves.		
So	far,	analysis	of	PDGF-A	expression	in	Xenopus	has	only	been	performed	using	low	
resolution	 radioactive	 in	 situ	 hybridization	 that	 can	 be	 easily	 confused	 with	
background	signal	(Ho	et	al.,	1994).	Here	I	employed	higher	resolution	colorimetric	
in	situ.	Further	I	confirmed	my	results,	concerning	the	co-expression	of	PDGFRα	and	
PDGF-A	by	RT-PCR,	a	much	more	sensitive	technique	than	in	situ	hybridization.	My	
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data	 suggest	 revisiting	 the	 studies	 of	 PDGF-A	 expression	 during	 early	 cephalic	
neural	 crest	 cell	migration	 in	 other	model	 organisms.	However,	 it	 is	 also	 possible	
that	the	PDGF-A/PDGFRα	has	a	divergent	role	in	cranial	neural	crest	cell	migration	
to	other	model	organism	than	Xenopus	laevis.	Nevertheless,	I	show	a	novel	way	of	
tissue-autonomous	 PDGF-A/PDGFRα	 signalling	 during	 neural	 crest	 cell	 migration.	
Future	 experiments	 have	 to	 clarify	 whether	 the	 ligand	 works	 in	 an	 autocrine	 or	
paracrine	manner	on	neural	crest	cells.	However	the	expression	in	neural	crest	cells	
itself	and	the	nature	of	the	long-from	PDGF-A	isoform,	with	its	ECM	binding	motif,	
suggests	at	least	in	part	autocrine	fashion	of	signalling	activation.	So	far	this	is	the	
first	report	of	a	autocrine	or	tissue-autonomous	role	of	PDGF	signalling,	apart	from	
malignant	 cancers	 (Heldin,	 2012).	 Interestingly,	 autocrine	 PDGF/PDGFR	 loop	 has	
been	 implicated	 in	 EMT	 maintenance	 and	 the	 metastatic	 potential	 of	 mammary	
cancer	 cells	 (Jechlinger	 et	 al.,	 2006b).	 This	 autocrine	 PDGF/PDGFR	 loop	 is	
established	as	a	consequence	of	TGF-β–induced	metastasis	which	is	well	known	to	
induce	EMT	in	epithelial	cells	and	invasiveness	of	metastasizing	cancers	(Jechlinger	
et	 al.,	 2006b;	 Thiery	 and	 Sleeman,	 2006).	 Neural	 crest	 cell	 EMT	 and	 cancer	
metastasis	 have	 been	 reported	 to	 use	 similar	 signalling	 pathways	 and	 molecular	
machinery	 to	 reach	 their	 migratory	 capacity	 (Theveneau	 and	 Mayor,	 2012).	
Consequently	TGF-β	signalling	might	be	one	of	the	responsible	triggers	to	start	the	
PDGF/PDGFR	 autocrine	 loop.	 However	 it	 is	 more	 likely	 that	 a	 set	 of	 different	
signalling	 pathways,	 for	 example	 WNT	 and	 BMP,	 are	 needed	 to	 start	 the	
PDGF/PDGFR	autocrine	or	tissue-autonomous	loop	in	neural	crest	cells.		
Various	 interactions	 between	 different	 ligands	 (PDGF-AA,	 PDGF-AB,	 PDGF-BB,	
PDGF-CC,	 PDGF-DD)	 and	 receptors	 (PDGFRα/Rα,	 PDGFRβ/Rβ,	 PDGFRα/Rβ)	 have	
been	described	 in	 vitro,	 but	 only	 the	 depletion	 PDGF-A	 and	 PDGF-C,	 upstream	of	
PDGFRα	 signalling,	 have	 been	 shown	 to	 be	 functionally	 important	 during	 mouse	
embryonic	development	 (Boström	et	al.,	1996;	Ding	et	al.,	2004;	Soriano,	1997).	 I	
cannot	 rule	out	a	potential	 role	of	PDGF-C	 in	Xenopus	neural	 crest	cell	migration,	
nonetheless	 a	 PDGF-C	 ligand	 has	 so	 far	 not	 been	 described	 for	 Xenopus	 laevis	
development.	 Likewise	 PDGFRβ	 expression	 has	 yet	 to	 be	 determined	 during	
Xenopus	 laevis	development.	PDGFRα	and	PDGFRβ	can	form	a	heterodimer	which	
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has	been	shown	to	be	functionally	active	during	neural	crest	cell	migration	in	mouse	
embryos	(Klinghoffer	et	al.,	2002;	Richarte	et	al.,	2007).	Future	investigations	have	
to	 look	 at	 the	 potential	 role	 of	 PDGFRβ	 and	 the	 PDGFRα/PDGFRβ	 heterodimer	
during	neural	 crest	 cell	migration	 in	Xenopus	CIL.	 Especially	 the	expression	of	 the	
PDGFRα/PDGFRβ	heterodimer,	 its	 ligand	binding	capacity	 in	vivo	 and	whether	 the	
downstream	 signalling	 diverges	 in	 general	 or	 in	 a	 spatial	 or	 temporal	 way,	 from	
PDGFRα/PDGFRα	homodimer	would	be	an	interesting	field	of	study	for	the	future.		
Not	 only	 the	 receptor	 has	 been	 shown	 to	 form	 heterodimers,	 also	 the	
heterodimeric	 ligand	 PDGF-AB	 has	 been	 reported	 to	 activate	 both	 PDGFRα	 and	
PDGFRb	receptor	dimers	in	vitro	(Heldin	et	al.,	1979).	Furthermore,	future	research	
has	 to	 investigate	 the	 potential	 role	 of	 heterodimeric	 PDGF	 ligands	 during	 neural	
crest	migration	in	different	model	organisms	in	vivo.	However	the	PDGF-B	ligand	is	
not	expressed	in	neural	crest	tissue	in	Xenopus	 laevis,	but	only	 in	some	regions	of	
the	neighbouring	neural	plate	(Giannetti	et	al.,	2016).	So	the	PDGF-AB	heterodimer	
might	 not	 have	 a	 role	 in	 Xenopus	 neural	 crest	 migration	 in	 vivo,	 but	 in	 the	
developing	central	nervous	system.	
In	line	with	my	data,	mouse	and	zebrafish	PDGFRα	knock-down	studies	have	shown	
defects	in	cranial	and	cardiac	neural	crest	cell	derived	tissues	(Eberhart	et	al.,	2008;	
Soriano,	1997;	Tallquist	et	al.,	2003).	In	this	study	I	focused	on	the	onset	of	neural	
crest	cell	migration,	however	it	would	be	very	informative	to	investigate	the	effect	
of	 PDGF-A	 and	 PDGFRα	 depletion	 on	 cranial	 neural	 crest	 cell	 derived	 tissues	 in	
Xenopus.	 In	mouse,	extensive	studies	have	shown	that	conditional	knock	down	of	
PDGFRα	signalling	using	the	Wnt1-Cre	driver	 line	 (Tallquist	et	al.,	2003)	 leads	to	a	
subset	of	the	phenotypes	observed	in	the	PDGFRα	mutant	embryo	(Grüneberg	and	
Truslove,	 1960;	 Robbins	 et	 al.,	 1999;	 Schatteman	 et	 al.,	 1992),	 including	 facial	
clefting,	 haemorrhaging	 in	 the	 midline,	 defects	 in	 the	 heart	 outflow	 tract	 and	
thymus	 malformations	 (Tallquist	 et	 al.,	 2003).	 The	 fact	 that	 only	 a	 subset	 of	
phenotypes	was	observed	could	have	been	caused	by	the	Wnt1-Cre	line	which	has	
been	recently	found	to	have	ectopic	activation	of	Wnt	signalling	(Lewis	et	al.,	2013).	
Also	the	Wnt1	driver	might	not	be	perfect	choice	for	a	conditional	knock	down	of	
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PDGFRα,	as	the	expression	of	Wnt1	 is	not	 limited	to	the	neural	crest	territories	 in	
the	embryo	and	the	onset	of	expression	might	be	to	late	to	affect	early	neural	crest	
cell	developmental	defects	(Barriga	et	al.,	2015;	McMahon	et	al.,	1992).		
I	 showed	 that	 loss-of-function	 of	 both	 PDGF-A	 and	 the	 receptor	 PDGFRα	 inhibits	
neural	crest	cell	migration	in	vivo	using	Morpholinos	against	PDGF-A	and	PDGFRα,	a	
dominant	 negative	 form	of	 the	 PDGFRα	 and	pharmacological	 inhibition	 of	 PDGFR	
phosphorylation,	AG1296.	During	neural	crest	specification	PDGFRα	expression	has	
been	 reported	 to	 be	 a	 downstream	 target	 of	 early	 neural	 crest	 cell	 progenitor	
transcription	factors	Pax3	and	Zic1	(Bae	et	al.,	2013).	Neural	crest	cell	specification	
was	 not	 affected	 using	 the	 Morpholinos	 and	 the	 dominant	 negative	 form	 of	
PDGFRα,	 excluding	 that	 the	 inhibition	 of	 neural	 crest	 cell	 migration	 is	 due	 to	 a	
defect	in	neural	crest	cell	specification.	The	use	of	antisense	Morpholinos	has	been	
recently	highly	debated	due	to	its	possibility	off-target	effects	and	the	availability	of	
the	CRISPR/Cas9	 system	 (Kok	 et	 al.,	 2015;	 Schulte-Merker	 and	 Stainier,	 2014).	 To	
verify	the	use	of	Morpholinos	 in	this	study	 I	performed	rescue	experiments.	Thus,	
proving	the	specificity	of	both	Morpholinos.	Nevertheless,	the	CRISPR/CAS9	system	
has	not	been	well	established	in	Xenopus	laevis	yet,	and	its	possible	superiority	to	
the	Morpholino	system	needs	to	be	carefully	validated.	
Analysis	 of	 PDGFRα	 signalling	 in	 zebrafish	 and	mouse	 did	 show	 a	wide	 variety	 of	
malformations	 in	 cranial	 and	 cardiac	 neural	 crest	 cell	 derivatives	 (Eberhart	 et	 al.,	
2008;	Soriano,	1997;	Tallquist	et	al.,	2003).	However,	other	studies	suggested	that	
only	 this	 subset	 of	 cranial	 and	 cardiac	 neural	 crest	 tissues	 is	 affected	 by	 PDGFRα	
depletion	 and	 that	 neural	 or	 pigment	 derivatives	 develop	 normally	 (Morrison-
Graham	et	al.,	1992;	Schatteman	et	al.,	1992;	Wehrle-Haller	et	al.,	1996).	This	might	
indicate	 that	 PDGFRα	 is	 only	 expressed	 or	 functions	 in	 a	 subset	 of	mouse	 neural	
crest	cells.	The	same	might	be	true	for	Xenopus	laevis	neural	crest	cells	and	future	
studies	 have	 to	 examine	 the	 cranial	 neural	 crest	 cell	 derivatives	 affected	 by	 a	
depletion	of	PDGFRα	signalling.	Here,	especially	the	use	of	an	inducible	knock-down	
system,	as	for	example	photo-convertible	Morpholinos,	would	allow	to	distinguish	
between	early	developmental	and	neural	crest	migratory	roles,	as	well	as	it	would	
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ensure	that	the	affected	cranial	neural	crest	derivatives	are	due	to	a	migratory	role	
of	PDGF	signalling	and	not	an	early	adverse	effect	of	development.		
Further	to	the	in	vivo	migration	studies,	I	show	that	the	cellular	behaviour,	at	least	
in	vitro,	is	controlled	by	the	PDGFRα	induced	neural	crest	cell	dispersion.	Additional	
PDGFRα	depletion	showed	that	the	signalling	has	no	effect	on	single	cell	motility	or	
chemotaxis	 towards	 SDF-1.	 Consistent	with	my	 observations,	 PDGFRα	 conditional	
knockdown	 using	 the	Wnt1-Cre	 line	 in	mice,	 have	 shown	 defects	 in	 neural	 crest	
explant	outgrowth	 in	 vitro	 (He	and	Soriano,	2013).	However,	 the	 same	study	also	
showed	 that	 PDGFRα	 controls	 chemotaxis	 towards	 PDGF-A	 of	 neural	 crest	
derivatives	 in	vitro	 (He	and	Soriano,	2013).	Further	exogenous	PDGF-A	source	has	
been	 shown	 to	 attract	 mouse	 cranial	 neural	 crest	 cells	 in	 vivo	 (Kawakami	 et	 al.,	
2011).	Although,	it	has	not	yet	been	fully	established	if	PDGFRα	signalling	can	act	as	
a	chemotactic	signal	during	mouse	neural	crest	cell	migration.		
One	 of	 the	 criteria,	 which	 need	 to	 be	 fulfilled	 to	 categorise	 a	 chemical	 signal	 as	
chemotaxing	 agent,	 is	 that	 the	 target	 tissue	 needs	 to	 express	 and	 secrete	 the	
chemotaxing	signal	and	the	responding	cell	has	to	express	an	appropriate	receptor.	
Consequently,	 with	 its	 tissue-autonomous	 expression	 PDGF-A/PDGFRα	 in	 neural	
crest	 cells,	 it	 is	unlikely	 that	PDGF-A	works	as	a	 chemotaxing	 signal	during	cranial	
neural	 crest	 cell	 migration	 in	 Xenopus.	 However,	 it	 might	 be	 classified	 as	 a	
chemokinetic	signal	or	PDGF-A	signalling	might	have	a	dual	 function	during	neural	
crest	migration.	Future	studies	need	to	look	into	the	possibility	of	PDGF	signalling	as	
a	chemotaxing	signal	during	cranial	neural	crest	cell	migration	in	Xenopus	laevis.		
4.3 PDGF-A/PDGFRα	and	N-cadherin	dependent	Contact	inhibition	of	
locomotion	
Neural	 crest	 cells	are	known	 to	undergo	EMT-like	dispersion	 in	 vitro	 (Kuriyama	et	
al.,	 2014)	 due	 to	 a	 switch	 of	 cell-cell	 adhesion	molecules,	 from	 E-cadherin	 to	 N-
cadherin	 (Scarpa	 et	 al.,	 2015).	 In	 line	with	 this	 data,	 I	 demonstrate	 that	 PDGFRα	
signalling	 controls	 neural	 crest	 cell-cell	 adhesion	 by	 regulating	 N-cadherin	 levels.	
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Importantly,	 we	 were	 able	 to	 partially	 rescue	 the	 inhibition	 of	 dispersion	 by	
overexpression	of	N-cadherin	mRNA.	This	strongly	suggests	that	PDGFRα	signalling	
works	upstream	of	N-cadherin	levels.	N-cadherin	has	been	shown	to	be	required	for	
CIL	 and	 a	 cell	 adhesion	 complex	 formed	 by	 N-cadherin,	 p120,	 a-catenin,	 and	 b-
catenin	 is	 transiently	 assembled	 upon	 cell-cell	 interactions	 in	 cranial	 neural	 crest	
cells	(Kuriyama	et	al.,	2014;	Theveneau	et	al.,	2010).	Inhibition	of	N-cadherin	leads	
to	loss	of	contact	dependent	polarity	(Theveneau	et	al.,	2010).	Thus	neural	crest	cell	
dispersion	 in	 vitro	and	neural	 crest	 cell	migration	 in	vivo	 have	been	 shown	 to	 be	
affected	by	a	loss	of	N-cadherin	(Theveneau	et	al.,	2010).	However	the	mechanism	
of	N-cadherin	dependent	contact	polarity	and	how	PDGFRα	signalling	controls	the	
level	 of	 N-cadherin	 still	 needs	 to	 be	 addressed	 in	 detail.	 For	 the	 latter,	 several	
possibilities	 are	 probable-	 PDGFRa	 could	 control	 N-cadherin	 levels	 directly	 or	
indirectly	 by	 regulation	 of	 its	 transcription,	 translation,	 posttranscriptional	
modification	or	by	modifying	its	turnover.		
More	recently	the	acquisition	of	CIL	behaviour	has	been	linked	to	EMT	and	a	switch	
to	N-cadherin	 in	 Xenopus	 cranial	 neural	 crest	 cell	migration	 (Scarpa	 et	 al.,	 2015).	
Scarpa	et	al.	showed	that	pre-migratory	neural	crest	cells	predominantly	express	E-
cadherin	and	no	N-cadherin	and	that	migrating	neural	crest	cells	that	went	through	
EMT,	express	E-cadherin	and	no	N-cadherin.	By	comparing	these	pre-migratory	and	
migratory	 neural	 crest	 cells,	 they	 showed	 that	 this	 switch	 from	 E-	 to	 N-cadherin	
during	 EMT	 is	 essential	 for	 acquisition	 of	 CIL	 behaviour	 (Scarpa	 et	 al.,	 2015).	 In	
context	with	 these	 findings,	 I	demonstrate	 that	PDGFRα	MO	 injected	neural	 crest	
cells	 were	 not	 able	 to	 undergo	 efficient	 CIL,	 in	 single	 cell	 collision	 and	 explant	
invasion	assays,	supporting	the	hypothesis	that	PDGFRα	is	regulating	CIL.		
However	 the	 mechanism	 how	 PDGFRα	 signalling	 is	 regulating	 the	 N-cadherin	
dependent	 CIL	 remains	 to	 be	 investigated.	 One	 possibility	 could	 be	 via	 RAC1	
pathway.	N-cadherin	expression	in	Xenopus	neural	crest	cells	promotes	polarisation	
of	RAC1	activity	towards	the	leading	edge	during	CIL	and	N-cadherin	depleted	cells	
display	a	reduction	in	protrusion	size	(Theveneau	et	al.,	2010).	As	expected,	due	to	
their	 reduction	 in	 N-cadherin,	 PDGFRα	 MO	 injected	 neural	 crest	 cell	 explants	
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displayed	a	decrease	in	protrusion	area,	indicating	a	loss	in	polarity.	Thus,	PDGFRα	
signalling	could	be	an	important	polarisation	cue	during	neural	crest	cell	migration.	
A	recent	study	found	that	N-cadherin	promotes	activation	of	PDGF	dependent	PI3K	
and	Rac	localization	at	the	free	edge.	This	is	thought	to	work	via	integrin	inhibition	
at	 the	 side	of	 cell-cell	 contact	by	N-cadherin	bound	p120,	while	 integrin-PI3K-Rac	
activation	 is	supported	at	the	free	edge	(Ouyang	et	al.,	2013).	This	result	 is	 in	 line	
with	 my	 observation,	 that	 loss	 of	 PDGF-A/PDGFRα	 signalling	 leads	 to	 a	
downregulation	 of	 N-cadherin	 in	 a	 PI3K	 dependent	 manner,	 and	 this	 eventually	
leads	to	a	loss	of	cell	polarity.	The	GTPase	Rac	and	its	regulation	of	cellular	polarity	
has	been	shown	to	be	essential	for	neural	crest	cell	collective	migration	(Moore	et	
al.,	 2013;	 Scarpa	 et	 al.,	 2015;	 Theveneau	 et	 al.,	 2010).	 Thus	 Rac	 might	 be	
downstream	 of	 the	 PDGFRα-PI3K-N-cadherin	 response.	 Future	 studies	 might	 in	
more	 detail	 look	 into	 the	 connection	 between	 Rac1	 and	 PDGFRα	 signalling.	
Consistent	with	the	presented	data,	PDGF	signalling	has	been	shown	to	control	N-
cadherin	 expression	 in	 the	migration	 of	mesoderm	 cells	 during	 chick	 gastrulation	
(Yang	 et	 al.,	 2008).	 However	 CIL	 has	 not	 been	 investigated	 in	 this	 study.	 Taken	
together	 my	 observations	 suggest	 that	 PDGFRα	 signalling	 controls	 EMT	 in	 a	 CIL	
dependent	manner	by	regulation	of	N-cadherin	levels.	
As	stated	before,	mouse	studies	reported	that	conditional	PDGFRα	KO	in	the	neural	
crest,	 using	 Wnt1-Cre1	 driver,	 showed	 palatogenesis	 defects,	 linked	 to	 delayed	
migration	 of	 neural	 crest	 in	 the	 frontal-nasal	 prominence	 (He	 and	 Soriano,	 2013;	
Tallquist	et	al.,	2003).	This	delayed	migration	in	mouse	could	be	consistent	with	the	
observed	 phenotype	 of	 CIL	 reduction	 in	 PDGFRα	 depleted	 neural	 crest	 cells.	
Isolation	 of	 PDGFRα	 KO	 mouse	 neural	 crest	 cells	 and	 in	 vitro	 analysis	 of	 their	
migratory	behaviour	could	help	to	elucidate	if	the	same	CIL	behaviour	as	in	Xenopus	
laevis	can	be	observed.	
Interestingly,	neural	crest	cell	EMT	and	migration	do	have	very	similar	characteristic	
with	 malignant	 cancer	 invasion	 (Theveneau	 and	 Mayor,	 2012).	 In	 line	 with	 this,	
PDGF	 signalling	 has	 been	 implicated	 in	 EMT	during	 cancer	 invasion	 (Eckert	 et	 al.,	
2011;	 Jechlinger	et	al.,	2006a;	Thiery	and	Sleeman,	2006).	Hyper-activation	of	 the	
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PDGF	signalling	pathway	have	been	shown	to	increase	invasive	properties	of	cancer	
cells	and	kinase	inhibitors	have	been	approved	for	clinical	use	(Heldin,	2012;	Wu	et	
al.,	 2013).	 For	 example,	 PDGFRα	 and	 PDGFRb	 expression	 has	 been	 shown	 to	 be	
specifically	 upregulated	 in	human	 late	 stage	mammary	 tumours	 (Jechlinger	 et	 al.,	
2006a).	 And	 autocrine	 PDGF/PDGFR	 signalling	 has	 been	 linked	 to	 increased	 EMT	
and	invasive	potential	of	mouse	oncogenic	mammary	cells	(Jechlinger	et	al.,	2006a).		
Interestingly,	 Abercrombie	 already	 hypothesised	 in	 1962,	 that	 homotypic	 CIL	
response	 between	 cancer	 cells	 would	 increase	 invasive	 behaviour.	 So	 far	 this	
interaction	has	not	been	 studied	 in	detail.	However	 it	 is	 intriguing	 to	hypothesise	
that	an	increase	in	CIL	response,	maybe	through	the	activation	of	a	PDGF-A/PDGFRα	
autocrine	 loop,	 could	 play	 a	 role	 during	 metastatic	 cancer	 invasion.	 Thus	 the	
presented	 data	 might	 be	 useful	 to	 develop	 future	 studies	 into	 PDGF	 signalling	
related	malignancies.		
4.4 PDGF-A/PDGFRα	and	PI3K/AKT	signalling	
Using	 a	 biosensor	 and	 pharmacological	 inhibition,	 I	 was	 able	 to	 link	 the	 PDGFRα	
signalling	 to	 the	 PI3K/AKT	 downstream	 pathway.	 PI3K	 signalling	 downstream	 of	
PDGFRα	appears	to	be	a	conserved	mechanism	in	development.	In	mouse	depletion	
of	 the	 PI3K	 binding	 domain	 in	 PDGFRα	 has	 been	 shown	 to	mimic	 phenotypes	 in	
craniofacial	 development	 of	 the	 complete	 knock-down	 (Klinghoffer	 et	 al.,	 2002).	
Also	 the	 increase	 of	 PI3K	 signalling	 in	 zebrafish	 is	 able	 to	 rescues	 craniofacial	
development	 in	a	PDGFRα	knock	down	background	(McCarthy	et	al.,	2016).	Albeit	
these	studies	 focus	on	the	 late,	 frontonasal	migration	of	cranial	neural	crest	cells,	
the	 PI3K/AKT	 signalling	 appears	 to	 be	 conserved	 for	 neural	 crest	 development.	
Nonetheless,	 it	 is	 noteworthy	 that	 crosstalk	 between	 the	 PI3K/AKT	 and	 FGF	
signalling	pathway	have	been	reported	to	converge	on	ERK	signalling	in	neural	crest	
cell	derivatives	(Vasudevan	et	al.,	2015).	However,	 I	did	not	observe	any	effect	on	
neural	 crest	 migration	 in	 vivo	 by	 pharmacological	 inhibition	 of	 the	 ERK/MAPK	
signalling	 pathway	 in	 Xenopus	 embryos.	 Additional	 to	 the	 PI3K/ATK	 signalling	
pathway,	I	cannot	exclude	that	the	PDGFRα	signalling	response	might	work	through	
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another	 downstream	 signalling	 effector	 such	 as	 JNK,	 PKC	 and	 Rac	 signalling	
pathways.	
Spatial	PI3K	activation	in	the	leading	edge	of	chemotaxing	cells	has	been	shown	to	
be	a	crucial	intracellular	guidance	cue	in	cell	culture	assays	and	Dictyostelium	(Cain	
and	Ridley,	2009;	Merlot	and	Firtel,	2003;	Yamaguchi	et	al.,	2015).	Contrary	to	this,	I	
did	 not	 detect	 high	 levels	 of	 ph-AKT-GFP	 localisation	 without	 PDGF-A	 protein	
addition	at	the	free	edge.	This	is	most	likely	due	to	low	levels	of	PDGF-A	protein	and	
a	 more	 sensitive	 sensor	 might	 reveal	 intracellular	 spatial	 differences	 in	 PI3K	
localisation.	
I	was	able	to	control	the	CIL	dependent	dispersion	process	 in	neural	crest	cells	by	
modulating	 PDGF-A/PDGFRα	 signalling.	 Depletion	 of	 PDGF-A/PDGFRα	 signalling	
inhibited	 dispersion.	 Most	 importantly	 the	 inhibition	 of	 dispersion	 by	 PDGFRα	
depletion	could	be	rescued	by	co-injection	with	N-cadherin.	This	proves	N-cadherin	
as	 a	 downstream	 target	 of	 the	 PDGFRα	 cellular	 response.	 Further	 analysis	 by	
immunoblotting	 showed	 that	 pharmacological	 inhibition	 of	 the	 PDGFR/PI3K/AKT	
axis	indeed	leads	to	a	downregulation	of	N-cadherin.	This	demonstrates	N-Cadherin	
as	 a	 regulator	 of	 CIL	 controlled	 by	 PI3K/AKT	 signalling.	 A	 remaining	 question	 for	
further	studies	will	be	the	link	between	AKT	and	N-cadherin	regulation.	However,	in	
a	recent	study	the	protein	p53,	which	is	know	for	its	tumorigenic	role,	was	reported	
as	 a	 downstream	 effector	 of	 AKT	 activation	 through	 PDGFRα	 signalling	 in	
craniofacial	 neural	 crest	 development	 in	 mouse	 (Fantauzzo	 and	 Soriano,	 2014).	
Interestingly	p53	has	 also	has	been	 linked	 to	EMT	and	 the	 regulation	of	 cadherin	
expressions	(Chang	et	al.,	2011).		
4.5 PDGF-A/PDGFRα	signalling	in	the	context	of	other	modes	of	NC	migration	
Here	I	show	that	the	regulation	of	N-cadherin	during	neural	crest	migration	is	PDGF-
A/PDGFRα	dependent	and	that	loss	of	N-cadherin	by	depletion	of	PDGFRα	signalling	
leads	to	an	inhibition	of	neural	crest	migration.	My	data	suggests	that	inhibition	of	
neural	 crest	 migration	 by	 PDGFRα	 depletion	 is	 due	 to	 a	 N-cadherin	 dependent	
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impairment	of	CIL.	As	described	 in	 chapter	1.1.3	Neural	 crest	migration	 collective	
migration	 of	 the	 neural	 crest	 cell	 stream	 is	 controlled	 by	 several	 different	
mechanisms,	 namely	 restriction	 into	different	 streams,	 cell-substrate	 interactions,	
chemotaxis,	CoA	and	CIL.	But	how	does	PDGF	signalling	fit	with	the	other	modes	of	
neural	 crest	 cell	 migration?	 In	 this	 chapter	 I	 will	 discuss	 PDGF	 signalling	 in	 the	
context	 of	 other	modes	 of	 NC	migration	 and	 its	 possible	 implications	 into	 future	
research.	
Permissive	spaces	have	been	thought	to	support	the	splitting	of	the	neural	crest	cell	
population	into	their	defined	streams.	In	Xenopus	laevis,	especially	fibronectin	has	
been	 shown	 to	 have	 a	 permissive	 role	 during	 neural	 crest	 migration	 (Perris	 and	
Perissinotto,	 2000).	 Interestingly,	 PDGF-AA	 binds	 directly	 to	 fibronectin	 and	
heparan	 sulphate	proteoglycans	 (HSPGs)	 and	which	 are	 required	PDGF-AA-guided	
mesendoderm	movement	 in	Xenopus	embryos	 (Smith	et	al.,	2009).	Thus	PDGF-AA	
together	 with	 fibronectin	 could	 play	 a	 dual	 role-	 in	 which	 fibronectin	 is	 the	
permissive	 agent	 allowing	 neural	 crest	 cell	 migration	 and	 PDGF-AA	 bound	 to	
fibronectin	 exercises	 CIL	 in	 order	 to	 polarise	 and	 channel	 the	 stream	 towards	 its	
target,	preventing	the	cells	to	invade	the	neighbouring	tissue.	Thus	PDGF-AA	would	
work	 as	 one	 of	 the	 reported	 non-permissive	 ligands	 (Eph	 and	 semaphorin)	
expressed	in	the	neural	crest	surrounding	tissue,	which	restrict	ectopic	neural	crest	
cell	migration.	
As	discussed	 in	chapter	4.2	PDGF-A/PDGFRα	signalling	 is	 required	 for	neural	 crest	
migration	 in	 Xenopus	 laevis.	 PDGFRα	 has	 been	 reported	 to	 controls	 chemotaxis	
towards	PDGF-A	of	mouse	neural	crest	derivatives	 in	vitro	 (He	and	Soriano,	2013)	
and	 exogenous	 PDGF-A	 source	 has	 been	 shown	 to	 attract	 mouse	 cranial	 neural	
crest	 cells	 in	 vivo	 (Kawakami	 et	 al.,	 2011).	 However,	 it	 has	 not	 yet	 been	 fully	
established	 if	 PDGFRα	 signalling	 can	 act	 as	 a	 chemotactic	 signal	 during	 mouse	
neural	 crest	 cell	 migration.	 In	 the	 case	 of	 Xenopus	 laevis	 PDGF-AA	 has	 not	 been	
reported	 to	 be	 a	 chemotactic	 signal	 during	 neural	 crest	 cell	 migration.	 My	 data	
suggest	that	this	 is	not	the	case	during	onset	of	neural	crest	cell	migration,	as	the	
ligand	 it	self	 is	expressed	by	neural	crest	cells.	This	however	does	not	exclude	the	
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possibility	of	PDGF	signalling	working	as	a	chemotaxing	signal	during	later	stages	of	
neural	 crest	 cell	migration,	which	would	give	PDGF-A	 signalling	a	dual	 role	during	
neural	 crest	migration.	 To	 investigate	 this	 chemotaxis	 assays	 towards	 a	 PDGF-AA	
source	 could	with	 pre-migratory	 (stage	 14)	 and	migratory	 (stage	 19)	 neural	 crest	
cells	could	be	performed.	
Cell	 substrate	 adhesion,	 chemotaxis	 and	 CoA	 modes	 provide	 ways	 that	 support	
neural	 crest	 cell	migration.	However	 they	need	CIL	mode	 to	 convene	appropriate	
polarity	to	the	migrating	neural	crest	cells.	CIL	seems	to	play	a	dual	 role	 in	neural	
crest	 cell	 migration.	 CIL	 between	 neural	 crest	 cells	 is	 thought	 to	 promote	 their	
collective	directional	migration	by	inhibition	of	protrusions	at	the	cell-cell	contact	in	
the	cluster	and	promoting	the	formation	of	protrusions	forming	at	the	free,	leading	
edge	(Mayor	and	Carmona-Fontaine,	2010).	In	Xenopus	neural	crest	cell	protrusive	
activity	so	far	has	been	shown	to	be	repressed	by	inhibition	of	small	GTPase	RAC1	in	
a	 N-cadherin	 and	 WNT-PCP	 signalling	 dependent	 way	 (Carmona-Fontaine	 et	 al.,	
2008b;	 Moore	 et	 al.,	 2013;	 Theveneau	 et	 al.,	 2010).	 Here,	 I	 show	 that	 the	 N-
cadherin	 required	 for	 CIL	 levels	 might	 regulate	 by	 PDGFRα	 signalling.	 Thus	
suggesting	that	PDGF	signalling	directly	regulates	inhibition	of	RAC1	at	the	cell-cell	
contact	thus	leading	to	polarization	of	the	neural	crest	cell	stream.	Additionally	it	is	
likely	that	the	WNT/PCP	and	PDGF	signalling	converge	at	 least	 in	the	regulation	of	
RAC1.	
4.6 Concluding	Remarks	
In	 conclusion,	 the	 results	 presented	 in	 this	 thesis	 show	 that	 PDGFRα	 signalling	 is	
required	 for	 neural	 crest	 cell	 migration.	 Both	 the	 ligand	 and	 the	 receptor	 are	
expressed	by	neural	 crest	 cells,	where	 they	act	 in	an	autocrine	 loop	 to	control	N-
cadherin	dependent	CIL	during	the	early	stages	of	neural	crest	cell	migration.	While	
this	work	has	 resolved	many	questions	 regarding	 the	nature	of	PDGF	signalling	 in	
Xenopus	laevis	neural	crest,	many	questions	continue	to	be	unanswered	such	as	the	
exact	mechanism	N-cadherin	regulation	via	the	PDGF-A/PDGFRα-PI3K-AKT	axis,	how	
N-cadherin	 itself	 is	 regulating	 subcellular	polarisation	and	 thus	polarisation	of	 the	
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collective	neural	 crest	 and	whether	PDGF	 signalling	 is	 involved	 in	other	modes	of	
neural	crest	cell	migration	as	chemotaxis	or	co-attraction	during	later	stages.	PDGF	
signalling	occurs	in	many	different	developmental	and	adult	cellular	processes.	The	
novel	 mechanism	 proposed	 in	 this	 thesis,	 by	 which	 PDGF	 signalling	 controls	 CIL,	
presents	 a	 new	 and	 exiting	 role	 of	 the	 signalling	 pathway,	 not	 only	 due	 to	 the	
nature	of	 the	dual	 expression	of	 the	 ligand	and	 receptor	 in	 the	 target	 tissue,	 but	
also	to	the	PDGF	pathways	and	CILs	role	in	development	and	cancer	metastasis		
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